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Abstract
Iron oxide magnetic nanocomposites can be used for a variety of biomedical
applications, including magnetic resonance imaging (MRI) and as site specific
drug delivery systems. By functionalising the surface of the nanocomposite,
other functions like cell labelling and targeting can also be realised. Sev-
eral iron oxide nanocomposites were prepared through microwave assisted
co-precipitation reactions, using polyelectrolytes and dopamine as surface sta-
bilisers. This provided a highly magnetic and versatile foundation that could
be used immediately in biological applications (such as MR imaging) but could
also be further functionalised extending the applications of the material. Func-
tionalisation was achieved via electrostatic interactions and carbodiimide cou-
pling which led to the development of a multifunctional nanocomposite capable
of supporting both fluorescent and targeting groups.
This work demonstrates that the construction of the nanocomposite is key
to unlocking the biomedical potential of the material. HRTEM and SQUID re-
sults demonstrate the importance of microwave irradiation in the formation of
highly crystalline materials. Microwave heating enhances crystal growth which
improves the magnetisation values of the composite, to beyond materials pre-
pared by traditional co-precipition methods. Polyelectrolytes can bestow ex-
cellent water stability on the particles, with the composite remaining in sus-
pension for over 8 weeks. MRI measurements show that the high magnetism,
combined with excellent water stability, translates into an effective MRI contrast
agent, with the prepared composite out performing other commercial agents.
Further functionalisation with fluorescent groups show other applications in cell
labelling, and the addition of targeting groups can further enhance the selec-
tivity of the composite.
This work results in the development of a highly magnetic, extremely water
stable iron oxide foundation, that can immediately be used as a MRI contrast
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The ’nano’ prefix has become an ubiquitous term in common parlance, with
the latest must-have gadget being Apple’s iPod nano; yet nanotechnology has
been used for centuries. An example of this is the Lycurgus cup, a Roman
glass chalice containing both gold and silver dust which changes colour when
light is shone through it. Unbeknownst to the Romans, they had actually pre-
pared nanoparticles of gold and silver. While bulk gold and silver are shiny
and metallic, these nanoparticles now take on size-dependant optical proper-
ties. Nanoparticles are typically below 100 nanometers in diameter, allowing
researchers to work with particles with size dimensions on the molecular and
cellular levels. One advantage of working at such small scales is that these par-
ticles may have unique properties when compared to their bulk equivalents.1
In bulk materials, the majority of atoms exist within the volume of the mate-
rial. In contrast, most atoms in nanoparticles are exposed at the surface. This
high surface to volume ratio can play a huge role in changing the properties of
nanoparticles.
1.2 Magnetic nanoparticles
The main aim of this work is to prepare a magnetic nanocomposite material,
capable of both cancer diagnosis and treatment. Magnetic nanocomposites for
biomedical applications commonly have a magnetic nanoparticle core, which
can be made of various types magnetic material such as magnetite (Fe3O4),2
maghemite (γ-Fe2O3)3 or cobalt ferrite (CoFe2O4).4 The magnetic core often
needs to be stabilised so that it is biocompatible and does not oxidise or de-
grade. This stability can be achieved in several ways, for example by employ-
ing surfactants.5–7 Once stabilised, other components can be attached to the
nanoparticle to provide further functionality. The scope for magnetic nanopar-
ticles in biomedical applications expands with this surface functionalisation, as
a whole variety of compounds can be attached to the nanocomposite unlock-
1
ing different functionalities.8 Unlocking the potential of biomedical magnetic
nanocomposites can be achieved though careful synthetic design. Each com-
ponent added to the composite will not only bestow new functionality but also
alter existing properties.
1.2.1 The spinel structure
The choice of magnetic core is very important as this governs the overall mag-
netic behaviour. Magnetite (Fe3O4) is a magnetic iron oxide which adopts an
inverse spinel structure, a mineral class with the general formula A2+B23+O42−.
The iron cations in magnetite occupy 16 of the total 32 octahedral (A) sites and
8 of the 64 tetrahedral (B) sites, as shown in Figure 1.9 Fe3O4 contains iron
ions in two oxidation states, Fe2+Fe23+O42−, where the Fe2+ ions occupy half
of the octahedral sites while the Fe3+ ions fill the remaining octahedral sites
and tetrahedral sites.10,11 Different iron oxides can be prepared by substituting
the Fe+2 ions with other similarly charged transition metals such as Co2+ or
Mn2+, with the transition metal used significantly altering the final properties of
the iron oxide.12,13 Maghemite (γ-Fe2O3) is another commonly prepared iron
oxide nanoparticle. It is an oxidised form of magnetite, which is Fe deficient.
The Fe2+ groups are oxidised into Fe3+ groups, and only 2113 Fe
3+ ions are
distributed between the 16 octahedral and 8 tetrahedral sites resulting in the
deficiency.11
1.2.2 Magnetic characteristics of iron oxide nanoparticles
Magnetism arises from the spin property of electrons. The combined spin and
orbital motion of the individual electrons, dictates the overall magnetic moment
of the atom.16 An overall net magnetic moment will occur if there are unpaired
electrons in the valence shell of the atom. The organisation of these unpaired
electrons and their response to an external magnetic field are used to classify
the types of magnetism the material displays. Single unpaired spins leads
to diamagnetism (when spins oppose the applied field) and paramagnetism
(when spins align and are proportional to the applied field), but the spins can
also form ordered magnetic states generating a magnetic moment significantly
2
Figure 1: Magnetite crystal structure drawn using the VESTA program,14 from the work
by Fleet.15 The iron atoms (brown) can be seen occupying some of the octahedral
sites and tetrahedral sites in the crystal, which themselves are defined by the overall
arrangement of oxygen atoms (red). For magnetite specifically, iron atoms occupy 16
of the 32 available octahedral sites and 8 of the 64 available tetrahedral sites. Half of
these octahedral sites will be occupied with Fe2+ ions while the remaining octahedral
sites and tetrahedral sites are occupied by Fe3+ ions resulting in an inverse spinel
structure.15
stronger than the applied field. These ordered states occur from the formation
of magnetic domains.
Individual magnetic moments can align parallel to each other, with large
regions of parallel magnetic moments forming a magnetic domain. Domains
form to reduce the internal energy of the material and contain magnetic spins
that are all aligned in one direction.17 Domains are separated by domain walls
and may be aligned randomly in comparison to neighbouring domains, shown
in Figure 2(b). When an external magnetic field is applied to a multi domain
magnetic material such as this, the domains may align in the direction of the
applied field. The degree of domain alignment is dependant on the strength
of the applied field. As the strength of the applied field increases, all domains
will irreversibly rotate to the crystallographic easy axis closest to the applied
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field direction (Figure 2(c)). Once all the moments are fully aligned in the di-
rection of the field, the sample has reached its saturation magnetisation (Ms).
The theoretical Ms values for some common magnetic materials are given in
Table 1.
Figure 2: (a) Randomly aligned magnetic moments in a paramagnetic material in ab-
sence of a magnetic field. (b) Orientation of magnetic moments within the domains of
an ordered magnetic material. The domains oppose each other when there is no ex-
ternal magnetic field. (c) Alignment of domains on application of an external magnetic
field to reach saturation magnetisation.
Table 1: Theoretical magnetisation saturation (Ms) values for bulk iron oxides. Substi-
tuting the Fe2+ groups with other transition metals changes the magnetic properties of
the material reflected in different theoretical Ms values.





Magnetic materials can be classified according to how they respond to the
application of an external magnetic field. Paramagnetic materials do not form
domains. When an external magnetic field is removed thermal energy in the
paramagnetic sample causes the moments to be randomly orientated again
eliminating any residual magnetism. This causes the paramagnetic material to
have little remanence or coercivity. Remanence relates to the residual mag-
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netism of a magnetic material when the external field is removed, while co-
ercivity is the applied magnetic field required to demagnetise the magnetic
material. Low remanence and coercivity results in minimal residual magnetism
which is desirable in the construction of biomedical agents as it reduces the
risk of magnetic agglomeration and the formation of blood clots. The organ-
isation of unpaired electrons into domains leads to other types of magnetic
materials. In a ordered ferromagnetic material, the individual magnetic mo-
ments of the material align with the applied field and also with each other to
form magnetic domains which may also align with the field. The existence of
the domains generates a much stronger magnetic field in the material. When
the field is removed, the thermal energy is not enough to randomly realign the
domains, leading to residual magnetism and coercivity.21 This residual mag-
netism may limit the use of bulk materials in biomedical applications, as it will
cause the particles to aggregate with each other. In antiferromagnetic ma-
terials, the magnetic moments within the domains are aligned antiparallel to
each other and cancel out, resulting in the magnetic domains displaying no net
magnetisation. Ferrimagnetic materials consist of magnetic regions aligned
antiparallel to each other but these regions are disproportionate to each other
which causes only partial cancellation of the magnetic moment in the material.
Ne´el observed this behaviour in Fe3O4.22 The Fe3+ ions on the A and B sites
cancel each other out, leaving only the the Fe2+ ions which are responsible for
the observed magnetic moment.
The behaviour of materials in an applied external magnetic field can be
studied using magnetisation curves. These are plots of magnetisation (M)
against applied field strength (H) and an example for a ferromagnet is shown in
Figure 3. Magnetisation curves give information about the coercivity and rema-
nence of the sample. The magnitude of these properties may be determined
from the hysteresis loop obtained during the measurement. The width of the
loop relates to coercivity, with a wider loop requiring stronger external fields to
demagnetise the material. The height of the hysteresis loop is an indication of
the remanence of the material.
As the size of the ferro/ferrimagnetic material decreases, so do the number
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Figure 3: Magnetisation measurements that would be generated from a multi-domain
ferromagnetic material. The ferromagnetic nature results in a hysteresis loop that
defines the samples magnetisation saturation (maxima of M), remanence (value of M
when H = 0) and coercivity (value of H when M = 0). Ferromagnetic materials produce
a wide hysteresis loop due to a high coercivity and remanence.
of magnetic domains within the particle. If the particle decreases to a small
enough size, it can become energetically unfavourable for multiple domains to
exist. In this case, one single domain will exist and the particle will have a
uniform magnetisation. A particle with a single domain is known as a super-
paramagnet. When this is exposed to an external magnetic field, the entire
magnetic moment of the particle aligns parallel to the field as shown in Fig-
ure 4. When removed from the external field, the particles lose this alignment
displaying no remanence or coercivity. This is advantageous for biomedical
applications, as the uniformity within the domain ensures high magnetisation
while the single domain ensures that particles will not agglomerate in the body
through ferromagnetic attractions. To display superparamagnetic behaviour,
the particles must be small enough to support a single domain and this size
limit is defined as a critical diameter. Materials below this diameter will be su-
perparamagnetic, while larger particles display ferromagnetic properties such
as remanence. The critical diameter varies for the material, with magnetite
nanoparticles being below 15 nm19,23,24 making particle size a very important
consideration in the construction of any magnetic nanocomposite.
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Figure 4: Schematic representation of superparamagnetic particles aligning with an
external magnetic field. Arrows denote the magnetic moments of the individual par-
ticles. The domains of superparamagnetic material oppose each other under stan-
dard conditions. When an external magnetic field is applied, the superparamagnetic
nanoparticles will align in the direction of the field. This alignment is lost when the
external field is removed.
Utilising nanoscale materials means that more of the atoms in the crystal
structure are exposed on the surface, making the formation of surface defects
an extremely important consideration during synthesis. During crystal forma-
tion, incomplete/under coordinated areas on the crystal surface will form due
to the lack of nearby ions. This breaks the symmetry on the surface, reduces
the coordination sites of ions to the surface and leads to the existence of bro-
ken magnetic exchange bonds. These effects contribute to a misalignment of
magnetic spins and are known as surface defects.25 The existence of such
surface defects reduces the saturation magnetisation since not all of the spins
will align when exposed to an external magnetic field. These defects are more
detrimental for nanoparticles, where a large number of atoms are exposed on
the particle surface increasing the effect of surface defects. Therefore the syn-
thesis method has to be carefully selected to ensure that the nanoparticles are
small enough to be single domain while minimising surface defect formation.26
1.3 Preparation of iron oxide nanoparticles
Not only does the synthetic method reduce surface defect formation but also
dictates other nanoparticle properties such as size and morphology. Control-
ling the individual steps of the synthesis method is fundamental to optimising
the potential of these nanoparticles for biomedical applications and a number
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of methods are considered below.
1.3.1 Co-precipitation methods
In co-precipitation, crystal formation occurs from the addition of a concentrated
base to a supersaturated solution of metal salts. For Fe3O4 nanoparticles,
ferric (Fe3+) and ferrous (Fe2+) salts (i.e. chlorides, nitrates, sulphates) are
dissolved in deoxygenated water in a stoichiometric ratio of 2:1 respectively.
When dissolved, the iron salts undergo a deprotonation reaction to form iron
hydroxides.27 The addition of a concentrated base (i.e. NH4OH, NaOH) to
the saturated solution causes nucleation of magnetite seed particles.28 The
reaction is given as follows:
Fe2+ + 2Fe3+ + 8OH− → Fe3O4 + 4H2O
Massart first reported this co-precipitation method for Fe3O4 but it has since
been adopted to prepare a variety of other iron oxides by substituting the
ferrous salt with other transition metal (II) ions.28–30 The advantages of this
method is that it is a quick, cheap and easy approach to preparing iron oxide
nanoparticles in a scalable reaction. As the particles are prepared in water,
stabilisation with hydrophilic platforms can be incorporated into the precipi-
tation step, resulting in the formation of water stable magnetic nanoparticles
(with the capacity for further functionalisation) in less than an hour via a one–
pot reaction. Nanoparticles prepared in this manner tend to be 10 nm, but
often display polydispersity, surface defects and Ms values of 45 emu g−1,
significantly lower than the theoretical bulk value of 98 emu g−1.31,32 The par-
ticle size and resulting magnetic properties can be affected by adjusting the
experimental conditions (i.e. temperature, precursor, precipitating agent) and
by considering the two stages of the co-precipitation reaction: nucleation and
growth.33–35 Nucleation is the formation of seed particles due to the addition
of the base. When the base is added, the dissolved precursors react with each
other to form very small iron oxide crystal seeds. If the crystal is too small, it is
unstable and redissolves back into solution but when large enough the crystal
is stable enough to start to grow and agglomerate. Growth is when the stable
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iron oxide seed particles agglomerate to form larger thermodynamically stable
particles.33 Control of these steps are needed to ensure a strong nucleation
stage (to produce a large amount of crystals) with a short growth stage (to
ensure the crystals remain small enough to be superparamagnetic).34 This is
illustrated by a LaMer diagram, shown in Figure 5, demonstrating how a strong
nucleation step results in the formation of many small nanoparticles.35
Figure 5: LaMer diagram illustrating the stages of nanocrystal formation and growth in
a coprecipitation reaction.35 Nucleation leads to the formation of many seed particles
of a small size, but as the reaction continues, these particles decrease in number while
increasing in crystallite size.
Pereira et al. have studied the effect of the base used to precipitate
the iron oxide, replacing sodium hydroxide with isopropanolamine and diiso-
propanolamine, and have observed an increase in Ms values.36 They attributed
this magnetisation increase due to a decrease in the formation of surface
defects. This occurs from the interactions of nitrogen and oxygen groups of
the base with the under-coordinated sites on the iron oxide surface (figure 6).
These surface defects form a magnetically dead layer which reduces Ms val-
ues. Minimising the formation of surface defects, reduces the formation of a
9
magnetically dead surface layer, which will improve the overall magnetisation
of the particles.
Figure 6: A schematic illustrating the effect of different bases on the formation of mag-
netically dead layers on iron oxides, based on the work by Pereira et al.36 Replacing
sodium hydroxide with isopropanolamine and diisopropanolamine reduces the forma-
tion of surface defects, leading to an increase in magnetisation values.
One of the attractive features of the co-precipitation approach is the ability
to stabilise iron oxide nanoparticles with hydrophilic groups during the precip-
itation reaction. For example, charged groups of a hydrophilic stabiliser, such
as a polyelectrolyte, can bind with the iron oxide surface as the particles are
precipitated.37,38 This is an extremely useful process as it allows for the de-
velopment of a water stable magnetic nanocomposite in a single reaction step
without any need for post processing. The formation of this water stable foun-
dation allows the particles to be immediately used in biomedical applications or
can allow further functionalisation through electrostatic interactions or aqueous
coupling reactions.
1.3.2 High temperature decomposition methods
High temperature decomposition methods often afford highly crystalline, ex-
tremely uniform iron oxide nanoparticles. These particles are prepared by dis-
solving metal precursors such as oleates or acetylacetates in a high boiling sol-
vent in the presence of a capping agent. This results in precursor decomposi-
tion and the formation of highly crystalline nanocrystals up to a few nanometers
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in size. This control over the resulting particle size through the careful selection
of solvent and capping agent is a major advantage of this method.39 Addition-
ally, this method also minimises surface defect formation, enhancing the crys-
tallinity of the iron oxide nanoparticles, which is reflected in high magnetisation
values close to the theoretical bulk value (82 emu g−1 vs 98 emu g−1).2,39,40
Sun et al. have prepared 16 nm magnetite nanocrystals with hexagonal mor-
phologies and have shown this method can be extended to provide a range
of monodisperse nanoparticles with sizes as small as 4 nm (Figure 7).2 The
hexagonal morphology is indicative of highly crystalline materials, which is re-
flected in the nanoparticles having Ms values above 80 emu/g.2,39 Bilecka et
al. have introduced an additional microwave irradiation step to the high tem-
perature decomposition reaction, reducing reaction times down to several min-
utes.41 Masala and coworkers have demonstrated that this high temperature
route can minimise the formation of surface defects when compared to aque-
ous methods.42 They prepared MnFe2O4 nanoparticles via a high temperature
decomposition reaction and compared them to particles formed in low temper-
ature aqueous coprecipitation and reverse micelle reactions. They identify that
the use of high temperatures allows for the controlled formation and growth
of the particles which leads to less under co-ordinated surface sites. This re-
duces surface disorder but increases crystallinity, which they correlated to a
significant increase in saturation magnetisation values. Comparing particles of
a similar size, the high temperature decomposition iron oxides (4.6 nm) have
significantly higher Ms values ( 50 emu g−1) than those prepared by aqueous
co-precipitation (13 emu g−1; 3 nm) and reverse micelle methods (30 emu g−1;
4 nm) which further illustrates this point.
One disadvantage of this approach is that the organic reaction conditions
and use of hydrophobic capping groups requires post processing to remove the
hydrophobic organic layer from the particles before they can be redispersed
into aqueous solutions. Several groups have developed methods to deal with
this. For example, Zhang et al. have developed a ligand exchange reaction to
replace the hydrophobic surface coating with a polyelectrolyte.43 The method
ensures that the polyelectrolyte is firmly bound and provides a hydrophilic com-
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Figure 7: TEM images of Fe3O4 nanoparticles prepared by high temperature decom-
position methods.2 Well defined particles with a hexagonal morphology can be ob-
served.
ponent to allow the particles to be redispersed into aqueous solutions, but this
post processing adds extra steps and time to the reaction. Ge et al. also de-
tailed a solvothermal method to stabilise iron oxide nanoparticles with polyelec-
trolyte to improve the stability of the particles in water but again the stabilisation
step occurred post synthesis adding to the overall reaction time.44
1.3.3 Hydrothermal approaches
Hydrothermal methods work by sealing dispersions of the starting materials
in a hydrothermal bomb and heating to high temperatures. In the case where
water is used as the solvent, the combination of the high temperatures (374◦C)
and pressures (up to 220 bar) generated in the closed system leads to super-
critical water.45 In this state, water lacks surface tension but has a very high vis-
cosity. This allows for normally insoluble compounds to now become highly sol-
uble. The increased pressure means that reactions can be accessed at lower
than normal reaction temperatures. Carvalho et al. have demonstrated that
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hydrothermal methods can be combined with co-precipitation techniques to
further increase particle size (17-20 nm) and Ms values (above 80 emu g−1).46
The advantage of this method is that the high reaction temperatures can in-
crease crystallinity without the need for post processing to remove the organic
components. Cai et al. prepared polyethyleneimine-Fe3O4 nanoparticles in a
single step hydrothermal synthesis method, illustrating that this method can
be combined with stabilisation and further functionalised with additional reac-
tions.47 Hydrothermal ageing can take several hours though and require high
temperatures, therefore continuous hydrothermal systems can be prepared,
allowing large scale production of nanoparticles as illustrated in the work by
Barner et al.48
1.3.4 Microwave assisted reactions
Microwave irradiation presents an interesting alternative to traditional heating
methods by offering rapid heating, controllability and faster reaction kinetics.
Microwave heating has been used previously for organic reactions to reduce re-
action times and suppress unwanted side reactions increasing the purity of the
final product.49 Microwave heating works on the principal of dielectric heating,
which is the ability of a material to absorb microwave irradiation and convert it
into heat. The heating mechanism relies on two principles: dipolar polarisation
and ionic conduction. When exposed to electromagnetic microwave irradiation,
charged groups such as dipoles or ions align with the incoming electric field of
the radiation. This is an oscillating field, with the result that the ions or dipoles
are constantly realigning with the field. When this oscillation is too quick for
the ions and dipoles to align fully, lag occurs which results in resistive heat-
ing. This is measured as the amount of microwave energy that is absorbed by
the sample and released as heat (the dielectric loss, e′′). The other heating
mechanism is ionic conduction which is the collision of the oscillating charged
particles (from the irradiation) which generates heat. This mechanism depends
in part on the solvent used (for example, ionic liquids couple extremely well to
the irradiation leading to excellent heat generation). The effectiveness of a sol-
vent is dictated by the ratio between the dielectric constant (e’, the ability of
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the solvent to be polarised by the microwave irradiation) and the dielectric loss
(e′′). This results in the dielectric loss tangent, tan δ, with a greater loss indi-
cating a better microwave solvent. Tan δ values over 0.5 are considered high
microwave absorbing solvents (e.g. ethylene glycol, ethanol), having efficient
microwave absorption allowing for rapid heating.49
Water is considered a medium microwave absorbing solvent with a tan δ
value of 0.123.50 Water has a resonance frequency of 18 GHz, larger than the
frequency of microwaves used in domestic/specialised systems (2.45 GHz).50
While this is less effective at microwave heating than some other solvents, the
use of water offers several advantages than other high absorbing solvents,
especially in the preparation of biomedical agents. Some ionic liquids are or-
ganic solvents which may coat the particle surface requiring post processing
to make the particles water stable. Utilising water as the solvent removes the
need for post processing and can allow for in situ stabilisation. Additionally
high microwave absorbing solvents heat up very rapidly which, while reducing
reaction times, can lead to pressure spikes depending on the reaction. The
slower ramping rate of heating water avoids this pressure spike, but utilising
a medium absorbing solvent still allows faster heating than conventional heat-
ing methods. Komarneni et al. have demonstrated that water still reaches a
desired temperature faster than conventional heating methods, showing the vi-
ability of the solvent in microwave reactions.51 In addition to enhanced heating
rates, microwave irradiation offers other advantages to conventional heating
methods. Use of microwave systems allows for the in situ monitoring of reac-
tion conditions such as temperature, internal pressure and microwave power.
This improves reproducibility and safety, as digital limiters can be put in place
to stop reactions from reaching dangerous conditions. There is also no contact
between the heating element and the reaction mixture, which again minimises
risk. Developments in microwave chemistry are improving the versatility of mi-
crowave systems, with current machines supporting a wide range of adaptors
and expansions and can also be modified to have bigger reaction containers
or auto samplers.
There have been only a few reports of incorporating microwave irradiation
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into iron oxide synthesis and the effectiveness of each approach. Enhanced
growth and crystallinity is desirable, but care has to be taken that the parti-
cles do not grow too large. Khollam et al. combined the hydrothermal tech-
nique with microwave irradiation resulting in the formation of highly crystalline
material with Ms values equivalent to high temperature decomposition meth-
ods.52 However, these particles were sub-micron ferromagnets, making them
too large and unsuitable for biomedical applications. Sreeja et al. incorporated
microwave irradiation into the co-precipitation reaction of maghemite nanopar-
ticles, noting an increase in the uniformity of the resulting particles.53 Hong et
al. also utilised microwave irradiation to age magnetite nanoparticles after they
had been co-precipitated, which improved crystallinity and ensured the par-
ticles did not grow in size and become ferromagnetic.54 They observed that
ageing the nanoparticles improved crystallinity, with after two hours treatment
highly crystalline nanoparticles with an Ms of 65.98 emu g−1 formed. Clearly,
there is a great opportunity for developments in the microwave preparation of
magnetic nanocomposite materials.
1.4 Biocompatibility of iron oxide nanoparticles
Biocompatibility is paramount in the construction of biomedical magnetic
nanoparticles. A magnetic nanocomposite needs to be designed so that it
is biocompatible with the body and can evade the biological elimination sys-
tem in order to maximise their life span in vivo. Bare iron oxides can oxidise
and degrade within cells damaging DNA causing mutations.55,56 They are also
unstable in aqueous solutions and will begin to cluster and agglomerate to
exclude water. Stabilisation provides a hydrophilic coating for these particles
minimising clustering. Clustering is undesirable as not only are larger parti-
cles more easily eliminated but agglomeration may lead to blocking of blood
vessels. Another major consideration is particle lifespan. There are a magni-
tude of biological systems in place to eliminate foreign groups from the body.
Therefore the magnetic composite needs to be designed to evade these mech-
anisms so it can reach the target site. One major elimination route is via the
reticuloendothelial system (RES). The RES consists of specialised phagocytic
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cells that are associated with the liver, lymph nodes and spleen. When ad-
ministered into the body, the RES coats the synthetic nanoparticles with pro-
teins and glycoproteins based on their size and composition. This process
is called opsonization and highlights the foreign nanoparticles to phagocytic
cells. Once opsonized, macrophages and Kupffer cells of the RES engulf the
nanoparticles and break them down. Larger particles (>200 nm) are more
easily coated with proteins highlighting them for elimination much quicker than
smaller particles.57 Smaller particles are still susceptible to elimination as very
small nanoparticles (<20 nm) can be filtered straight into urine from the kid-
neys without the need for opsonisation. These are depicted in Figure 8.58 For
access to diseased cells, there are reports of particles of up to 700 nm being
able to penetrate the endothelium, but larger sizes may cause clotting in blood
vessels and can increase opsonisation.58,59 Sizes of between 30 and 150 nm
have been reported to be the optimal size for magnetic nanocomposites as the
particles are still small enough to be taken up by cells and will not be blocked
in transit.60,61
Figure 8: The fate of nanoparticles in the body based on size, with smaller particles
lasting longer in the body as they can evade the reticuloendothelial system.58 Particle
size also effects elimination method, with larger particles being removed by opsonisa-
tion while smaller particles are filtered straight out of the bloodstream by the kidneys.
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Surface charge and coating can have a great effect on evading RES and
increasing the composites lifespan in the body. Hydrophobic surfaces are
more easily coated with opsonisation proteins resulting in quicker elimina-
tion.62 Gaur et al. reported that hydrophilic coatings can resist this process,
thereby prolonging the particle life.63 Regulating the surface charge is a key
consideration, as highly positive coatings can attach non-specifically to cells
whereas strongly negatively charged particles are more likely to be taken up
by the liver.61 The other significant consideration is the route of administration,
as this can affect how the particles are processed and eliminated. Nanopar-
ticles injected directly into the body are normally broken down by phagocytic
cells, while oral administration exposes the particles to gastric acids which
may reduce absorption.58 When administered subcutaneously, the nanoparti-
cles are transported through the lymphatic system and may be broken down
there. This can be manipulated to ensure particles specifically reach lymphatic
tumours.64
1.5 Stabilisation of iron oxide nanoparticles
Biological considerations illustrate that stabilisers are essential in the construc-
tion of biomedical magnetic nanocomposites. Not only do they ensure biocom-
patibility, but can also enhance existing properties and bestow new properties
such as water stability and anchor points for further functionalisation. A wide
range of materials can be used to stabilise iron oxide nanoparticles such as sil-
ica,7,65,66 polymers/polyelectrolytes37,67–69 and organic surfactants6,70,71 with
each stabiliser changing the particle size, morphology and properties. One
common stabiliser is silica, as the silica layers are strongly bound to the iron
oxide surface, are biocompatible and can allow for further surface functionali-
sation. Silica coatings are bound to the iron oxide surface through the conden-
sation of orthosilicate groups with the iron groups on the surface.7,72 A typical
stabilisation reaction involves alkoxysilanes undergoing hydrolysis in solution.
The unstable silane groups then undergo a condensation reaction with iron
groups on the iron oxide surface forming an Fe-O-Si bond. This silica layer can
then be further grown through additional condensation reactions, allowing the
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stabiliser thickness to be controlled.66 The silica coating is covalently bound
to the iron oxide surface minimising the risk of desorption. The ability to add
and grow the initial silica layer allows for further functionalisation of the parti-
cles through the use of alkoxysilane linkers (i.e. 3-aminopropyltriethoxysilane).
These linkers contain silicate groups that can condense on the silica surface
and alternative functional groups to provide attachment points for other moi-
eties. Chekina et al. have reported a method which binds amine groups to the
silica surface via the Sto¨ber method, which can be further functionalised using
carbodiimide coupling.73 McCarthy et al. illustrated a range of functionalisation
reactions for silica coatings highlighting the versatility of this approach allow-
ing for the development of multifunctional nanocomposites supporting multiple
groups.74 There are some caveats with silica stabilisers though as the stabili-
sation reaction has to be done separately post particle synthesis. Additionally,
silica coatings have been shown to adversely effect magnetisation values by in-
troducing a magnetically dead layer and increasing surface disorder with Park
and coworkers reporting a decrease in magnetic properties from silica coated
magnetite nanoparticles.75 This is confirmed by Hui et al. who prepared a se-
ries of magnetite nanoparticles coated with silica layers of varying thickness
noting a decrease in Ms values as layer thickness increases (with a decrease
from 57.5 emu g−1 to 26 emu g−1 with a 20 nm silica layer).76
Polymers have traditionally been used to protect iron oxide nanopar-
ticles and offer excellent water stability when bound. One example are
polyelectrolytes, which consist of a series monomers that contain ionisable
groups which disassociate in water leaving a charged chain. These charged
chains can then bind to the iron oxide via electrostatic interactions between
the monomers and oppositely charged surface ions.77,78 The polyelectrolyte
properties are dictated by the monomer composition and the chain length.
Examples of polyelectrolytes are poly(sodium-4-styrene sulphonate),37,38
poly(diallyldimethylammonium chloride)79,80 and poly(acrylic acid).81–83 Poly-
electrolyte lengths can vary with chains of under 1,000 monomers to other
chains over 1,000,000 monomers, with the larger lengths capable of support-
ing many iron oxide groups. The advantage of using polyelectrolytes is that
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they can be extremely hydrophilic with excellent water stability, with variable
chain lengths allowing for further optimisation. Also, the electrostatic binding
method can be performed simultaneously with precipitation, reducing reaction
times and steps.
Polyelectrolytes are considered strong or weak based on their disassocia-
tion rate. Strong polyelectrolytes have easily ionisable groups that will disasso-
ciate under a wide range of conditions leaving a fully charged polyelectrolyte
behind.84,85 In the fully dissociated case, all monomers are exposed for bind-
ing with a repulsion effect between the charged monomers forcing the chain
to adopt a linear conformation. Weak polyelectrolytes can be partially ionised
in solution and the disassociation rate is greatly affected by experimental con-
ditions such as pH.86,87 This disassociation of the group then affects how the
polyelectrolyte behaves in solution. Here, the binding sites are only partially
exposed, with the non charged areas forming loops and folds as there is no
repulsion forcing this conformation. The occurrence of these loops and folds
increases the polyelectrolyte layer thickness, demonstrated in Figure 9. This
can affect the composite size and ultimate use in biological applications, with
larger materials more easily removed by the RES.
Figure 9: A schematic illustrating the differences in weak/strong polyelectrolytes on
polyelectrolyte layer formation.85 Strong polyelectrolytes adopt a linear conformation
forming a flat surface on the substrate. The weak polyelectrolyte binds to the surface,
but the formation of loops and folds results in the formation of a much thicker layer.
Polyelectrolytes have already been shown to be effective in the prepara-
tion of ferrofluids, with the work by Lin et al. stabilising magnetic nanoparti-
19
cles with poly(acrylic acid).81 They have developed a ferrofluid in a one step
co-precipitation reaction that incorporated stabilisation into the precipitation
stage. Light scattering techniques confirm that the material is water stable,
with a hydrodynamic radius of 100 nm in neutral solutions. Polyelectrolyte-
stabilised magnetic nanoparticles can also behave as promising MRI contrast
agents.37,38 Polyelectrolytes can also be used to stabilise iron oxide nanopar-
ticles prepared from high temperature decomposition methods with the work
by Zhang et al. and Ge et al. showing that hydrophobic iron oxide can be sta-
bilised by hydrophilic polyelectrolyte and redispersed in solution.43,44 Utilising
a chain-based stabiliser rather than a layer-based coating will also affect Ms
values and ultimately biological applications. Polyelectrolytes can limit crystal
growth ensuring the particles are small enough to be superparamagnetic but
also provide a magnetically dead layer that reduces Ms values.69,81 The struc-
tural flexibility afforded by polyelectrolytes can also enhance biological appli-
cations. Attaching iron oxides to a chain, rather than fixing iron oxide clusters
in an inorganic scaffold, allows the composite to adopt different conformations
in solution.7 As reported by several groups, when placed in an external mag-
netic polyelectrolyte stabilised magnetic nanocomposites form linear assem-
blies with a noticeable enhancement to MRI properties.37,38,88
Another common type of stabiliser is organic or fatty acids, such as oleic
acid.6,71 These possess long chains which can offer an organic environment
for the entrapment and transport of hydrophobic drugs such as paclitaxel.89
Ligand exchange can transfer these particles into water for subsequent biolog-
ical use.70,89 Another popular biocompatible stabiliser is dopamine which can
bestow water stability on the iron oxide nanoparticles and can also be further
functionalised through the amine group. Dopamine is an example of a catechol
(1,2-dihydroxybenzene), with a terminal amine group. Catechols have a high
affinity for iron oxide surfaces. Dopamine preferentially binds to under coordi-
nated sites on the iron oxide surface via the hydroxide groups leading to the
formation of a strong bidentate bond as shown in Figure 10.90–94 The terminal
amine can undergo a wide range of coupling reactions allowing for the attach-
ment of groups that can extend the lifespan of the composite in the body such
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as polyethylene glycol,95 fluorescent groups for imaging,96 and chemotherapy
agents for cancer treatment.97
Figure 10: Dopamine binding to γ-Fe2O3 particle surfaces calculated by ab initio cal-
culations by Fouineau et al.93 This illustrates the bidentate binding of the catechol
group.
1.6 Diagnostic and therapeutic applications
Through careful design and manipulation of the iron oxide core and surface
coatings, these magnetic nanocomposites can be adapted to be used for a
variety of biomedical applications, including magnetic resonance imaging, flu-
orescent labelling and site specific drug delivery systems.
1.6.1 Magnetic resonance imaging (MRI)
Magnetic nanoparticles have a key role in diagnostic purposes such as con-
trast agents for magnetic resonance imaging (MRI). MRI at its heart is a nuclear
magnetic resonance experiment. It is a non-invasive imaging technique which
works by manipulating the magnetic moments of protons within the body. Pro-
tons from water and lipids have very small magnetic moments. However, there
is a very high concentration of protons in the body, which causes an overall
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net magnetisation that can be measured by MR imaging. When exposed to an
external magnetic field, there is an alignment of the magnetic moments either
parallel or anti-parallel to the external magnetic field. There is a slight differ-
ence in population between these two spins levels due to the anti-parallel align-
ment requiring slightly more energy. In MRI measurements, a radio frequency
(rf) pulse is applied causing the aligned magnetic moments of the protons to
become excited and de-align with the original applied field.98 This pulse is cal-
culated to be the energy difference between the two spin states, known as the
Larmor frequency. Once the pulse is turned off, the spins will naturally realign
with the applied field via longitudinal or transverse relaxation mechanisms.99
Longitudinal relaxation is known as T1 recovery or spin-lattice relaxation, where
the energy from the excited nuclei is lost to the surroundings. Shorter T1 relax-
ation times result in greater image intensity as the protons are relaxing faster
between measurements.100 Transverse relaxation is known as T2 recovery or
spin-spin relaxation and is the dissipation of energy from the interaction of the
protons with other nuclei. Shorter T2 relaxation times decrease signal inten-
sity, increasing image contrast.100 After multiple measurements, the difference
in relaxation times between tissues provides an image, with areas of high pro-
ton concentration showing with a greater intensity.
The MR image can be improved with the use of contrast agents, which
shorten the T1 or T2 relaxation times and improves the resolution of the im-
age. Contrast agents are magnetic materials and the relaxation nature is de-
termined by what relaxation time is more affected by the material, giving rise to
T1- or T2-weighted contrast agents. The relaxation behaviour can be monitored
experimentally using nuclear magnetic resonance dispersion (NMRD) profiles.









where 1/Ti(obs) is the observed relaxation rate of the system (contrast agent
plus solvent), Ti(diam) is the relaxation time of diamagnetic contribution (i.e. the
system without the contrast agent), C is concentration and ri is the relaxivity.
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The relaxivity is calculated for both longitudinal (i = 1) and transverse (i = 2)
relaxation of the contrast agent and the ratio of the two relaxivities can be used
to determine the effect of the contrast agent. For a contrast agent that im-
proves T1 signals, high r1 relaxivities are required with a low r2/r1 ratio. For a T2
contrast agent, high r2 relaxivities and a high r2/r1 ratio are desired. Traditional
T1 MRI contrast agents are gadolinium-based compounds, whereas T2 con-
trast agents tend to be iron oxide based.101,102 Different MRI images can be
taken of the body depending the weighting given on T1 or T2 measurements.
There are many commercial MRI contrast agents available and their relaxivity
values are given in Table 2. Key considerations for contrast agent behaviour
are water stability and magnetic properties. High water stability ensures that
the particles can be dispersed into solution, increasing the composites expo-
sure to protons, while a high magnetic saturation ensures a stronger magnetic
field is generated by the particles during the measurement. Exploring different
synthesis methods and iron oxide compositions can tailor these properties to
allow for the development of contrast agents.
Table 2: Relaxivities of commercially available iron oxide based contrast agents.101,102
Relaxivities in mM−1 s−1.
Name (Commerical) Coating type r1 r2
Ferumoxil (Lumirem) Siloxane 3.2 72.0
Ferumoxide (Feridex) Dextran 23.9 98.3
Ferucarbotran (Resovist) Carboxydextran 25.4 151.0
Ferumoxtran (Sinerem) Dextran 10.0 60.0
Feruglose (Clariscan) Carbohydrate PEG 20.0 35.0
Na et al. have reported a contrast agent using iron oxide nanoparti-
cles obtained from a high temperature decomposition method, stabilised with
poly(acrylic) acid (PAA), PEG and catechol groups.103 They observed that in-
creasing the particle size improves r2 relaxivity values. 23 nm particles had an
r2 value of 254 mM−1 s−1, while 11 nm particles had r2 values above most
commercial agents at 181 mM−1 s−1. Lee et al. have developed biocom-
patible iron oxide nanocubes, with a phospholipid coating.104 The prepared
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nanocubes were biocompatible with MDA-MB-231 human breast cancer cells
and displayed excellent Ms values (132.1 emu g−1), reflected in strong r2 values
(324 mM−1 s−1).The high relaxivity values allowed single cell imaging which is
a promising avenue for the monitoring of transplanted cells. This work was
further improved upon by Lee et al. who optimised the particle size.105 They
prepared 22 nm cubes with a relaxivity value of 761 mM−1 s−1, one of the high-
est values found in the literature and over 6 times more effective than commer-
cially available MRI contrast agents. They also found that as the nanoparticle
size increased, r2 values begin to decrease as the strong ferrimagnetic nature
of the particles are enough to completely dephase the protons in water making
them unsuitable for MRI analysis.
Relaxivity values are also greatly affected by the nature of the stabiliser.
For example, Maity et al. have developed a one-pot coprecipitation method to
prepare superparamagnetic iron oxide nanoparticles with a terephthalic acid,
or 2-amino terephthalic acid, coating.106 The particles had saturation mag-
netisation values of 74 emu g−1 but with r2 values of 450.8 mM−1 s−1, and
761 mM−1 s−1 for the 2-amino terephthalic acid and terephthalic acid coating
respectively (Figure 11). The author attribute this increase to the stabiliser pro-
viding pathways allowing spin transfer from the superparamagnetic iron oxide
to the protons surrounding the composite. They used a stabiliser containing
diamagnetic spacers with pi-conjugated bonds to provide the pathway to the
surrounding protons. This indicates that the correct choice of stabiliser can
also enhance relaxivity values alongside optimisation of the iron oxide core.
Stabilisers can also improve relaxivity values by affecting the orientation or
conformation of the magnetic nanoparticles. When bound to a polyelectrolyte
chain for example, iron oxide nanoparticles are water stable and when exposed
to a magnetic field the flexibility of the polyelectrolyte chain allows the particles
to align with the external field leading to the formation of linear assemblies.
This has been observed by several groups, with the adoption of a linear con-
formation increasing composite surface area which increases the amount of
protons that can interact with the composite and therefore increasing relaxivity
values.37,38,88
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Figure 11: Cell testing and MRI measurements of iron oxide nanoparticles stabilised
with terephthalic acid and 2-amino terephthalic acid by Maity et al.106 Cell testing
shows no measurable toxicity (a), while increased transverse relaxation rates (b) and
image darkening in phantom experiments (c) illustrate the increased effectiveness of
the stabilised nanoparticles as a T2 contrast agent.
Utilising iron oxides as T1 contrast agents over traditional gadolinium-based
agents offers many advantages, the largest being reduced toxicity. Free
gadolinium ions can chelate and precipitate in the blood making them very
toxic, so they have to be protected before they can be used.107 Iron oxide
based materials have been shown to be far more biocompatible minimising
this risk. Shen et al. developed ultra-small iron oxide nanoparticles to be used
as T1 contrast agents.108 They observed that a smaller size, with decreas-
ing magnetic properties and increasing surface defects, are key to suppress-
ing the T2 relaxation but maximising the T1 relaxation. Fe3O4 nanoparticles,
with sizes ranging form 1.9 to 13.8 nm, were prepared using sodium citrate as
growth limiter to control particle size. The 1.9 nm particles had an Ms value of
4.54 emu g−1 but a r2/r1 ratio of 2.03 which is consistent with T1 gadolinium
based contrast agents. Sandiford et al. also designed iron oxide nanoparticles
as T1 contrast agents.109 They prepared slightly larger nanoparticles of 5.5 nm
which has a similar r2/r1 ratio 2.97 but were found to be better than commer-
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cial MRI contrast agents in general. The nanoparticles were synthesised using
an organic technique and stabilised with PEG via a 1,1-bisphosphonate group
which could then be labelled with the gamma-emitting isotope 99mTC for dual
imaging purposes.
Groups have worked towards the construction of contrast agents that can
act as both T1 and T2 contrast agents. This is best illustrated in the work by
Li et al. who prepared iron oxide nanoparticles via an aqueous coprecipitation
method stabilised with poly(methacrylic acid).110 These ultra-small nanoparti-
cles had an average size of 3.3 nm and an Ms value of 16 emu g−1 with the
resulting particles having an r1 relaxivity value of 8.3 mM−1 s−1 and a r2 re-
laxivity value of 35.1 mM−1 s−1. In vivo T1 and T2 measurements confirm the
particles can be used as a dual contrast agent.
1.6.2 Cell labelling and tracking
Functional groups can be bound to the surface of iron oxide based nanocom-
posites via exposed anchor groups which can be tailored depending on the
desired application. An example of this is the attachment of fluorescent com-
pounds which makes the nanocomposite suitable for confocal imaging, mon-
itoring cell uptake and cell tracking. There are a vast range of fluorescent
materials that can be bound to the composite such as organic dyes,111–113
quantum dots,114–116 and porphyirins.117,118 Organic dyes mainly are used as
they tend to be biocompatible and can easily be bound to magnetic nanoparti-
cles through a variety of coupling reactions. There are a wide range of organic
dyes that have been employed in biomedical applications including acridine or-
ange,112 Rhodamine B,113,119 and fluorescein isothiocyanate.120 Alternatives
such as quantum dots can be tailored to fluoresce at different wavelengths but
can be quite toxic.121–123
The attachment method of the moiety is key in the development of fluores-
cent nanoparticles. The group needs to be bound in such a way that it will
not detach from the composite early, which could interfere with measurements
or adversely affect the body. There are a number of approaches to attaching
functional groups to magnetic nanocomposites. One example is to prepare a
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hollow vessel and load the fluorescent/functional group into the pores of the
the vessel. This is illustrated in the work by Ma´rquez et al. who filled hollow
magnetite/silica spheres with Rhodamine B and measured the loading and re-
lease kinetics.124 SEM images confirm the formation of hollow microspheres,
while loading and release kinetics show that the material is contained in the
silica shell with release dictated by environmental conditions such as pH and
temperature. Foy and coworkers have prepared oleic acid coated magnetite
nanoparticles and loading hydrophobic NIR (near infrared) dyes into the or-
ganic surface layer.125 The composite was then bound to a block co-polymer
to make the particles water stable and then exposed to MCF-5 xenograft breast
tumours. They observed that the dye remained in the composite as the parti-
cles were taken up by the cells, which displayed increase fluorescence inten-
sity, as shown in Figure 12.
Figure 12: In vivo images of dye functionalised magnetic nanoparticles localised at
a tumour site via magnetic targeting.125 Nanocomposite concentration increases over
time shown by an increase in fluorescence intensity.
An alternative approach is to attach the fluorescent group via electrostatic
attractions. By mixing the charged fluorescent group with a stabiliser of the
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opposite charge, the dye can be bound to the material via electrostatic at-
tractions.126,127 The disadvantage of this approach is that the bound fluo-
rescent group can disassociate from the composite releasing the dye early.
Salgueirin˜o-Maceira et al. have bound quantum dots to the polyelectrolyte
layer of a magnetic composite via electrostatic attractions and subsequently
coated the composite with a silica layer to avoid desorption.116 Guo took a
different approach by depositing quantum dots directly on silica spheres con-
taining magnetite nanoparticles and then protecting the overall composite with
another silica layer to entrap the dye.128 The addition of the silica layer did
not diminish the composite fluorescence, as observed by confocal imaging.
Another common method for grafting fluorescent groups to magnetic nanopar-
ticles is through covalent coupling. Covalent coupling offers many advantages,
one of which is the formation of a strong bond between the fluorescent group
and the particle surface, which minimises early desorption. There are a wide
range of possible covalent coupling reactions but a common method is carbodi-
imide coupling. This is a versatile binding method that allows the attachment
of functional groups through the formation of an amide bond between amine
and carboxylic acid groups. This is illustrated in the work by Hu et al. who
have attached 9-amino acridine groups to PEG-stabilised Fe3O4 nanoparticles
via carbodiimide coupling.112 Qu et al. bound Fluorescein and Rhodamine B
groups to iron oxide materials by carbodiimide coupling.111 They demonstrated
that a wide range of capping materials (including dopamine) can be used to
bind fluorescent groups and that the carbodiimide coupling method allows the
attachment of these groups through either the amine or carboxylic acid groups.
1.6.3 Site-specific drug delivery systems
Through functionalisation, one of the most promising applications for mag-
netic nanoparticles is the development of site-specific drug delivery systems.
Chemotherapy is a very effective treatment against cancerous cells, destroying
harmful cells or inhibiting tumour growth. The downside of this approach is that
it can be non-specific, often targeting healthy cells alongside cancerous cells.
Therefore, a carrier system is needed to transport these drugs to ensure they
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specifically target the afflicted cells. Magnetic nanoparticles are a very promis-
ing avenue for this, as the addition of the magnetic functionality allows them
to be guided in vivo and held at the site by an external magnetic field.129 This
localises the drug, increasing its uptake into the cancerous cells at the target
site while minimising the drugs effect on the surrounding healthy cells. There
are many possible drugs to be used in chemotherapy such as Epirubicin,130
Paclitaxel,89,131 Doxorubicin,132,133 RU 58668 (A steroid antiestrogen)134 and
Rapamycin89 so developing a magnetic carrier is highly desirable to ensure
that these compounds can be used to their full effect. An early example of
magnetic drug targeting was reported by Lu¨bbe et al. who bound the anti-
cancer drug Epirubicin to magnetic nanoparticles that were coated with starch
polymers.130 Epirubicin (4’-epidoxorubicin) is an antibiotic that is used to treat
tumours. The anionic phosphate groups of the starch polymers allowed for
the electrostatic binding of the positively charged amino groups of the sugars
in Epirubicin. Initially the study showed that the unloaded ferrofluid was bio-
compatible with no noticeable toxicity. The composite was then loaded, held
over the tumour site with a magnetic field and after 7-14 days they found a
visible change in the tumour which led to a complete loss of the tumour, illus-
trating the effectiveness of magnetic targeting. In a more recent example, the
work by Zhou et al. illustrates the benefits of magnetic targeting by compar-
ing doxorubicin (DOX) loaded magnetite nanoparticles to free doxorubicin.133
The drug is bound to the PEG stabiliser on the iron oxide surface via an imine
bond which can be broken under acidic conditions allowing for controlled re-
lease. They determined that at pH 7.4 DOX release was less than 10% (after
48 hours) but as the pH decreased to 5.4 this release increased to over 50%
over 10 hours. The acidic environments of tumours allowed for a controlled re-
lease of the drug and reduced the risk of drug distribution to healthy sites. The
nanocomposite-bound drug was found to be significantly more effective than
the free DOX, demonstrating that not only does magnetic targeting minimise
the risk of damaging healthy cells but lower concentrations of the drug can be
used for magnetic targeting.
In addition to selectivity, another advantage of drug delivery systems is al-
29
lowing for the distribution of hydrophobic drugs into cells. The magnetic carrier
acts a hydrophilic platform, to which the drug can be bound and transported.
For example RU 58668 is an effective anti-tumour steroid compound but is
hydrophobic and cannot be distributed into aqueous cells without modification.
Plassat et al. circumvented this issue by trapping RU 58668 into magnetic vesi-
cles containing maghemite and rhodamine molecules.134 The vesicles create
an hydrophobic environment to contain the drug, while the hydrophilic shell
and the magnetic particles allows the transport of the drug into the aqueous
site. Electron microscopy and confocal imaging confirms the uptake and ac-
cumulation of the nanoparticles in MCF-7 cells under a 0.44 T magnet and
tumour growth was inhibited from 40% to over 60% when magnetic target-
ing was employed. Poor dispersion can also be an issue for chemotherapy
agents. For example, Paclitaxel is known to have poor solubility and requires
a hydrophilic carrier. Dilnawaz et al. bound Paciltaxel to magnetic nanopar-
ticles functionalised with glyceryl monooleate, making the overall composite
hydrophilic.89 The composite was also loaded with fluorescent groups and con-
focal microscopy confirmed uptake of the drug along with decreasing tumour
size demonstrating the composites effectiveness as a drug delivery agent.
When the loaded composite reaches the targeted site, a reliable mecha-
nism is needed to allow the release of drug so that it can interact with the
cancerous cells. The release mechanism is based on how the drug is bound
to the composite. One common method is to use the extreme environments
of cancerous cells to increase the natural release of the drug. This is demon-
strated in the work by Zhang et al. who prepared a hollow shell composite
containing magnetite, silica and fluorescent NaYF4 layers.132 The chemother-
apy agent DOX was loaded into the cavity and dispersed in tumour tissue,
where it showed increased uptake by the cells and sustained release of the
drug. Drug release increased with as the pH decreased, with the acidic envi-
ronment of tumour cells allowing for selective release. This is echoed in the
work by Yang et al. who loaded oleic acid stabilised iron oxide nanoparticles
containing DOX groups into silica nanoparticles with a polymer containing pH
sensitive groups.135 The polymer then limited drug release under normal phys-
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iological cell conditions but accelerated drug release in acidic conditions. Hu et
al. took a similar approach by developing a silica shell-like system that contains
ibuprofen loaded magnetite particles, but surrounded the particles with a ther-
mally responsive polymer to act as the release mechanism.136 When heated,
the silica shell ruptured releasing the drug. Not only do the trapped magnetite
nanoparticles allow for magnetic targeting, but can also provide the heat to
rupture the shell via hyperthermic heating. Transmission electron microscopy
was used to to confirm this rupture and the release of the drug (Figure 13).
Figure 13: Confocal and MRI images of ruptured magnetic nanocomposites incubated
with cells for 24 hr, showing the release of the trapped compound and darkening of
the MR image.136
By attaching the drug to the composite via a specific type of bond, enzymes
that are exclusive to or in higher concentration in cancerous cells can break
that bond ensuring that the drug is only released where it is needed. This is
illustrated in the work by Lee et al. who bound gemcitabine, a chemotherapy
drug used in the treatment of pancreatic cancer, to iron oxide nanoparticles
via a tetra peptide (GFLG) linker.137 This bond can be cleaved by the enzyme
cathepsin B, which is found in elevated concentrations in pancreatic tumour
cells. The nanoparticles were taken up by the cells (confirmed by MR imag-
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ing) and tumour growth was inhibited by 50% indicating both the cleavage of
the drug and effectiveness of the composite. Hwu et al. also bound Pacli-
taxel to magnetic nanoparticles via a Michael addition reaction using PEG with
a phosphodiester as a linker.131 This both enhanced the hydrophilicity of the
composite while allowing a degree of selective targeting, as phosphate groups
preferably bind to cancer cells and the enzyme phosphodiesterase (which will
break the bond) is found in much higher concentrations in these cells. Ex-
perimental conditions showed that phosphodiesterase broke the bond holding
the paclitaxel, relasing 91% of the drug over 10 days. The release was slow to
begin with but after the 4th day drug release rapidly increased as the bonds be-
came more exposed. Additionally this method resulted in very little free drug
seen in the untargeted cells due to lower enzyme concentration. Lee et al.
loaded DOX into a magnetic silica composite bound with cyclodextrin.138 The
cyclodextrin component blocks the pores that release the drug, which can be
cleaved by glutathione. This is found at higher concentrations in cancer cells in
comparison to healthy cells, and when exposed to cyclodextrin, the disulphide
units within the blocker are cleaved, releasing the drug. Cell testing shows
that without glutathione the drug is retained in the composite for 5 days. When
added to cancer cells, the DOX is released quickly, as shown in a shrinking
and ultimately death of the cancer cells within the same timeframe.
Magnetic targeting illustrates that chemotherapy agents can be localised
within tumours, but selectivity can be improved further through the attachment
of targeting groups to the nanocomposite. One common targeting group is
folic acid, as folate receptors are over expressed in human cancer cells. Zhu et
al. demonstrated the effectiveness of folic acid as the targeting group by bind-
ing it to hollow magnetite/silica spheres and monitoring their uptake into HeLa
cells.139 They observed the particles being primarily taken up by folic acid re-
ceptor endocytosis. They prepared hollow particles that could be loaded with
DOX to cause cell death, with the folate groups ensuring that the particles are
specifically taken up by tumour cells. Liong et al. also demonstrates the ver-
satility of folic acid targeting, showing that folic acid bound magnetic nanocom-
posites can effectively guide Paclitaxel and Camptothecin (another chemother-
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apy drug) to cancerous cells.140 There are many other examples of a wide
range of chemotherapy agents specifically targeting cancerous cells through
the use of folic acid functionalisation.141–143 The combination of the folic acid
targeting, drug delivery systems and attachment of luminescent groups has led
to the development of multifunctional nanocomposites that can target, detect
and treat cancerous cells. Lee et al. have prepared an iron oxide nanocom-
posite that was a drug delivery vehicle, a T2 contrast agent (r2: 76.2 mM−1
s−1) and a fluorescent label.144 Delivery of the chemotherapy agent was moni-
tored via confocal imaging. MR images confirm the materials use as a contrast
agent, while microscopy images show the cells had undergone apoptosis due
to the DOX component. Wang et al. also developed a multifunctional treat-
ment/diagnostic platform but incorporated targeting groups into the composite
to ensure that the drug is distributed at the intended site.145 They bound folic
acid to the composite so it would be taken up by HeLa cells. Additionally they
bound the photosensitive component aluminium phthalocyanine to the com-
posite to destroy the cancerous cell through photodynamic therapy. Hu et
al. developed nanocomposites with amiphilic diblock co-polymers which al-
lowed for controlled release of Paclitaxel.146 They additionally attached folic
acid for specific targeting of cells and the magnetic components allowed for
high r2 relaxivities (121.1 mM−1 s−1). Yang et al. also prepared a multifunc-
tional nanocomposite, containing targeting ligands and DOX bound via link-
ers to a PEG coating.147 The hydrophilic PEG layer enhanced water stability
and the composites lifespan within the body, while the magnetic core showed
good r2 relaxivity values of 345.1 mM−1 s−1. The chemotherapy agent was
bound through a hydrazone linkage, which allowed the composite to be taken
up through the folate receptors and cleaved within the cell ensuring no prema-
ture leakage.
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1.7 Aims and objectives
Figure 14: Schematic representation of the type of multifunctional nanocomposite pre-
pared as part of this project. A magnetic core is coated with a protective stabiliser
(shown in blue) which can support other functional groups such as drugs (red) or flu-
orescent moieties (green) via covalent coupling.
The ultimate aim of the current work was to prepare a highly magnetic, bio-
compatible, water stable iron oxide based nanocomposite with potential appli-
cations in fluorescent cell tracking, MR imaging and as a drug delivery system.
A representation of such a multifunctional platform is shown in Figure 14. The
literature has shown that careful design of the nanocomposite is key to unlock-
ing the potential of iron oxide materials.
The scientific and technical objectives of this work was to prepare a series
of iron oxide nanoparticles via a microwave assisted co-precipitation method,
and to analyse these reactions to determine the best magnetic foundation for
the composite. The synthesis method was explored in-depth with a particular
focus on the effects of microwave irradiation on iron oxide formation, size, mor-
phology and crystallinity. A highly effective, extremely water stable T2 MRI con-
trast agent was developed through the stabilisation of iron oxide nanoparticles
with polyelectrolytes. The properties of these polyelectrolytes was examined
in detail (such charge and chain length), to maximise the potential of these
materials as a MRI contrast agent. Ultimately, these pieces of work were com-
bined to develop a multifunctional nanocomposite capable of supporting both
fluorescent and targeting groups without any sacrifice to water stability and
crystallinity. The prepared materials was characterised using a wide range of
characterisation techniques (XRD, FTIR, Raman, TGA, DLS, UV-Vis, Fluores-
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cence, AAS, NMR and SQUID measurements). The ultimate effectiveness of
the materials was demonstrated through biological characterisation techniques
such as MR imaging, confocal microscopy and cell testing.
The co-precipitation method was used over high temperature decomposi-
tion methods, as this enables the synthesis of particles over a very quick time-
frame with simultaneous precipitation and stabilisation allowing the formation
of water stable nanocomposites in a single step. This work distinguishes itself
from traditional co-precipitation reactions in two major ways. Microwave irra-
diation was used to minimise surface defects formed from the co-precipitation
process and to decrease reaction temperatures and times when compared to
high temperature decomposition methods. Additionally dopamine and poly-
electrolyte stabilisers was used to not only bestow excellent water stability, but
to improve under co-ordinated surface sites further enhancing magnetisation
values and provide anchoring points to allow for a wide range of functional
groups to be attached to the nanocomposite.
This research lead to the development of a new family of multifunctional
magnetic nanocomposites, which display excellent water stability coupled with
strong magnetic properties and capability for further functionalisation in a
quick, reproducible one step method. There has been little work incorporat-
ing microwave irradiation into the development iron oxide nanoparticles and
there has yet to be a systematic study into the variation of charge and chain
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Chapter 2 Experimental procedures
2.1 Characterisation techniques
2.1.1 X-ray diffraction (XRD)
XRD analyses the crystal structure of the material allowing for determination of
atom positions and unit cell parameters. This information can distinguish differ-
ent iron oxides and information can be gleaned on crystallite sizes. Crystalline
materials consist of atoms arranged in repeating ordered patterns resulting in
a lattice. X-rays interact with these atoms and may be diffracted, as depicted in
Figure 15. Most of the scattered X-rays cancel each other out through destruc-
tive interference, but a few of the scattered waves are constructive and add to
each other. This can be detected and used in crystal assignment, according to
Bragg’s law:
nλ = 2dsinθ (2)
where n is an integer, λ is the wavelength of X-ray irradiation used, d is
the distance between lattice planes and θ is the angle between the X-ray and
the scattering plane. According to this law, the constructively scattered X-rays
are related to the size and shape of the unit cell (as the d component relates
to the spacing between the planes of the lattice) allowing multiple scattered
waves to form diffraction peaks which can be used to calculate the crystallo-
graphic parameters of the unit cell. In an XRD measurement, electrons are
generated from a source (a filament, the cathode) and are fired at a metal an-
ode at high speeds (i.e. Cu, Mo) ionising the metals and generating X-rays.
The X-rays then hit the target and scatter forming destructive and constructive
waves, with the constructively scattered waves detected. Measurements are
taken leading to the formation of a diffraction pattern, with the individual peaks
relating to lattice planes in the crystal structure. By assigning these planes, the
shape and size of unit cell can be determined which is an indicator on the iden-
tity the material. Substitution of atoms within the crystal structure will slightly
change the parameters of the unit cell, and the different atoms themselves will
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cause a slight change in the scattering angles of X-rays resulting in a shifting
of the diffraction peaks. This shifting effect can be used to distinguish materials
with similar crystal structures.1,2 X-ray diffraction and the use of Bragg’s law
in crystal structure determination is especially significant as this is the 100th
anniversary of the award of the Noble Prize for Physics to Sir William Lawrence
Bragg and Sir William Henry Bragg for their pioneering work in crystallography.
Figure 15: Diffraction of X-rays within a lattice structure. Destructive waves will cancel
each other out but constructive waves can be detected and measured. According to
Bragg’s law, these constructive waves are specific to the lattice spacings and can be
used to determine the crystal structure of a material. A and B are incident X-rays, A’
and B’ are the diffracted rays.
XRD can also be used to calculate the primary particle size of nanoscale
materials. The primary particle size is the average crystallite size calculated
from the XRD broadening and is representative of the sample tested in the
XRD. The XRD primary particle size was compared to the observed particle
sizes measured from TEM images. Paul Scherrer observed that when the
particle size is very small (less than 200 nm), the scattered X-rays undergo
a broadening effect, which translates into broad peaks in the X-ray diffraction
pattern.3 This peak broadening can be measured and the Scherrer equation





where T is the crystallite size, K is the shape factor of the particle, λ is
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the X-ray wavelength, β is the line broadening at half intensity (FWHM) and
θ is the Bragg angle of a peak. The Scherrer equation is effective at calcu-
lating the primary particle size, but is limited to uniform well defined particles,
as irregular particle shapes will affect the shape factor, resulting in a unre-
liable measurement.4 Other factors can also contribute to peak broadening
such as strain, and instrumental broadening. Instrument broadening can oc-
cur in several ways (i.e. from the X-ray source profile, optics) and can increase
the width of the peaks, therefore resulting in a discrepancy between the ac-
tual crystallite size and that predicted by the Scherrer formula. Unfortunately,
instrumental broadening was not taken into account for these results, which
is reflected in part in the differences between the TEM and XRD results. As
such the XRD Scherrer broadening values gives an average crystal size rep-
resentative of the entire sample, while the TEM measurements will account for
individual particle morphology and give a size distribution of the particles. X-
ray diffraction patterns were collected using a Bruker D8 X-ray Diffractometer.
A standard measurement took 4 hours 30 minutes, between 20 to 700 2θ. The
X-ray wavelength was 1.5408A˚ using a copper source (40kV, 40 mA). Several
samples in chapter 5 (sample B and sample E in figure 54) and chapter 6
(Mag/Dop/PSSS in figure 85 and the microwave assisted co-precipitated mi-
crowaved Mag/PSSS/Dop/A-9-CA/FA sample in figure 88) were measured at
the University of Glasgow using a Panalytical X’Pert. A standard measurement
took 2 hours, between 20 to 800 2θ. The X-ray wavelength was 1.5408A˚ using
a copper source (40kV, 40 mA).
2.1.2 Selected area electron diffraction (SAED)
SAED is a crystallographic technique similar to XRD that gives information
about crystal structure. This technique is incorporated into electron microscopy
systems and substitutes X-ray radiation with an electron beam. The wave-
length of the electron beam used in TEM measurement is on the same order
of magnitude as the interplanar spacing of the crystal causing the crystal lat-
tice to act as a diffraction grating, scattering the beam. This scattering is still
bound by Bragg diffraction, with the scattering angles characteristic to the crys-
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tal structure. The scattered beam hits a detector, with the signal recorded as
a spot. Multiple measurements are taken at various angles to obtain multiple
diffraction spots relating to the unit cell of the crystal. Measurements at dif-
ferent angles are not necessarily needed though if the sampling area contains
numerous randomly orientated nanocrystals. The resulting pattern is a series
of concentric circles made up of these diffraction spots, with each circle indica-
tive of a lattice plane.5,6 SAED measurements were collected on a FEI Tecnai
TF20 instrument fitted with a field emission gun, operated at 200 keV, at the
University of Glasgow, by Fraser J. Douglas and Donald MacLaren.
2.1.3 Vibrational spectroscopy
Vibrational spectroscopy is a technique which measures the interaction of
chemical bonds with radiation of specific wavelengths. Chemical bonds are
capable of absorbing radiation, which will excite the molecule. The nature of
the excitation (and which groups are affected) is dependant on the wavelength
of light used. Infra-red and visible light causes the bonds within the structure
to vibrate. This vibration can be a bending or stretching of the bond which
is either symmetrical or anti symmetrical to the molecule as a whole and is
specific to that type of bond. This specificity allows chemical bonds to be as-
signed to these vibrations, multiple vibrations results in a pattern that is unique
to a chemical structure. Two vibrational spectroscopy techniques have been
employed here: infra-red (IR) spectroscopy and Raman spectroscopy. The
two methods are complementary as the measurable vibrations are dictated
by selection rules, with one method being able to detect vibrations that the
other cannot. IR absorption causes a change of charge separation in polar
molecules. Therefore IR light is only absorbed if the molecule has a perma-
nent dipole moment. Raman spectroscopy depends on the polarisability of
molecule and relates to how the molecules polarisability can be deformed.
IR spectroscopy measures the absorption of light by the sample. In a stan-
dard FTIR measurement, a sample is exposed to a range of IR wavelengths.
Some of this light is absorbed by the sample and the remaining light hits the
detector and compared with a full reference beam. The wavelengths of the
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infra-red light that is shone on the sample changes slightly and another mea-
surement is taken. This is repeated and a spectrum is produced containing
multiple absorptions. These absorptions can be assigned to chemical bonds
which can be used in identifying the composite. The IR instrument used for
analysis is the Shimadzu IRAffinity-1. Dried powders were characterised us-
ing the golden gate bridge component. All measurements were taken over a
range of 400-4000 cm−1 with a resolution of 1 cm−1 for 256 scans. A back-
ground spectrum was taken before every session using the parameters above
to eliminate interfering signals from atmospheric H2O and CO2.
Raman spectroscopy measurements involve exciting the sample with a
laser of a specific wavelength within the visible light range of the electromag-
netic spectrum. The sample is excited by the light and releases an inelastic
scattered photon of a different energy, either higher (anti-Stokes) in energy,
or lower (Stokes) in energy to the excitation wavelength (Rayleigh line). This
photon is detected and the difference between the excitation wavelength is
characteristic of the vibrational mode that was excited by the light, allowing the
peaks to be assigned to a chemical structure. Raman measurements were
collected using a Horiba Jobin Yvon LabRAMHR system. The system was cal-
ibrated with a silica standard and samples were focuses using 50x objective
lens. For sample measurements, a spatula tip of the dried powder was placed
on a aluminium tray (aluminium is Raman invisible). All samples were tested
with the 35 mW 637 nm (red) laser using a 10% and 25% filter. Acquisition
time was 3 seconds with a total of 30 acquisitions for each measurement. An
average measurement took 90 seconds and each sample was tested multiple
times.
2.1.4 Thermogravimetric analysis (TGA)
TGA can be used to identify and quantify the organic components of the
nanocomposite. TGA measurements involve monitoring a samples mass over
a range of increasing temperatures. The principal behind TG analysis is that as
a multicomponent material is heated, the individual components will degrade
and vaporise, decreasing the sample mass. The decomposition temperatures
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of the components are specific to the material and the individual mass losses
of specific components can be identified. This leads to the formation of a mul-
tistep TGA profile with each step relating to a specific component of the com-
posite. In addition to identifying the individual component, the mass loss of the
steps can be used to quantify how much material is bound to the composite.
During a measurement, the sample is heated in a sealed chamber with the
internal environment determined by the gas cylinder attached to the machine.
Therefore the environment the sample is heated in can be controlled, which
can be used to induce transitions such as oxidation during the measurement.7
Attaching a compressed air cylinder to the machine will cause the sample to
oxidise during heating, whereas if a oxygen free gas is used (i.e. nitrogen or
argon), the oxidation of the sample can be limited. High temperature transi-
tions such as oxidation occur over a specific temperature range and can cause
the sample to change in mass, which will be reflected as a mass gain/loss in
the TGA profile. This change can then be cross referenced with similar TGA
profiles in the literature and can give an indication on the transformation of the
material when heated in certain atmospheres. TGA measurements were done
on a Netsch STA 409 PC Luxx. All measurements were performed in an air en-
vironment unless specified otherwise. 25 mg of the dried powder was heated
in a alumina crucible to 700◦C with a ramp of 3 ◦C/min.
2.1.5 Nuclear magnetic resonance (NMR) spectroscopy
NMR spectroscopy can be used to identify the chemical structure of the organic
stabiliser materials and to confirm the formation of coupling bonds (i.e. amide
bonds). 1H NMR spectroscopy measures the magnetic moment of protons in
a sample. The magnetic moment generated by a proton is very small but in
a sample there is a very large amount of protons, causing the small magnetic
spins to generate a significant net signal which can be measured. In a mea-
surement, the spins are aligned with an external field and a radio pulse is used
to excite/knock the signals off the applied axis. The spins will then realign to
this applied field and this relaxation process is measured. The resulting signal
can then be interpreted and assigned to a chemical structure, based on the
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chemical shifting of the peaks. NMR data was collected using a JEOL ECS
spectrometer (400 MHz). Single pulse 1H NMR data at 25◦C was collected
of the samples. All samples were dissolved in D2O solvent, with TMS used
as a reference peak. Data were collected and analysed using the Jeol Delta
software package
2.1.6 Transmission electron microscopy (TEM)
Electron microscopy can be employed to identify and measure particle mor-
phology and size. TEM is ideal for nanoparticle analysis as image resolution
is high enough to allow crystallite size and morphology measurements. TEM
images are obtained by firing an electron beam through a sample. The beam
passes through thin areas of the sample while the dense areas absorb more
of the beam. The electrons that pass through then hit a detector creating an
image, with the areas that absorbed the beam generating contrast. As such
the prepared samples need to be thin enough to allow passage of the elec-
trons and of low concentrations so clustering does not obscure the particles.
The samples were measured on a JEOL JEM (200-fx) at 120 kV. Dry samples
were dispersed in ethanol and sonicated for 15 minutes. A drop of the solu-
tion was then transferred onto a carbon coated copper grid, covered and left
to dry overnight for analysis. For water based samples, 100 µL was dispersed
in 3 mL millipore water. A drop of this solution was placed on a carbon coated
copper grid, covered and left to dry overnight. Samples exposed to a magnetic
field were prepared in the same way but was left to dry over a 2 T magnetic
block overnight. Images were taken at 100x, 200x and 40000x magnification.
Particle sizing was done using the ImageJ software and for every sample 100
particles were measured to calculate an average size and standard deviation.
High resolution TEM were performed on a FEI Tecnai TF20 instrument fitted
with a field emission gun, operated at 200 keV at the University of Glasgow,
by Fraser J. Douglas and Donald MacLaren. HR-TEM samples were prepared
by dispersing the sample in deionised water and dropping the solution onto an
amorphous holey carbon coated grid.
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2.1.7 Dynamic light scattering (DLS)
DLS measures the hydrodynamic radius and clustering of particles in solution.
Knowledge of cluster size and the size distribution profiles can infer water sta-
bility and determine the particles suitability for biomedical applications. DLS
measurements work by tracking the movement and speed of particles in so-
lution using a laser. In solution the particles undergo Brownian motion (the
random movement of particles due to the interaction of other particles). A
DLS measurement takes multiple scans of the sample in quick succession and
compares the images to track the movement and speed of the particles in so-
lution. The Stokes-Einstein equation defines the relationship between particle





where D is the diffusion constant, kB is the Boltzmann constant, T is tem-
perature, η is the dynamic viscosity and r is radius of the particles. Using this
equation it can be calculated that larger particles have lower diffusion coeffi-
cients, resulting in slower movement in solution. DLS utilises this principle by
measuring the movement and speed of particles throughout a series of mea-
surements. If there has been large particle movement between the scans, this
indicates fast unimpeded movement (due to high diffusion coefficients) and that
the particles are quite small. The reverse is true with larger particles, with little
movement indicating a small diffusion coefficient. The detection of this particle
movement is done through the scattering of light by the particles in solution. In
a measurement a laser is shone into the solute and suspended particles will
deflect this light into a detector. This is recorded as a light spot in an image. For
a suspension, there will be a large amount of scattering resulting in a speckle
pattern consisting of light and dark spots. Multiple patterns are collected and
compared. If there is correlation between the patterns, large particle sizes can
be inferred from this. Inversely if there is little correlation between the patterns,
then significant particle movement must be causing this variation suggesting
smaller particle sizes. Algorithms are then applied to the correlation between
the signals to calculate the size distribution.
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The DLS instrument used for analysis was a Zeta sizer nano series (Nano-
ZS) manufactured by Malvern Instruments. All samples were tested in dispos-
able low volume plastic cuvettes (1 mL) at 25◦C. A single measurement con-
sists of between 12-20 scans (which was determined by the software). Each
measurement was repeated 3 times and averages were calculated from the
results. Samples were measured repeatedly over several months to determine
the effect of time on water stability and the hydrodynamic radius of the sample.
All measurements passed software quality checks, unless noted otherwise.
2.1.8 Zeta potentials
Zeta potential measurements can be used to additionally confirm particle water
stability. Zeta potentials are a measure of a particles surface charge which can
provide information on clustering. When dispersed in solution, the particles
are either positively or negatively charged ions. The particles attract solvent
ions of opposite charge, leading to the formation of an electrical double layer
(Figure 16). Solvent ions that are close to the surface are strongly bound to the
particle forming the inner Stern layer, while solvent ions further away are only
loosely bound. Loosely bound ions in this area form the second outer layer,
called the diffuse layer. Ions within this diffuse layer will still move with the par-
ticle in the solution, but ions at a distance beyond this layer are unaffected by
the particles’ charge. The boundary to the diffuse layer and beyond is known
as the slipping plane and the potential that exists at the slipping plane is the
zeta potential of the particle. This is a measure of the potential difference be-
tween the particles diffuse layer and the dispersion medium, with the potential
varying depending on the distance between the slipping plane and the parti-
cle surface. A particle with a high surface charge will have a greater effect on
solvent ions in solution, resulting in a larger slipping plane and therefore in-
creasing the zeta potential. If this zeta potential is a high value, the particles in
solution will tend to repel each other and not cluster and flocculate. If the zeta
potential is low, then there is not this repulsion force, that will stop clustering.
The dividing line where the zeta potential is large enough to repel neighbouring
particles is accepted at above +30 mV or below -30 mV.8
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Figure 16: When dispersed in solution, an electrical double layer forms around the
particle. For a negatively charged iron oxide nanoparticles, initially a strongly bound
positively charged solvent layer forms on the particle surface. This charge then attracts
oppositely charged solvent ions to form a weakly bound outer layer, and an overall
electrical double layer. Beyond this double layer, the charged solvent ions are not
attracted to the iron oxide. The boundary between the outer layer and beyond is known
as the slipping plane. The potential of the slipping plane is the zeta potential of the
particle.
A particles zeta potential is measured using electrophoresis. A specialist
zeta cell containing two electrodes is filled with the tested suspension. A elec-
trical current is passed through the cell, causing the charged particles to move
to the opposite electrode. The movements of the particles are measured with a
laser. Particles with a greater zeta potential move faster than the particles with
a lower zeta potential. Zeta potentials were measured on a zeta sizer nano
series (Nano-ZS) manufactured by Malvern Instruments. Samples were tested
in a disposable folded capillary zeta cell. Each measurement consisted of 12
runs and 3 measurements for each sample with averages being calculated
from these measurements.
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2.1.9 Biological cell testing
Toxicity studies were undertaken at the School of Biosciences at the University
of Kent and performed on UKF-NB-3 neuroblastoma cells, primary human reti-
nal pigment epithelial cells (RPE) and Primary human fibroblasts (HFF). Mea-
surements were taken by James D. Budge, Lara C. Sanders, Martin Michaelis
and Mark Smales. Dispersions were incubated with these cells with increasing
concentration for one week. The aim was to ensure that the nanocomposite
base was non toxic and biocompatible with a wide range of cells. An MTT
dye assay was then used to determine the cell viability after one week. UKF-
NB-3 cells were cultivated in IMDM supplemented with 10% foetal calf serum
(FCS), 100 IU/mL penicillin, and 100 mg/mL streptomycin. Retinal pigment ep-
ithelial cells were cultured in DMEM supplemented with 20% FCS, 100 IU/mL
penicillin, and 100 mg/mL streptomycin. Fibroblasts were cultured in DMEM
supplemented with 10% FCS, 100 IU/mL penicillin, and 100 mg/mL strepto-
mycin. All cells were cultivated at 37◦C in humidified 5% CO2.9,10 Cell viability
upon the addition of nanoparticle preparations at different concentrations was
determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) dye reduction assay after 120 h of incubation.9,10
2.1.10 Magnetic property measurements
The magnetic properties of the nanocomposites were determined using a Su-
perconducting QUantum Interference Device (SQUID). SQUIDs are capable of
detecting very small changes in magnetisation values while being able to work
in a range of external magnetic fields at a variety of temperatures. This allows
the accurate assessment of the nanoparticles magnetic properties in a variety
of external conditions. A SQUID magnetometer works on the principle of a
Josephson junction to detect the changes in magnetisation. The Josephson
effect is a supercurrent, a current that flows indefinitely without the addition of
a voltage. The Josephson junction is constructed from two superconductors
separated by a thin layer. In a SQUID measurement, the sample is passed
through the coils containing the supercurrent, under an applied magnetic field.
The magnetic flux of the tested sample will affect this supercurrent. A change
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in magnetic flux of the sample causes a proportional change in the current of
the superconducting loop. The voltage of the current is monitored which al-
lows changes in magnetisation to be equated to changes in voltage. Under
standard conditions the current is split equally between the system. With the
addition of the samples magnetic field, this current will begin to favour one side
of the system and starts to split causing different voltage readings through-
out the system. This change of voltage is recorded with a sensitive detec-
tor, allowing SQUIDs to detect very small changes in magnetisation. SQUID
measurements were taken at the University of Glasgow and at the University
of California, Santa Barbara on a Quantum Design SQUID magnetometer by
Serena A. Corr, Oonagh M. Collins and Edmund J. Cussen. Samples were
immobilised within wax to stop particle agitation during measurements. Mea-
surements involved several cycles collecting data between 20 x 103 G to -20 x
103 G. All samples were tested at both 300 K and 10 K, to observe magnetic
properties.
2.1.11 Atomic absorption spectroscopy (AAS)
AAS determines the elemental composition and concentrations of metal ions
in a composite. AAS can be used to calculate the iron concentrations of dis-
persions, which can then be used alongside MRI testing to calculate relaxivity
values for the dispersions. AAS works on calculating the absorption of light
by vaporised metals and correlating this to the Beer-Lambert law so a concen-
tration can be calculated. The sample is prepared by dissolving completely in
acid and then vaporised using a flame atomiser, freeing the metal ions. Now in
the gas state, the metal ions can be excited by light. Excitation of the particles
is due to the absorption of light with a wavelength specific to the metal that
is being excited (for example, for iron detection a lamp with a wavelength of
302.1 nm is needed). The AAS used was an AAnalyst 800 manufactured by
Perkin Elmer. For all samples a calibration curve made up of five iron stan-
dards (ranging from 1-10 ppm) with concentrations and absorptions calculated
before the measurement. AAS samples were made from the final washings of
the samples with 5 drops of HCl added to 1 mL of the washing. The sample
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was then heated and evaporated to form a concentrated liquid. Millipore water
was then added to the sample and evaporated off another 3 times. The final
concentrated liquid was then diluted with millipore water (25 mL) and trans-
ferred into a volumetric flask for later use. Iron samples were tested with the
302.1 nm wavelength lamp with a slit width of 0.2 nm.
2.1.12 MRI measurements
MRI measurements allow for determination of relaxivities of the magnetic
nanocomposites to evaluate their efficacy as contrast agents. MR imaging
was performed at Kings College London by Jindrich Cinatl Jr., Dirk Krueger
and Rafael T. M. de Rosales with a standard extremity flex coil on a clinical 3T
MRI scanner (Achieva, Philips Healthcare, Best, The Netherlands). T2 was de-
termined with a 2D multi-spin-echo sequence. The acquired imaging data was
transferred to a computer running Matlab and analysed using an in-house Mat-
lab tool to obtain the relaxation time, T2, for each Fe concentration. Excel was
used to plot the relaxation rate, R2, over the concentration and the relaxivity
value was determined using linear regression.
2.1.13 UV-Vis and fluorescence spectroscopy
UV-Vis spectroscopy measures the excitation of electrons by the absorption
of light, whereas fluorimetry detects the emission of energy as photons by
the excited electrons returning back to the ground state. Materials that are
conjugated contain pi or non bonding electrons which can absorb ultra-violet
to visible light. When exposed to this light, the electrons absorb this energy
and become excited, promoting them to higher orbitals. This is the transition
from the highest occupied molecular orbital (HOMO) to the lowest unoccupied
molecular orbital (LUMO). The wavelength required for this transition relates
to the energy gap between the HOMO and LUMO states, with a larger gap
requiring longer wavelengths to excite. The electrons cannot maintain this ex-
cited state and will decay back down to a ground state, releasing this energy in
a variety of processes, which is measured by fluorescence spectroscopy. UV-
Vis spectroscopy looks at the transition of the electron from the ground state to
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the excited state. The absorbance of light by a sample is dictated by the Beer
lambert law (which is related to the concentration of fluorescent groups within
the sample), which outlines the selection rules to determine which electronic
transitions are allowed and which are forbidden. A scanning monochroma-
tor allows specific wavelengths to be used, allowing a measurement to cycle
through a range of wavelengths. As absorption follows the Beer-Lambert law,
samples must be diluted before measurement as the law only works with low
concentrations of samples (below an absorbance of 1). Additionally, scatter-
ing of light by inorganic groups can affect UV-Vis measurements, limiting its
application with nanocomposites containing inorganic cores.11,12 All UV-Vis
measurements were performed on a UNIcam UV-500 containing a deuterium
(200-400 nm) and tungsten lamp (300-700 nm) with lamp change at 325 nm. All
samples were measured in a low volume glass cuvette (1 mL) and the system
was dual beam requiring a second matching cuvette filled with a standard/blank
to be in at all times. Measurements were taken between 200-600 nm, with a
resolution of 4 nm and a normal scan speed. All samples were tested in (or
diluted with) millipore water unless stated otherwise.
Fluorometry was used to observed the energy release from the transition
of excited electrons back to the ground state. Fluorescence is the release
of this excited energy as a photon and can be measured using a fluorime-
ter. The wavelength emitted through this energy release is specific to the
fluorophore that is used, allowing fluorimetry to be used as an identification
technique confirming the binding of fluorescent groups. This technique can
also measure any quenching effects from attaching fluorescent groups to the
magnetic nanocomposites. Quenching can occur with magnetic materials and
can reduce the fluorescence of materials which is undesirable. The unpaired
electrons in the magnetic core provide an alternative pathway for the excitation
energy to dissipate into. This reduces energy that can be released by the flu-
orophore as a photon reducing the overall fluorescence. Weak fluorescence
can limit the materials use in biological applications such as confocal imaging,
but this effect can be limited through the careful use of spacers to separate
the magnetic component from the fluorescent component. Two types of mea-
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surements can be taken with a fluorimeter, an excitation scan and a emission
scan. An emission scan maps the emission of photons from fluorophores by
exciting the sample at a specific wavelength. Using the absorption maxima
obtained from UV-Vis spectroscopy, the sample is excited at a specific wave-
length and detectors within the fluorimeter track the emission of the sample,
to determine the optimal emission wavelength. The other type of scan is an
excitation spectrum and is the opposite to an emission spectrum. With this the
detection wavelength is kept constant (the emission wavelength) and the ex-
citation wavelengths are cycled to measure the absorption of the sample. As
such an excitation spectrum can be similar to a UV-Vis absorption spectrum.
Excitation measurements are also unaffected by light scattering from the inor-
ganic cores, allowing for excitation measurements for materials with inorganic
cores.12 All measurements were performed on a FluoroMax-2 manufactured
by Jobin YVON SPEX Instruments S.A. The dispersions collected from the
composites were tested in a clear 4 sided quartz curvette. Emission and ex-
citation spectra were obtained for all samples, 20 measurements were taken
for each spectrum with the results averaged out. Excitation and emission slit
widths were set to 2 nm.
2.1.14 Confocal imaging
Confocal microscopy allows for the imaging of fluorescent materials. Tradi-
tionally fluorescent microscopy methods involves exciting the entire sample
with a low wavelength light and then detecting the higher wavelength emis-
sion. Confocal imaging follows the same principle but differs in two different
ways. Instead of flooding the entire sample with light (which can interfere with
measurements), the sample is instead excited by a single beam of light, which
limits the unwanted excitation and emission of neighbouring areas. Confocal
imaging also uses a spatial pinhole over the detector to limit the background
light from hitting the detector. The aim is to limit fluorescence of the sample in
areas out of focus of the microscope as these will adversely effect the image.
This results in improved resolution and contrast of the image, but the point
excitation method can only measure a small area requiring scanning of the im-
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age. Confocal measurements were taken at the University of Kent by James D.
Budge, Lara C. Sanders, Martin Michaelis and Mark Smales to monitor the up-
take of fluorescent nanoparticles into UKF-NB-3 neuroblastoma cells. Multiple
images at varying depths were taken to confirm particle distribution through-
out the cell. UKF-NB3 cells were seeded at 2 x 105 cells/well in a 24 well
plate, containing a coverslip in each well, and grown at 37◦C for 48 hours.
Rhodamine conjugated nanoparticles were diluted to 0.099 mg/L iron concen-
tration in media, 1 mL added to appropriate wells and incubated for 3 hours
before aspirating and fixing with methanol at -20◦C for 5 minutes. Coverslips
were mounted using mowiol and anti-fade and slides examined using a Leica
confocal laser scanning (TCS 4; x 63 oil lens) microscope.
2.2 Materials and equipment
Hydrochloric acid, potassium dihydrogen phosphate, dipotassium hydrogen
phosphate and sodium chloride were acquired from Fisher Scientific. All other
chemicals were obtained from Sigma Aldrich. All water used was millipore
water, obtained from a Barnstead easy pure II machine by Thermo Scientific.
The microwave synthesiser used was a CEM Discover SP. The centrifuge used
was a Sanyo Centaur 2 MSE. Air sensitive reactions were performed using a
Schlenk line, using N2 gas to provide the inert atmosphere. Toxic or air sensi-
tive materials were prepared in a glove box and stored in sealed Schlenk tubes.
The glove box used is an MBraun Labstar. Powders were stored in glass vials
filled with nitrogen before and after the addition of the powder. Water washings
were stored in 50 mL centrifuge tubes.
2.3 Synthetic procedures for chapter 3
2.3.1 Deoxygenated water
Millipore water (100 mL) was heated to boiling in a round bottom flask using
a heating mantle. The sample was then taken off the heat and left to cool
naturally for over 3 hours with nitrogen gas bubbled into the water at a slow but
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constant rate. Once cooled, the nitrogen flow was stopped and the flask was
sealed with parafilm. The water was used within 3 days after preparation.
2.3.2 Microwave heating water reactions
Deoxygenated water (22.5 mL) was transferred into a microwave vessel
(30 mL) with magnetic fleas and sealed using a plastic cap. The system was
then programmed to heat the sample to 150◦C with the power set to 10 W.
The sample was given 20 minutes ramping time, 5 minutes reaction time and
then cooled naturally (with none of the samples taking longer than 40 minutes
to cool). The measurement was repeated with the power increasing by 10 W
increments, with the final measurement heating at 150 W. 15 measurements
were taken in total.
2.3.3 Microwave assisted synthesis of magnetite nanoparticles
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. The solution was heated to
80◦C in an oil bath. Ammonium hydroxide (10 mL, 28-30%) was injected into
the heated solution forming a jet black precipitate. The solution was stirred for
20 minutes. The suspension was transferred into a microwave tube (30 mL)
and sealed with a rubber cap. The tube was heated by microwave radiation to
150◦C at 100 W for 20 minutes (including an additional 10 minutes allocated by
the instrument for temperature ramping). Once cooled the sample was washed
by magnetic decantation with millipore water (30 mL x 5) and ethanol (20 mL).
The black powder was stored in a glass vial and the washings were discarded.
2.3.4 Microwave assisted synthesis of cobalt ferrite nanoparticles
Cobalt (II) nitrate hexahydrate (1.4582 g, 5 mmol) and iron (II) chloride tetrahy-
drate (1.981 g, 10 mmol) were weighed out in a glove box. Cobalt (II) nitrate
hexahydrate is toxic, therefore these materials were weighed out in a glove box
to minimise particle exposure. These were then dissolved in deoxygenated
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water (12.5 mL) and stirred for 15 minutes. An wine red solution formed. The
solution was heated to 80◦C in an oil bath. Ammonium hydroxide (10 mL, 28-
30%) was injected into the heated solution forming a jet black precipitate. The
solution was stirred for 20 minutes. The suspension was taken out of the oil
bath and left to cool for 10 minutes. The suspension was then transferred into
a microwave tube (30 mL) and sealed with a rubber cap. The tube was heated
by microwave radiation to 150◦C at 100 W for 20 minutes (including an addi-
tional 10 minutes allocated by the instrument for temperature ramping). Once
cooled the sample was washed by magnetic decantation with millipore water
(30 mL x 5) and ethanol (20 mL). The black powder was stored in a glass vial
and the washings were discarded.
2.3.5 Microwave assisted synthesis of copper ferrite nanoparticles
Copper (II) chloride dihydrate (0.851 g, 5 mmol) and iron (II) chloride tetrahy-
drate (1.985 g, 10 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. A lime green solution formed. The solution was heated
to 80◦C in an oil bath. Ammonium hydroxide (10 mL, 28-30%) was injected into
the heated solution forming a dark black precipitate. The solution was stirred
for 20 minutes. The suspension was taken out of the oil bath and left to cool
for 10 minutes. The suspension was then transferred into a microwave tube
(30 mL) and sealed with a rubber cap. The tube was heated by microwave
radiation to 150◦C at 100 W for 20 minutes (including an additional 10 minutes
allocated by the instrument for temperature ramping). Once cooled the sam-
ple was washed by magnetic decantation with millipore water (30 mL x 5) and
ethanol (20 mL). The black powder was stored in a glass vial and the washings
were discarded.
2.3.6 Microwave assisted synthesis of manganese ferrite nanoparticles
Manganese (II) chloride tetrahydrate (0.989 g, 5 mmol) and iron (III) chlo-
ride hexahydrate (2.701 g, 10 mmol) were dissolved in deoxygenated water
(12.5 mL) and stirred for 15 minutes. An dark orange solution formed. The
solution was heated to 80◦C in an oil bath. Ammonium hydroxide (10 mL, 28-
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30%) was injected into the heated solution forming a black precipitate. The
solution was stirred for 20 minutes. The suspension was taken out of the oil
bath and left to cool for 10 minutes. The suspension was then transferred into
a microwave tube (30 mL) and sealed with a rubber cap. The tube was heated
by microwave radiation to 150◦C at 100W for 20 minutes (including an addi-
tional 10 minutes allocated by the instrument for temperature ramping). Once
cooled the sample was washed by magnetic decantation with millipore water
(30 mL x 5) and ethanol (20 mL). The black powder was stored in a glass vial
and the washings were discarded.
2.3.7 One pot microwave assisted synthesis of iron oxide nanoparticles
Urea (0.719 g, mmol) was dissolved in deoxygenated water (12.5 mL) and and
stirred for 15 minutes. Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and
iron (II) chloride tetrahydrate (0.990 g, 5 mmol) were then dissolved in the urea
solution. An orange solution formed. The solution was transferred into a mi-
crowave tube (30 mL) and sealed with a rubber cap. The tube was heated by
microwave radiation to 150◦C at 100W for 20 minutes (including 10 minutes for
temperature ramping). Once cooled a brick red precipitate formed. The sam-
ple was washed by magnetic decantation with millipore water (30 mL x 5) and
ethanol (20 mL). The red powder was stored in a glass vial and the washings
were discarded.
2.4 Synthetic procedures for chapter 4
2.4.1 Microwave assisted synthesis of magnetite nanoparticles sta-
bilised with poly(sodium 4-styrenesulfonate)
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL)
and stirred for 15 minutes. An orange solution formed. Poly(sodium-4-
styrenesulfonate) (0.1 g, 1.4µmol, 70,000 Mwt) was then added to the iron
chloride solution. The solution was heated to 80◦C in an oil bath. Ammonium
hydroxide (10 mL, 28-30%) was injected into the heated solution forming a jet
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black precipitate. The solution was stirred for 20 minutes. The suspension was
taken out of the oil bath and left to cool for 10 minutes. The suspension was
then transferred into a microwave tube (30 mL) and sealed with a rubber cap.
The tube was heated by microwave radiation to 150◦C at 100W for 20 minutes
(including an additional 10 minutes allocated by the instrument for temperature
ramping). Once cooled the sample was washed by magnetic decantation with
millipore water (30 mL x 5) and ethanol (20 mL). After the second water wash-
ing a stable suspension formed. The black powder was stored in a glass vial
and the third, forth and fifth washing was stored in a centrifuge tube and kept
stationary. The other washings were discarded.
2.4.2 Microwave assisted synthesis of magnetite nanoparticles sta-
bilised with sodium polyphosphate
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Sodium polyphosphate
(0.1 g, 1 µmol, 100,000 Mwt) was then added to the iron chloride solution.
The solution was heated to 80◦C in an oil bath. Ammonium hydroxide (10 mL,
28-30%) was injected into the heated solution forming a jet black precipitate.
The solution was stirred for 20 minutes. The suspension was taken out of the
oil bath and left to cool for 10 minutes. The suspension was then transferred
into a microwave tube (30 mL) and sealed with a rubber cap. The tube was
heated by microwave radiation to 150◦C at 100W for 20 minutes (including an
additional 10 minutes allocated by the instrument for temperature ramping).
Once cooled the sample was washed by magnetic decantation with millipore
water (30 mL x 5) and ethanol (20 mL). After the second water washing a stable
suspension formed. The black powder was stored in a glass vial and the third,
forth and fifth washing was stored in a centrifuge tube and kept stationary. The
other washings were discarded.
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2.4.3 Microwave assisted synthesis of Fe3O4/poly(sodium 4-
styrenesulfonate) nanoparticles functionalised with Rhodamine
B
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL)
and stirred for 15 minutes. An orange solution formed. Poly(sodium-4-
styrenesulfonate) (0.1 g, 1.4 µmol, 70,000 Mwt) was then added to the iron
chloride solution. The solution was heated to 80◦C in an oil bath. Ammonium
hydroxide (10 mL, 28-30%) was injected into the heated solution forming a jet
black precipitate. The solution was stirred for 20 minutes. The suspension was
taken out of the oil bath and left to cool for 10 minutes. The suspension was
then transferred into a microwave tube (30 mL) and sealed with a rubber cap.
The tube was heated by microwave radiation to 150◦C at 100W for 20 minutes
(including an additional 10 minutes allocated by the instrument for tempera-
ture ramping). Once cooled the sample was washed by magnetic decantation
with millipore water (30 mL x 2) and redispersed into millipore water (30 mL).
Rhodamine B (0.005 g, 0.01 mmol) was dissolved in millipore water (10 mL)
and then added to the iron oxide solution. This was left to stir for 1 hour. The
solution was drained and then washed by magnetic decantation with millipore
water (30 mL x 5) and ethanol (20 mL). A water stable suspension formed im-
mediately. The black powder was stored in a glass vial and the third, forth and
fifth washing were stored in a centrifuge tube and kept stationary. The other
washings were discarded.
2.5 Synthetic procedures for chapter 5
2.5.1 Microwave assisted synthesis of magnetite nanoparticles sta-
bilised with poly(acrylic acid)
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Poly(acrylic acid) (0.1 g)
was then added to the iron chloride solution. Three different stabilisers were
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tested:
Table 3: The PAA polyelectrolyte sizes and classifications used to stabilise iron oxide
particles in chapter 5
Polyelectrolyte name Polyelectrolyte Mwt Sample name
V. Low Mwt 1,800 Sample A
High Mwt 400,000-500,000 Sample B
V. High Mwt 1,250,000 Sample C
The solution was heated to 80◦C in an oil bath. Ammonium hydroxide
(10 mL, 28-30%) was injected into the heated solution forming a jet black pre-
cipitate. The solution was stirred for 20 minutes. The suspension was taken
out of the oil bath and left to cool for 10 minutes. The suspension was then
transferred into a microwave tube (30 mL) and sealed with a rubber cap. The
tube was heated by microwave radiation to 150◦C at 100W for 20 minutes (in-
cluding an additional 10 minutes allocated by the instrument for temperature
ramping). Once cooled the sample was washed by magnetic decantation with
millipore water (30 mL x 5) and ethanol (20 mL). After the second water wash-
ing a stable suspension formed. The black powder was stored in a glass vial
and the third, forth and fifth washing were stored in a centrifuge tube and kept
stationary. The other washings were discarded.
2.5.2 Microwave assisted synthesis of magnetite nanoparticles sta-
bilised with poly(diallyldimethylammonium chloride)
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chlo-
ride tetrahydrate (0.990 g, 5 mmol) were dissolved in deoxygenated wa-
ter (12.5 mL) and stirred for 15 minutes. An orange solution formed.
Poly(diallyldimethylammonium chloride) (0.1 g) was then added to the iron
chloride solution. Three different stabilisers were tested:
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Table 4: The pDADMAC polyelectrolyte sizes and classifications used to stabilise iron
oxide particles in chapter 5
Polyelectrolyte name Polyelectrolyte Mwt Sample name
Low Mwt <100,000 Sample D
Medium Mwt 100,000-200,000 Sample E
High Mwt 400,000-500,000 Sample F
The solution was heated to 80◦C in an oil bath. Ammonium hydroxide
(10 mL, 28-30%) was injected into the heated solution forming a jet black pre-
cipitate. The solution was stirred for 20 minutes. The suspension was taken
out of the oil bath and left to cool for 10 minutes. The suspension was then
transferred into a microwave tube (30 mL) and sealed with a rubber cap. The
tube was heated by microwave radiation to 150◦C at 100W for 20 minutes (in-
cluding an additional 10 minutes allocated by the instrument for temperature
ramping). Once cooled the sample was washed by magnetic decantation with
millipore water (30 mL x 5) and ethanol (20 mL). After the second water wash-
ing a stable suspension formed. The black powder was stored in a glass vial
and the third, forth and fifth washing were stored in a centrifuge tube and kept
stationary. The other washings were discarded.
2.6 Synthetic procedures for chapter 6
2.6.1 Phosphate buffer solution
Potassium dihydrogen phosphate (0.023 g, 0.169 mmol), dipotassium hy-
drogen phosphate (0.023 g, 0.132 mmol) and sodium chloride (0.876 g,
14.9 mmol) was dissolved in millipore water (100 ml).
2.6.2 EDCI coupling of dopamine to poly(acrylic acid) using organic sol-
vents
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (0.321 g, 1.67 mmol)
was dissolved in dimethylformamide (10 mL) and triethylamine (18 mL). A
cloudy white suspension formed. The solution was cooled in an ice bath.
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Poly(acrylic acid) (0.973 g, 0.54 mmol, 1800 Mwt) was added to the solution.
This solution was heated to 80◦C and took 20 minutes to fully dissolve. In a
separate container, dopamine hydrochloride (0.473 g, 2.5 mmol) was dissolved
in dimethylformamide (10 mL) and triethylamine (18 mL). This was stirred for 30
minutes and then N-hydroxysuccinimide (0.037 g, 0.32 mmol) was added. The
solutions were mixed and left to heat at 80◦C for 5 days.The solution changed
to a dark red colour after 24 hours. This colour lightened after 48 hours and a
dark brown sludge formed. After 5 days, the solution was evaporated using a
rotary evaporator leaving behind a viscous dark brown liquid. This was stored
in a glass vial under nitrogen
2.6.3 EDCI coupling of dopamine to poly(acrylic acid) using water
Poly(acrylic acid) (0.218 g, 0.12 mmol, 1800 Mwt) and 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDCI) (0.173 g, 0.9 mmol) were dis-
solved in phosphate buffer solution (30 mL). Dopamine hydrochloride (0.171 g,
0.9 mmol) was then added to form a cloudy white solution. The pH of the solu-
tion was 6 and needed no further adjustment. The solution was stirred for 48
hours. The solution was then purified with dialysis and the excess solvent was
evaporated to leave a white powder.
2.6.4 Co-precipitation of Fe3O4 nanoparticles stabilised with dopamine
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochloride
(0.100 g, 0.52 mmol) was then added to the iron chloride solution. The solution
then changed to a dark green colour. The solution was heated to 80◦C in an
oil bath. Ammonium hydroxide (10 mL, 28-30%) was injected into the heated
solution forming a jet black precipitate. The solution was stirred for 20 minutes.
Once cooled the sample was washed by magnetic decantation with millipore
water (30 mL x 5) and ethanol (20 mL). After the second water washing a stable
suspension formed. The black powder was stored in a glass vial and the third,
forth and fifth washing were stored in a centrifuge tube and kept stationary.
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The other washings were discarded.
2.6.5 Co-precipitation of Fe3O4 nanoparticles stabilised with a
dopamine/poly (acrylic acid) composite prepared in organic
solvents
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. The dopamine/poly(acrylic
acid) composite (0.100 g, 1,800 Mwt PAA) was then added to the iron chloride
solution. A brown precipitate appeared to form with the addition of the sta-
biliser. The solution was heated to 80◦C in an oil bath. Ammonium hydroxide
(10 mL, 28-30%) was injected into the heated solution forming a jet black pre-
cipitate. The solution was stirred for 20 minutes. Once cooled the sample was
washed by magnetic decantation with millipore water (30 mL x 5) and ethanol
(20 mL). After the second water washing a stable suspension formed. The
black powder was stored in a glass vial and the third, forth and fifth washing
were stored in a centrifuge tube and kept stationary. The other washings were
discarded.
2.6.6 Co-precipitation of Fe3O4 nanoparticles stabilised with a
dopamine/poly (acrylic acid) composite prepared in water
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. The dopamine/poly(acrylic
acid) composite (0.100 g, 1,800 Mwt PAA) was then added to the iron chlo-
ride solution. The solution then changed to a dark green colour. The solution
was heated to 80◦C in an oil bath. Ammonium hydroxide (10 mL, 28-30%) was
injected into the heated solution forming a jet black precipitate. The solution
was stirred for 20 minutes. Once cooled the sample was washed by magnetic
decantation with millipore water (30 mL x 5) and ethanol (20 mL). After the sec-
ond water washing a stable suspension formed. The black powder was stored
in a glass vial and the third, forth and fifth washing were stored in a centrifuge
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tube and kept stationary. The other washings were discarded.
2.6.7 Co-precipitation of Fe3O4 nanoparticles stabilised with
dopamine/acridine-9-carboxylic acid composite
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochloride
(0.100 g, 0.52 mmol) was then added to the iron chloride solution. The solu-
tion then changed to a dark green. The solution was heated to 80◦C in an
oil bath. Ammonium hydroxide (10 mL, 28-30%) was injected into the heated
solution forming a jet black precipitate. The solution was stirred for 20 minutes.
Once cooled the sample was washed by magnetic decantation with millipore
water (30 mL x 2) until the solution was pH 7. In a separate round bottom
flask acridine-9-carboxylic acid (0.015 g, 0.06 mmol) was dissolved in phos-
phate buffer (30 mL). 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI)
(0.173 g, 0.9 mmol) was then added to the solution. This solution was then
added to the iron oxide suspension and was left to stir for 24 hours in the dark.
The solution was then drained and the precipitate was washed with millipore
water (30 mL x 5) and ethanol (20 mL). A stable suspension formed with the
first water washing. The black powder was stored in a glass vial and all wash-
ings were collected and stored in a centrifuge tubes. A second sample was
prepared where the sample was washed with phosphate buffer solution after
the conjugation of acridine-9-carboxylic acid. All 5 phosphate buffer washings
were collected and stored.
2.6.8 Acridine-9-carboxylic acid standard
Acridine-9-carboxylic acid was dissolved in millipore water (0.010 g,
0.044 mmol). 5 drops of hydrochloric acid was added to the solution to help
dissolve the solid.
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2.6.9 Preparation of folic acid/N-hydroxysuccinimide composite via an
carbodiimide coupling reaction
Folic acid (2.0 g, 4.5 mmol) was dissolved in dry dimethylformamide (75 mL).
N,N’-Dicyclohexylcarbodiimide (0.62 g, 3 mmol) and N-hydroxysuccinimide
(0.51 g, 4.4 mmol) were then dissolved in the solution and left to stir for 24
hours in the dark. A viscous yellow solution formed. This was then filtered
using a Buchner funnel to leave a clear yellow solution. This was then precipi-
tated in diethyl ether to form an orange precipitate. This was dried in a vacuum
oven at room temperature. The resulting product was stored in a glass vial
under nitrogen.
2.6.10 Functionalisation of magnetite/dopamine nanoparticles with a
folic acid/ N-hydroxysuccinimide composite
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochloride
(0.100 g, mmol) was then added to the iron chloride solution. The solution
colour changed to a dark green. The solution was heated to 80◦C in an oil
bath. Ammonium hydroxide (10 mL, 28-30%) was injected into the heated so-
lution forming a jet black precipitate. The solution was stirred for 20 minutes.
The precipitate was washed with millipore water (30 mL) twice and then redis-
persed in phosphate buffer (20 mL). The folic acid/N-hydroxysuccinimide com-
posite (0.080 g ) was sonicated in phosphate buffer (10 mL) for 15 minutes.
The folic acid composite was then added to the iron oxide solution and was left
to stir overnight. The solution was then drained and the precipitate was then
washed with millipore water (30 mL x 5) and ethanol (20 mL). A stable suspen-
sion formed with the first water washing. The black powder was stored in a
glass vial and all washings were collected and stored in a centrifuge tubes.
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2.6.11 Co-precipitation of Fe3O4 nanoparticles stabilised with dopamine
and poly(sodium-4-styrenesulfonate) simultaneously
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochlo-
ride (0.100 g, mmol) and poly(sodium-4-styrenesulfonate) (0.100 g, 1.4 µmol,
70,000 Mwt) were then added to the iron chloride solution. The solution then
changed to a dark green. The solution was heated to 80◦C in an oil bath.
Ammonium hydroxide (10 mL, 28-30%) was injected into the heated solution
forming a jet black precipitate. The solution was stirred for 20 minutes. Once
cooled the sample was washed by magnetic decantation with millipore water
(30 mL x 5) and ethanol (20 mL). After the third water washing a stable sus-
pension formed. The black powder was stored in a glass vial and the third to
fifth washings were stored in a centrifuge tube and kept stationary. The other
washings were discarded.
2.6.12 Co-precipitation of Fe3O4 nanoparticles functionalised with
poly(sodium-4-styrenesulfonate), dopamine, acridine-9-
carboxylic acid and folic acid.
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochloride
(0.100 g, 0.52 mmol) and poly(sodium-4-styrenesulfonate) (0.100 g, 1.4 µmol,
70,000 Mwt) were then added to the iron chloride solution. The solution then
changed to a dark green colour. The solution was heated to 80◦C in an oil
bath. Ammonium hydroxide (10 mL, 28-30%) was injected into the heated so-
lution forming a jet black precipitate. The solution was stirred for 20 minutes.
Once cooled the sample was washed by magnetic decantation with millipore
water (30 mL x 2) until the solution was pH 7. In a separate round bottom flask,
acridine-9-carboxylic acid (0.015 g, 0.067 mmol) was dissolved in phosphate
buffer (30 mL).1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (0.173 g,
0.9 mmol) was then added to the solution. This solution was then added to the
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iron oxide suspension and was left to stir for 24 hours in the dark. This solution
was then added to the iron oxide suspension and was left to stir for 24 hours
in the dark. The solution was drained using magnetic separation and then
redispersed in phosphate buffer (20 mL). The folic acid/N-hydroxysuccinimide
composite (0.080 g) was sonicated in phosphate buffer (10 mL) for 15 minutes.
The folic acid composite was then added to the iron oxide solution and was left
to stir overnight. The solution was then drained and the precipitate was then
washed with millipore water (30 mL x 5) and ethanol (20 mL). A stable suspen-
sion formed with the first water washing. The black powder was stored in a
glass vial and all washings were collected and stored in a centrifuge tubes.
2.6.13 Microwave-assisted co-precipitation of Fe3O4 nanoparticles
functionalised with poly(sodium-4-styrenesulfonate), dopamine,
acridine-9-carboxylic acid and folic acid
Iron (III) chloride hexahydrate (2.700 g, 10 mmol) and iron (II) chloride tetrahy-
drate (0.990 g, 5 mmol) were dissolved in deoxygenated water (12.5 mL) and
stirred for 15 minutes. An orange solution formed. Dopamine hydrochlo-
ride (0.100 g, 0.52 mmol) and poly(sodium-4-styrenesulfonate) (0.100 g, mmol)
were then added to the iron chloride solution. The solution then changed
to a dark green. The solution was heated to 80◦C in an oil bath. Ammo-
nium hydroxide (10 mL, 28-30%) was injected into the heated solution form-
ing a jet black precipitate. The solution was stirred for 20 minutes. The
suspension was taken out of the oil bath and left to cool for 10 minutes.
The suspension was then transferred into a microwave tube (30 mL) and
sealed with a rubber cap. The tube was heated by microwave radiation to
150◦C at 100W for 20 minutes (including an additional 10 minutes allocated
by the instrument for temperature ramping). Once cooled the sample was
washed by magnetic decantation with millipore water (30 mL x 2) until the so-
lution was pH 7. In a separate round bottom flask, acridine-9-carboxylic acid
(0.015 g, 0.067 mmol) was dissolved in phosphate buffer (30 mL).1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCI) (0.173 g, 0.9 mmol) was then added
to the solution. This solution was then added to the iron oxide suspension
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and was left to stir for 24 hours in the dark. The solution was drained using
magnetic separation and then redispersed in phosphate buffer (20 mL). The
folic acid/N-hydroxysuccinimide composite (0.080 g) was sonicated in phos-
phate buffer (10 mL) for 15 minutes. The folic acid composite was then added
to the iron oxide solution and was left to stir overnight. The solution was then
drained and the precipitate was then washed with millipore water (30 mL x 5)
and ethanol (20 mL). A stable suspension formed with the first water washing.
The black powder was stored in a glass vial and all washings were collected
and stored in centrifuge tubes.
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Chapter 3: Iron oxide Synthesis
3.1 General introduction and objectives
The magnetic property of nanoparticles is an important consideration for their
use in biomedical applications, such as magnetic hyperthermia, MR imaging,
targeted drug delivery and cell tracking.1–4 Small superparamagnetic nanopar-
ticles are promising candidates for use in the diagnosis and treatment of can-
cerous areas. These single domain magnetic nanoparticles are advantageous
as while the individual domain is strongly magnetic, the particles themselves do
not retain any residual magnetism outside an applied magnetic field. This al-
lows the particles to be highly magnetic when needed, but prevents agglomera-
tion and clotting through residual magnetic attractions. Optimising the resulting
magnetic properties is therefore desirable and may be achieved by tailoring the
synthesis method. High temperature solvothermal methods are traditionally
used to prepare highly crystalline and magnetic materials.5–8 Aqueous meth-
ods allow for the formation of water stable nanoparticles in a simple and often
shorter timeframe. However, the crystallinity of these particles often suffers
compared to the high temperature organic routes.9,10 The aim of this chap-
ter is to develop an aqueous-based route to preparing highly crystalline iron
oxide nanoparticles which will bypass the need for additional post-synthesis
work up required with organic methods. To accomplish this, microwave irra-
diation will be incorporated into the traditional co-precipitation method. Given
that microwave heating works through the dielectric heating effect, the entire
reaction should heat quickly and at a uniform rate. Here, a fast nucleation
step, where iron oxide seeds form on addition of base, will be followed by a
controlled growth step under microwave heating to improve crystallinity while
maintaining the small particle size. This co-precipitation method is versatile
and can be used to prepare a wide range of iron oxides.
Magnetite and several other iron oxides will be prepared and characterised
to determine if the microwave assisted co-precipitation method can be modi-
fied to maximise particle crystallinity and hence magnetic properties. A series
of spinel oxides will be prepared including cobalt ferrite (CoFe2O4), copper fer-
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rite (CuFe2O4) and manganese ferrite (MnFe2O4). The major objective of this
work is to optimise the synthesis method to develop a highly magnetic founda-
tion which can be built upon to prepare water stable, biocompatible magnetic
nanocomposites.
3.2 Characterisation of iron oxide nanoparticles
Figure 17: Magnetically respon-
sive Fe3O4 nanoparticles from mi-
crowave assisted co-precipitation.
Iron oxide nanoparticles were prepared
via a microwave assisted co-precipitation
method. Briefly, seed particles were pre-
cipitated from a saturated solution of metal
chlorides by the addition of a base, before
being treated with microwave irradiation for
20 minutes at 150◦C. In order to determine
the best microwave reaction conditions for
preparing iron oxides, several optimisation
reactions were performed. Heating is key to
controlling crystal growth, so exploration of
heating ranges and times is essential in understanding the formation of highly
crystalline iron oxides. A standard 20 minute co-precipitation reaction was per-
formed at a series of temperatures (50, 75, 100, 125, 150, 175◦C) to establish
the minimum temperature needed to form magnetically responsive iron oxide
nanoparticles. Too low temperatures (less than 125◦C) led to an incomplete
reaction with the formation of a red/brown powder (indicating oxidation). Above
125◦C a magnetically responsive black powder formed (Figure 17), 150◦C was
chosen as the reaction temperature, as it ensures the consistent formation of a
magnetic powder without heating to excessive temperatures. The reaction time
for the 150◦C co-precipitation reaction was also varied (5, 10, 15, 20, 25, 30
minutes) to determine the best heating time. Again, too short reaction times
lead to the formation of a non magnetic red powder. 20 minutes was found
to be sufficient time to produce jet black magnetic iron oxide powders without
excessive reaction times.
The reaction conditions was further optimised by adjusting the heating rate
79
and microwave system settings. Digital heating methods allows greater con-
trol over the systems heating rate and can monitor the internal conditions of a
reaction. Time taken for the system to reach temperature is the ramping time.
Rapid ramping times can cause pressure increases/spikes within the vessel
which can also affect the reaction. Ramping times (and therefore frequency of
pressure spikes) are controlled by the microwave power of a system which is
variable. The higher the microwave power, the quicker the heating time and
the larger the pressure increase. Therefore the optimal power setting needs
to be determined to ensure quick ramping times without generating excessive
pressures. The optimal microwave power was determined through a series
of heating reactions on blank water samples. 15 reactions were undertaken,
which involved heating a blank water sample to 150◦C while varying the mi-
crowave power (10-150W, with measurements in 10 W increments (figure 18)).
Reaction temperature was monitored using infrared (IR) thermometers to al-
low for non-invasive, volume independent measurements. Once at tempera-
ture, power would be cut or cycled to minimise heat loss and ensure a consis-
tent temperature. It was observed that at lower powers, the system could not
reach the 150◦C temperature needed for the co-precipitation reaction. Above
70 W the system could reach the temperature, with the ramping time needed to
reach the temperature decreasing as power increases. At high powers (above
100 W) this decrease in ramping time is minimal.
The heating power above 70 W needs to be further optimised as higher
powers can decrease ramping times needed, but consideration also has to be
made for the pressure within the vessel. The addition of metal chlorides and
ammonium hydroxide will generate increased pressure during the reaction and
pressure spikes can occur with fast ramping times. High pressures can dam-
age the reaction vessel and can be a serious safety hazard, so microwave sys-
tems have safety cut-offs to prevent the reaction going over 300 PSI. If broken
the system turns off the heating element and stops the reaction prematurely
which can result in a brick red non magnetic sample. Figure 19 compares
the blank water reaction against a standard iron oxide co-precipitation reaction
heated to 150◦C at 100 W. The addition of reaction materials causes a signif-
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icant increase in pressure, with the pressure at the peak of the reaction over
double the pressure of the water reaction. At 100 W the pressure in a vessel
is significantly below the safety limits, ensuring that any pressure spike will not
trip the cut off ending the reaction early. Higher powers can be used, but con-
sistency is essential to ensure the formation of a crystalline magnetic material.
A power setting of 100 W ensures that the sample will heat quickly, but also
goes to completion.
Figure 18: Microwave heating profiles for blank water samples at varying microwave
powers (10-150W). 70◦C is the base power needed to heat the samples up to the
target temperature (150◦C), with powers above this reducing the ramping time needed.
From these optimisation reactions, the reaction conditions for all subse-
quent co-precipitation reactions was chosen to be 150◦C at 100 W for 20 min-
utes. For all prepared samples, a black, magnetically responsive precipitate
formed (Figure 17). The dried powders were characterised with XRD, FTIR,
Raman, TEM and SQUID measurements.
3.2.1 Structural characterisation
Powder XRD patterns were collected of the ferrite nanoparticles to confirm the
spinel structure and to calculate the average primary particle size using the
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Scherrer equation. Figure 20 shows the patterns for magnetite (red), cobalt
ferrite (green), copper ferrite (blue) and manganese ferrite (yellow), alongside
the ICSD standard for magnetite (purple).
Figure 19: Heating profiles for a blank water reaction (orange) and a typical copre-
cipitation iron oxide reaction (blue). Upon addition of ammonia and starting materials
ramping times and internal pressures increases. At 100 W, the co-precipitation reac-
tion can still reach the optimum temperature of 150◦C while remaining under the safety
pressure limits.
The magnetite pattern matches that of the standard from the ICSD
database and to previously reported patterns of magnetite.9,11–14 All other fer-
rite samples also display the spinel pattern but a shifting of the peaks is also
observed. This shifting of the peaks is due in part to the change in lattice pa-
rameters from both substituting the Fe2+ ions with other transition metal ions.
Substituting the M+2 ion will vary the ionic radius of the ions in the crystal
structure changing the unit cell size slightly. This changes the overall lattice
parameters causing the X-rays to diffract at a slightly different angle, which is
reflected by a shifting in the peaks. Lee et al. substituted Fe2+ groups with a
variety of transition metals, observing that the varying ionic radii along with the
metal distribution in the spinel structure causes this shifting effect.15 Gomes
et al. observed that by increasing the ionic radii of the M2+ ions, this results
in a greater distortion in the packing of the oxygen ions increasing the lat-
tice parameters, and therefore showing a greater shifting effect.16 This effect
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can be seen in the prepared sample with the difference between the MnFe2O4
(largest ionic radii) and CuFe2O4 (smallest ionic radii) samples. All patterns
agree with standards from the ICSD database.16–18 The broad XRD peaks
indicate the formation of nanoparticles and the average sizes has been calcu-
lated using the Scherrer equation. These results are detailed in Table 7. The
magnetite nanoparticles were the smallest in size at 11.2 nm with the cobalt
ferrite nanoparticles being the largest at 24.7 nm.
Figure 20: XRD patterns of ferrite nanoparticles synthesised via a microwave assisted
coprecipitation method. All samples share the same inverse spinel crystal structure
but peak shifting distinguishes the samples. An ICSD standard for magnetite (purple)
is included, with this and all of the other samples agreeing with the respective ICSD
standards.11,16–18
Often, it can be difficult to distinguish between different iron oxide nanopar-
ticles using powder XRD, e.g. the patterns for magnetite (Fe3O4) and
maghemite (γ-Fe2O3) are very similar. Therefore, FTIR and Raman spec-
troscopy have been employed to further investigate these particles, since differ-
ent metal-oxygen bonds will have different vibrational energies.15,19 Figure 21
shows the FTIR measurements of the ferrite nanoparticles.
Magnetite displays an Fe-O stretch at 560 cm−1.7,20 A similar stretch is
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observed for all other ferrite samples, with a shift in the peak position due
to the substitution of Fe2+ ions for another transition metal. This substitution
retains the iron oxide inverse spinel structure but by changing the ionic radius
it alters bond lengths and how the bond absorbs infra-red energy. This change
in absorption results in a slight shifting effect of this metal oxygen bond. Lee et
al. observed that the signal shifts to a higher frequency due to the greater bond
strength of the metal oxygen bond.15 This is reflected in the FTIR results with
the manganese ferrite shifting to a lower wavelength. Manganese ions have
the largest ionic radius of the tested transition metals, causing it to form the
weakest bond resulting in a shift to lower wave numbers. This shifting effect
has been confirmed by other groups with the patterns matching reports in the
literature.21–23
Figure 21: IR spectra of magnetite (red), manganese ferrite (yellow), cobalt ferrite
(green) and copper ferrite (light blue).
In order to obtain Raman data, the measurement was carried out using a
637 nm red laser with a 10% filter. Care must be taken in performing these
measurements, as heating and eventual oxidation of the particles can occur
upon excessive laser exposure. To demonstrate this, an initial measurement
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was collected at a laser power of 35 mW for 90 seconds. The samples were
then exposed to the laser for 3 minutes and then re-measured, with the results
for magnetite shown in Figure 22. Initially, the sample gives four peaks at 186,
364, 503 and 696 cm−1 (Table 5). These bands occur due to specific vibrations
within the crystal structure, which can be associated to bonds using group
theory. Gasparov et al. determined that the unit cell for magnetite crystals
consists of 56 atoms with the smallest (Bravais) cell containing 42 vibrational
modes. 5 of these modes are Raman active: A1g, Eg and three T2g modes.24
Each of these modes contain several symmetry elements that make a bond
in the crystal structure and are assigned Mulliken symbol (i.e. A1g, Eg) to
represent these combined symmetry elements.
Four of these modes can be observed in the collected magnetite pattern.
The broad band at around 696 cm−1 is an A1g band, characteristic of mag-
netite.24–27 This vibration is specific to the arrangement of oxygen groups in
the spinel structure and is the strongest band in the spectrum.24,28 The band
at 503 cm−1 relates to the Eg mode and is the bond between the oxygen groups
and the B site (Fe2+ and Fe3+) in the inverse spinel structure. The final two
bands are at 186 and 364 cm−1 relating to the T2g mode. This is from the vi-
brations of the bonds between the oxygen atoms and the iron groups in the A
site of the spinel (Fe3+). Gasparov et al. predicted these bands to be at 193
and 310 cm−1 , with the discrepancy/shifting in the observed pattern indicating
powder oxidation.24 The oxidised variant maghemite, has a T1 Raman band
at 350 cm−1 due to the increased oxidised Fe3+ content. The observed band
is closer to the maghemite assignment suggesting that the particles contains
mixed magnetite and maghemite phases, due to the presence of bands relat-
ing to both iron oxide types. This mixed phase is supported by the very slight
brown colour of the powder in the microscopy image (Figure 23(a)).
After continual exposure to the laser (Figure 22(b)), significant changes
are noted. As observed from the microscope images, the black/brown powder
turns red (Figure23(b)) and the broad magnetite/maghemite peaks disappear
to be replaced by several sharp peaks. The peak positions (Table 5) and the
red powder are characteristic of the iron oxide hematite (α-Fe2O3), which has a
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significantly more complex structure with 7 active Raman peaks (five Eg bands
and two A1g bands).28 These peaks are accounted for and in good agreement
with hematite patterns found in the literature.25,26,29 The small shoulder on the
607 cm−1 Eg band is an LO (Longitudinal optical) Eu vibration from residual
maghemite, indicating that the sample can be oxidised further.25,29
Figure 22: Raman spectrum of Fe3O4 nanoparticles before (a) and after (b) continuous
exposure to the Raman laser. Prior to prolonged laser exposure, a mixture of mag-
netite and maghemite peaks can be seen, while after exposure the pattern matches
that of hematite (an oxidised ferrite).
Figure 23: Microscope images of magnetite nanoparticles before (a) and after (b)
exposure to a higher power laser. The brown/red colour of the particles before the
measurement (left) suggest a slight oxidation of the sample. After prolonged exposure
to the stronger laser (right), the formation of red areas confirms oxidation into hematite.
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Table 5: Raman peak and vibrational mode assignment for magnetite nanoparticles
before and after oxidation by the laser. Before oxidation, the sample displays mag-
netite (A1g) and magnetite/maghemite vibrational modes (V. mode) such as Eg and
T2g. After continual exposure to the laser, sharp hematite bands appear suggesting
oxidation.25,29
Pre Oxidation Post Oxidation
Raman Shift (cm−1) V. mode Raman Shift (cm−1) V. mode
364 Eg 224 A1g
503 T2g 245 Eg





All other ferrite samples display a similar spectrum, containing A1g bands
and a mixture of Eg/T2g/T1 bands suggesting that the powder is mixed phase
containing maghemite impurities (Figure 24 and Table 6). Substitution of the
Fe2+ ion with transition metal ions will change the bond lengths of the crys-
tal structure and how the Raman waves scatter from the bonds. The spinel
structure and bond types are retained but the expanded/compressed lattice di-
mensions cause a shifting of the peaks. All samples have a strong broad A1g
bands characteristic of the oxygen packing in the ferrite structure. The cobalt
ferrite sample starts showing a large number of sharp peaks indicating that
the sample has partly oxidised into hematite. The specific cobalt ferrite peaks
are noted at 670 (A1g), 394 and 460 cm−1 corresponding to literature values
for CoFe2O4.19,30–32 However, the sharp bands at 218, 277 and 593 cm−1 cor-
respond to hematite.25,26,29 Complete oxidation would remove the A1g band
suggesting only partial oxidation of the sample. The copper ferrite sample
shows a pattern similar to magnetite, with an Eg band at 510 cm−1 and two T2g
bands at 187 and 350 cm−1. The presence of the T2g bands indicate a mixed
material containing both magnetite and maghemite (with the 350 cm−1 band
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possibly being a T1 maghemite band). Little shifting is seen for the copper
ferrite sample making it difficult to distinguish from the magnetite sample.33
The manganese ferrite sample only has two Raman bands, the A1g band at
622 cm−1 and the T2g band at 322 cm−1. Significant shifting of these bands
can be seen when compared to the magnetite pattern highlighting the effect of
manganese doping with the shifting of the A1g band. This pattern and assign-
ment agrees with previous literature reports for manganese ferrite.19,25
Figure 24: Raman spectra of (a) magnetite, (b) cobalt ferrite, (c) copper ferrite and (d)
manganese ferrite, with all samples displaying typical ferrite bands.
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Table 6: Raman peak and vibrational mode assignment for transition metal ferrite
particles. Between the common peaks of Eg and A1g shifting of the peaks positions
can be observed, which can be used to distinguish the particles from each other.
Sample T2g (1) Eg T2g (2) A1g
Fe3O4 364 503 696
CoFe2O4 394 460 670
CuFe2O4 187 350 510 688
MnFe2O4 322 622
3.2.2 Particle size and crystallinity
The primary particle sizes for all samples were measured from 100 particles
using TEM and are shown in Figure 25 and Table 7. Aggregation is noted for
all samples, due to drying effects from preparing the grids. Great variation can
be seen in particle size and morphology between the samples. The magnetite
nanoparticles are smallest in size and distribution (12 ± 2 nm). All other par-
ticles have larger sizes, with greater size distributions also noted (Figure 26).
The largest of the particles is cobalt ferrite with an average size of 40.4 nm
± 24.7 nm and a wide size variance with some individual particles being over
70 nm in size. When compared to the Scherrer XRD measurements, both re-
sults show an increase in particle size. There is a slight agreement between the
results although the TEM images show a greater size increase for the cobalt
ferrite and manganese ferrite sample, than with the Scherrer measurements.
Table 7: Average particle sizes calculated from the TEM images (n=100) and XRD
patterns. Both types of characterisation results show an increase in nanoparticle size
in comparison to magnetite.
Sample
TEM XRD
Size (S.D) (nm) Scherrer (nm)
Magnetite 12.1 (1.99) 11.2
Cobalt Ferrite 40.4 (14.93) 24.7
Copper Ferrite 18.9 (3.01) 14.8
Manganese Ferrite 37.9 (7.02) 23.7
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Figure 25: TEM images taken of magnetite, cobalt ferrite, copper ferrite and man-
ganese ferrite. Clustering can be seen in all samples from drying effects. Magnetite,
Cobalt, manganese ferrite begin to show a hexagonal morphology, whereas the cop-
per nanoparticles are much smaller in size and more ill defined.
Given the small size and uniformity of the magnetite nanoparticles, high
resolution electron microscopy images were recorded to further examine these
nanoparticles. Figure 27 confirms the formation of single crystal nanoparti-
cles. The particles take a hexagonal morphology, with a monodisperse size
and shape distribution. The hexagonal morphology is associated with a high
crystallinity and is commonly seen in high temperature solvothermal synthesis
methods.5,6 Interplanar distances were also measured using HRTEM, with the
distances further characteristic of the inverse spinel structure.7,34 The SAED
pattern obtained is characteristic for magnetite with the diffraction spots corre-
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sponding to the spinel structure. The lattice patterns calculated from the im-
ages agree with previous XRD results and SAED patterns of magnetite found
within the literature.6,34
Figure 26: Histograms of the primary particle sizes of (a) magnetite, (b) cobalt ferrite,
(c) copper ferrite and (d) manganese ferrite dried in ambient conditions (n=100). Mag-
netite shows the smallest size distribution of all the ferrites, while cobalt ferrite has the
largest.
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Figure 27: High resolution TEM images (image a-c) and SAED image (image d) of
magnetite nanoparticles. Well defined highly crystalline magnetite particles were ob-
served that formed traditional hexagonal morphologies. Lattice spacings and SAED
measurements confirm the identity of the magnetite core.
3.2.3 Magnetic property measurements
The magnetic properties of the ferrite nanoparticles were measured using
SQUID magnetometry, with magnetisation curves obtained at 300K and 10K
in a magnetic field of up to 5 x104 G and are plotted in Figures 28 and 29. In
ordered materials (e.g. ferromagnets), where the individual magnetic moments
can align parallel with each other to form magnetic domains, all domains can
be aligned in the same direction as an applied external magnetic field. This
can be experimentally observed in the form of M-H curves, where M is the
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magnetisation and H is the applied magnetic field strength. Often, for ferro-
and ferrimagnetic materials, there is a hysteresis noted in this curve, which
provides information on the coercivity (the applied magnetic field required to
demagnetise the sample) and the remanence (the residual magnetism of the
material once the applied magnetic field has been removed). The high residual
magnetism of ferromagnetic bulk materials and resulting magnetic attractions
can lead to agglomeration. Changes in particle size can drive large changes in
the M-H curve behaviour. One important example of this is the case of super-
paramagnetic single-domain particles, which are of the order of 10 nm, where
all spins therein aligned parallel or anti-parallel to the easy axis. This magnetic
anisotropy is a result of the spins aligning along a preferred crystallographic
direction.
At 300K, the magnetite sample does not display a hysteresis loop, showing
negligible coercivity and remanence (Figure 28(a)). This behaviour is indicative
of superparamagnetic single domain magnetic nanoparticles.35–38 The satura-
tion magnetisation (Ms) of the magnetite sample at 300 K is 65.2 emu/g and
is unsaturated up to fields of 5 x104 G, further characteristic of superpara-
magnetic material.9,35 The Ms value is a measure of the magnetic spin and
domain strength within the particles. Saturation is reached when all of the
magnetic spins within the domain are aligned in respect to an external mag-
netic field. The higher the value, the stronger the external magnetic field needs
to be to align the spins, meaning more spins within the domain and therefore
a stronger magnetic domain. The stronger the domain, the greater magnetic
field generated by the particles when used in biological applications. For para-
magnetic/superparamagnetic materials, saturation cannot be reached even at
high applied fields. This is due to ambient thermal energy causing the spins
in paramagnetic/single domain materials to agitate and become slightly mis-
aligned with the applied field. Magnetic spins in multi domain materials re-
quire more energy to agitate than the ambient thermal energy, eliminating this
misalignment, causing the material to magnetically saturate in weak external
magnetic fields. The saturation point can therefore be an additional approach
to distinguishing between ferromagnetic and superparamagnetic material. Op-
93
timisation of the particles magnetism is essential, as a strong magnetic domain
increases MRI efficacy, while superparamagnetism eliminates the risk of ag-
glomeration/clotting.
Figure 29(a) shows the same sample but measured at 10 K. The Ms value
increases and now the particles start to display residual magnetism, with a
slight hysteresis noted. This hysteresis forms due to the low thermal energy
being unable to randomise the magnetic spins when removed from the external
field. The particles are still not completely saturated even when cooled, further
confirming the particles superparamagnetic nature. This is due to the single
domain structure causing a slight misalignment of magnetic moments with the
external field. As the sample is cooled these spins remained slightly misaligned
stopping complete saturation.9,35 Very high external fields are needed to fully
align the individual (paramagnetic) moments to the external field.
This superparamagnetic behaviour is desirable for biomedical applications
as the particles show no residual magnetism, eliminating the risk of magnetic
agglomeration when in the body. The critical diameter for magnetite is reported
to be between 10 and 15 nm.35,39 TEM images and XRD measurements show
that the particle size is below this critical diameter which is reflected in super-
paramagnetic curves in the SQUID measurements.
The Ms values for these magnetite nanoparticles are below the theoreti-
cal maximum for bulk magnetite, most likely due to some spin disorder on the
particle surface.10 However, the values obtained here have higher Ms values
than those observed for magnetite nanoparticles synthesised by traditional co-
precipitation methods (Ms = 40-50 emu/g).9,10 The improved Ms values are due
to the use of microwave irradiation during particle synthesis. Microwave irra-
diation promotes crystal growth and reduces surface defects/spin disorder. As
the particles are single domain, high crystallinity is essential to the formation
of this domain. Surface defects introduced from stunted crystal growth, in-
troduces spin disorder reducing the alignment of magnetic moments within the
domain, lowering Ms values. Highly crystalline nanoparticles have very few sur-
face defects which is reflected in improved Ms values. High temperatures are
one of the more common methods to limit defect formation. Magnetite particles
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Figure 28: Magnetic measurements of (a) magnetite, (b) cobalt ferrite, (c) copper fer-
rite and (d) manganese ferrite at 300 K. Magnetite and copper ferrite samples display
no hysteresisand do not saturate, indicating superparamagnetism, whereas cobalt and
manganese ferrite show ferromagnetic properties.
prepared by high temperature solvothermal methods display high crystallinity
due to heating and as a result, high magnetisation values (60-85 emu/g).5–8 Mi-
crowave irradiation achieves the same effect on crystal growth as conventional
heating methods, but can be incorporated into co-precipitation reactions to pro-
duce highly crystalline water stable materials. This high degree of crystallinity
is confirmed from previous HRTEM images, and is reflected in the increased
Ms values.
The other iron oxide samples showed varying magnetic properties, based
on their size and morphology. The largest of the particles was cobalt ferrite
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Figure 29: Magnetic measurements of (a) magnetite, (b) cobalt ferrite, (c) copper
ferrite and (d) manganese ferrite at 10 K. All samples display hysteresis in their profiles.
(40.4 nm) with the increased size reflecting very high Ms values and the ob-
servation of a hysteresis and residual magnetism (figure 28 (b)). The particles
were above the critical diameter and too large to be single domain (determined
by Maaz et al. as 28 nm).40 Multiple domains increase the energy require-
ments to randomise the magnetic spins above the ambient thermal energy,
resulting in ferromagnetic properties. This is problematic for biomedical ap-
plications as under normal conditions the particles will agglomerate through
magnetic attractions which can cause clotting. The hexagonal morphology of
the particles shown in TEM images indicate that the particles are very crys-
talline. This results in the cobalt ferrite nanoparticles having the highest Ms
values of all the samples (table 8). When compared to other reports of cobalt
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ferrite in the literature, the prepared particles show slightly higher magnetisa-
tion values to the literature; 58.3-68 emu/g.40,41 The magnetisation values are
close to the theoretical maximum for bulk cobalt ferrite (80.8 emu/g), illustrating
that microwave irradiation enhances cobalt ferrite crystal growth. The literature
also demonstrates how to prepare particles below the critical diameter. Kim et
al. observed that higher temperatures promoted crystal growth and therefore
an increase in particle sizes.41 Rajendran et al. managed to prepare super-
paramagnetic cobalt ferrite nanoparticles using a low temperature method that
were 6nm in size.42 These particles displayed superparamagnetic properties,
supporting the relationship between heat and particle size.
The small size and poorly defined particle morphology of the copper ferrite
nanoparticles is reflected in the lowest Ms values of all of the samples (fig-
ure 28 (c)). The ill defined morphology suggests multiple defects within the
crystal which reduces domain strength and Ms values. The particles display
no residual magnetism or coercivity which is characteristic of superparamag-
netism.35–38 Copper ferrite is classified as a soft magnet with a theoretical
maximum of 55 emu/g, so the lower values of between 25-35 emu/g were to
be expected.43–45 The effect of microwave irradiation is clearly seen with the
the prepared particles having an saturation magnetisation much greater than
other reported samples and very close to the theoretical maximum.43–45 The
high Ms values are due to the Fe3+/Fe2+ content in the iron oxide. The particles
were prepared from copper (II) chloride dihydrate and iron (II) chloride tetrahy-
drate. During synthesis the Fe2+ ions will oxidise into the Fe3+ ions (which with
the Cu2+ ions) form the A2+B23+O42− spinel structure of copper ferrite. This
oxidation of the iron ions depends on the reaction environment though, with
many co-precipitation techniques oxidising the Fe2+ precursor by bubbling air
through the starting solution.46,47 In the reaction detailed in this chapter, this
induced oxidation was limited from the extensive use of air sensitive techniques
(such as using a schlenk line and deoxygenated water), leading to the copper
ferrite particles being precipitated from a mixture of Fe2+ and Fe3+ ions. This
results in the final spinel structure containing a mixture of Fe3+, Fe2+ and Cu2+
ions and making it non stoichiometric copper ferrite. Thapa et al. prepared a
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similar material with increasing Fe2+ concentrations noting that the replace-
ment of Fe3+ ions with Fe2+ ions caused a significant increase in Ms values
for copper ferrite.48 This can be seen with this sample with a saturation value
very close to the theoretical maxiumum indicating non-stoichmeteric copper
ferrite nanoparticles. This altered stoichiometery was also observed in the Ra-
man/FTIR/XRD patterns with the lack of peak shifting expected from the cop-
per groups (figures 24, 21 and 20). The larger morphologies and decreased
Ms values indicate that there is a copper component to the particles. Even with
optimisation, pure copper ferrite nanoparticles are restricted by the theoretical
bulk Ms maximum of 55 emu/g limiting their application in comparison to the
other iron oxide particles.
Interestingly, the manganese ferrite nanoparticles were larger in size than
magnetite, but with similar Ms values (figure 28 (d)). The theoretical maximum
for manganese ferrite was calculated to be 80 emu/g with the prepared parti-
cles very close to this value (66.9 emu/g) due to increased crystal growth from
microwave irradiation. The particles did not exhibit hysteresis even at room
temperature, indicating the particles are superparamagnetic. When compared
to the literature, Deraz et al. prepared particles of a similar size (34 nm) and Ms
values, identifying that the particles are multi domain, with very small coercivity
and remanence values.49 The formation of multiple domains are responsible
for the particles high magnetisation values, which are close to the bulk value.
Tang et al. notes a similar occurrence with smaller 25 nm particles, which are
close to bulk value but display a slight remanence.50 This remanence and co-
ercivity is lost when the particles are below 10nm indicating that the particles
prepared in this chapter are above the single domain critical diameter, which
risks the formation of multi domain particles.50,51 For the sample in this chap-
ter, microwave irradiation resulted in the formation of particles close to their
bulk values, but the increased particle size is undesirable, as the literature
suggests the onset of ferromagnetic behaviour from the size increase (despite
the lack of hysteresis on the SQUID results) which will ultimately limit biological
applications.
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Table 8: Magnetisation saturation values for iron oxides at 300K and 10K. The larger
particles tended to show higher Ms values. Upon cooling the Ms values for all sam-
ples increased. Microwave irradiation shows in increase in Ms values for all samples
bringing them close to their theoretical bulk Ms values
Sample
Theoretical This Chapter Literature Values
MsValues Size Ms (Emu/g) Size Ms (Emu/g)
300K (nm) 300K 10K (nm) 300K
Magnetite 9252 12 65.2 81 810 5110
Cobalt Ferrite 8040 40 76.4 82.7 2540 6840
Copper Ferrite 5543 18 55.1 63.2 2045 32.845
Manganese Ferrite 8050 37.9 66.9 80.1 2550 6850
The literature illustrates that manganese ferrite shows enhanced proper-
ties as an MRI contrast agent, so optimisation of the particles, is needed to
unlock this potential.51,53,54 Reports by other groups suggest that prolonged
heating does not cause a significant increase in particle size but will improve
superparamagnetic properties.22,55 Kodama et al. notes that a longer ageing
step during synthesis can reduce the formation of surface defects.22 Chen et
al. also noted that prolonged digestion times produces smaller particles guar-
anteeing them to be superparamagnetic.55 This can be applied to the method
listed in this chapter by prolonging the conventional and microwave heating
steps.
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3.3 Attempted one pot microwave synthesis of Fe3O4
nanoparticles
Figure 30: Non-magnetic, red pre-
cipitate obtained from the one step
urea based co-precipitation reac-
tion.
The results have shown that incorpo-
rating microwave irradiation into the co-
precipitation reaction results in highly mag-
netic iron oxide nanoparticles. An attempt
was made to make the synthetic process
a single-step, one-pot reaction. To do this,
urea was added to the metal chloride so-
lution instead of ammonia as a base. The
aim here was that as the vessel was heated
and as the reaction progressed, the urea
would break down to form an in situ base,
which would precipitate the nanoparticles.
However, instead of a black, magnetically
responsive powder characteristic of mag-
netite, a non-magnetic red powder (figure 30) was obtained using this method,
which was characterised with XRD, FTIR and Raman spectroscopy.
3.3.1 Powder characterisation
Figure 31 shows substantial changes in the powder XRD pattern for this sam-
ple. Peak broadening allows the particle size to be calculated using the Scher-
rer equation. The nanoparticles were significantly larger than bare magnetite
nanoparticles with an average size of 26.37 nm. The peak positioning is char-
acteristic of the hexagonal hematite structure, and agrees with the ICSD stan-
dard for hematite.56
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Figure 31: XRD pattern of iron oxide nanoparticles synthesised via a microwave as-
sisted coprecipitation method using urea (red). The original magnetite peaks are
shown in blue. Peak positions are characteristic of hematite and match the ICSD
standard for hematite (yellow).56
The FTIR measurement also highlights the differences between magnetite
and red powder (figure 32). The iron oxide peak shifted to a lower wavenumber
(515 cm−1) and a second peak formed (425 cm−1). These peaks are charac-
teristic of hematite (which is also brick red in colour) which agrees with the
literature.28,29 Chernyshova et al. have assigned the two peaks as the asym-
metrical A2u/Eu modes at 425 cm−1 and the mode Eu at 515 cm−1.29 Hematite
(Fe2O3) is an oxidised form of iron oxide, containing only Fe3+ groups with both
of the above modes relating to the Fe-O bonds in the crystal structure.
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Figure 32: FTIR Spectra of iron oxide nanoparticles synthesised in a co-precipitation
reaction using urea (yellow) or the standard ammonium hydroxide (blue). The am-
monium hydroxide reaction shows the characteristic magnetite stretch at 560 cm−1
(blue) whereas the urea reaction shows two peaks at 425 cm−1 and 515 cm−1 which
is characteristic of hematite.29
Raman spectroscopy of the powder confirms the samples identity as
hematite (figure 33 and table 9). It has been observed that hematite has 7
active bands (five Eg bands and two A1g bands) which are all accounted for in
the spectrum below.29 These bands all relate to iron oxygen bonds within the
structure. The initial Raman spectrum is almost identical to the oxidised mag-
netite sample with the formation of several intense sharp peaks (figures 22 (b)
and 33). After continual exposure to the laser, the pattern does not change
but the measurement area darkens indicating burning (figure 34). The per-
sistence of the sharp peaks after heating, further confirms that the powder
is hematite. These peaks also match with hematite patterns found within the
literature.25,29 The metastable maghemite impurity at 650 cm−1 is absent for
the hematite sample confirming complete formation of hematite from the urea
based reaction.
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Figure 33: Raman spectra of iron oxide nanoparticles (green) after exposure to a
higher power laser and iron oxide particles prepared via a urea based coprecipitation
reaction (red, along with peak assignments). After significant exposure to the Raman
laser, the spectrum changes significantly to match the hematite sample. A small shoul-
der remains in the oxidised sample though which is due to a maghemitite impurity.
Table 9: Raman peak and vibrational mode assignment for hematite nanoparticles.
The absence of the metastable maghemite impurity at 651cm−1 suggests complete
transition the iron oxide particles into the hematite crystal structure.









Figure 34: Microscope images of hematite nanoparticles before (a) and after (b) expo-
sure to a higher power laser. The red colour of the powder is characteristic of hematite.
After exposure to the laser a darkening of the sample can be seen due to burning.
3.4 Discussion and conclusions
This approach details a co-precipitation method that is quick and simple, which
can prepare iron oxide nanoparticles with a similar crystallinity/magnetisation
as the iron oxides prepared by solvothermal methods. The TEM and SQUID
results show that the incorporation of microwave irradiation is responsible for
this increase in crystallinity. This is confirmed by other groups incorporating mi-
crowave irradiation into their reactions.57–59 Many groups found that microwave
irradiation enhanced crystal growth to such a degree that particles size in-
creased significantly leading to ferromagnetism.57,58 Hong et al. separated
microwave irradiation from the precipitation step to age the nanoparticles af-
terwards ensuring the particles remain superparamagnetic.59 They observed
that 2 hours ageing improved crystallinity (resulting in a Ms of 70.48 emu/g)
while retaining a particle size (9nm) below the critical diameter. The method
used in this chapter, utilises ageing to prepare particle of a similar crystallinity
and size but demonstrates that similar results can be achieved within in a much
shorter timeframe (20 minutes).
Comparing the synthesised iron oxides, the magnetite sample appears to
be most suitable for biomedical applications. This sample has the smallest
particle size while having the highest magnetisation values and displaying su-
perparamagnetic behaviour. Both the copper and cobalt ferrite samples were
104
unsuitable for biomedical use, with the copper ferrite sample having the lowest
magnetisation of all of the samples. The cobalt ferrite sample was the oppo-
site displaying significant ferromagnetism due to the large particle size. Further
optimisation would either sacrifice crystallinity (for cobalt ferrite) or significantly
alter the particle stoichiometry (for copper ferrite). The most promising alterna-
tive is manganese ferrite which has a similar Ms value to magnetite, but further
optimisation needs to be made before the particles are suitable for biomedi-
cal applications. The larger particle size increases the chance of oponization
and elimination from the body. Optimisation of the synthesis method through
increased heating times can circumvent these problems leading to the devel-
opment of a manganese ferrite nanoparticle with enhanced MRI properties
and equivalent Ms values to microwave assisted prepared magnetite nanopar-
ticles.51,53,54
The other focus of this chapter is the development of a one-pot microwave
assisted co-precipitation reaction utilising urea as a base. The method used
in this chapter caused the iron oxide to oxidise into the magnetically non re-
sponsive hematite. Several groups have avoided the formation of hematite in
urea based co-precipitation methods by adjusting the reaction conditions.60–62
One notable example is the work by Lian et al. which undertook a similar co-
precipitation reaction but repeated the reaction in both a sealed vessel (as with
this chapter) and under reflux.60 When heated in a sealed vessel hematite
forms but when heated under reflux, this oxidation is avoided (forming mag-
netite). Oxidation was attributed to the carbon dioxide formed from the decom-
position of urea. The carbon dioxide formed interacts with the iron groups in a
closed vessel oxidising the Fe2+ groups forming hematite. Heating the sample
under reflux though, stops CO2 from oxidising the iron oxides. The microwave
system can be adapted to support reflux experiments providing a possible way
to circumvent the oxidation of the nanoparticles, allowing the development of
this one pot synthesis method.
From the results of this chapter, it is clear that microwave assisted coprecip-
itated magnetite nanoparticles are an excellent foundation for the development
of biomedical magnetic nanocomposites. These particles display a high crys-
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tallinity with very high Ms values at room temperature without any sacrifice to
size or superparamagnetism. In addition to a strong magnetic foundation, the
other advantage of using the co-precipitation technique is that stabilisation and
functionalisation of the iron oxide can be done simultaneously with precipita-
tion. This allows for the development of water stable functionalised nanocom-
posites in a single reaction without any addition to the synthesis time. Previous
work by the group demonstrates this by stabilising magnetite with the polyelec-
trolyte PSSS.63,64 Future work will be to incorporate this stabilisation step into
the microwave assisted coprecipitation reaction to prepare water stable highly




[1] Berry, C. C.; Curtis, A. S. G. J. Phys. D: Appl. Phys. 2003, 36, 198–206.
[2] Gupta, A. K.; Gupta, M. Biomaterials 2005, 26, 3995–4021.
[3] Mornet, S.; Vasseur, S.; Grasset, F.; Veverka, P.; Goglio, G.; Demour-
gues, A.; Portier, J.; Pollert, E.; Duguet, E. Prog. Solid. State. Ch. 2006,
34, 237–247.
[4] Neuberger, T.; Scho¨pf, B.; Hofmann, H.; Hofmann, M.; von Rechen-
berg, B. J. Magn. Magn. Mater. 2005, 293, 483–496.
[5] Sun, S.; Zeng, H. J. Am. Chem. Soc. 2002, 124, 8204–8205.
[6] Sun, S.; Zeng, H.; Robinson, D. B.; Raoux, S.; Rice, P. M.; Wang, S. X.;
Li, G. J. Am. Chem. Soc. 2004, 126, 273–279.
[7] Tian, Y.; Yu, B.; Li, X.; Li, K. J. Mater. Chem. 2011, 21, 2476–2481.
[8] Hou, Y.; Yu, J.; Gao, S. J. Mater. Chem. 2003, 13, 1983–1987.
[9] Mikhaylova, M.; Kim, D. K.; Bobrysheva, N.; Osmolowsky, M.; Se-
menov, V.; Tsakalakos, T.; Muhammed, M. Langmuir 2004, 20, 2472–
2477.
[10] Morel, A.-L.; Nikitenko, S. I.; Gionnet, K.; Wattiaux, A.; Lai-Kee-Him, J.;
Labrugere, C.; Chevalier, B.; Deleris, G.; Petibois, C.; Brisson, A.; Si-
monoff, M. ACS Nano 2008, 2, 847–856.
[11] Fleet, M. E. Acta. Cryst. 1981, B37, 917–920.
[12] Mahmoudi, M.; Simchi, .; Milani, A. S.; Stroeve, P. J. Colloid. Interf. Sci.
2009, 336, 510–518.
[13] Cheng, F.-Y.; Su, C.-H.; Yang, Y.-S.; Yeh, C.-S.; Tsai, C.-Y.; Wu, C.-L.;
Wu, M.-T.; Shieh, D.-B. Biomaterials 2005, 26, 729–738.
[14] Kim, D. K.; Zhang, Y.; Voit, W.; Rao, K. V.; Muhammed, M. J Magn. Magn.
Mater. 2001, 225, 30–36.
107
[15] Li, F.; Liu, J.; Evans, D. G.; Duan, X. Chem. Mater. 2004, 16, 1597–1602.
[16] Gomes, J.; Sousa, M.; Tourinho, F.; Itri, M.-F. R.; Depeyrot, J. J. Magn.
Magn. Mater. 2005, 289, 184–187.
[17] Antic, B.; Kremenovic´, A.; Nikolic, A. S.; Stoiljkovic, M. J. Phys. Chem. B
2004, 108, 12646–12651.
[18] Ferreira, T.; Waerenborgh, J.; Mendonc¸a, M.; Nunes, M.; Costa, F. Solid
State Sci. 2003, 5, 383–392.
[19] Valde´s-Solı´s, T.; Tartaj, P.; Marba´n, G.; Fuertes, A. B. Nanotechnology
2007, 18, 145603.
[20] Zaitsev, V. S.; Filimonov, D. S.; Presnyakov, I. A.; Gambino, R. J.; Chu, B.
J. Colloid Interf. Sci. 1999, 212, 49–57.
[21] Ponhan, W.; Maensiri, S. Solid State Sci. 2009, 11, 479–484.
[22] Kodama, T.; Ookubo, M.; Miura, S.; Kitayama, Y. Mater. Res. Bull. 1996,
31, 1501–1512.
[23] Naseri, M. G.; Saion, E. B.; Ahangar, H. A.; Shaari, A. H.; Hashim, M. J.
Nanomater 2010, 2010, 1–8.
[24] Gasparov, L. V.; Arenas, D.; Choi, K.-Y.; Gu¨ntherodt, G.; Berger, H.;
Forro, L.; Margaritondo, G.; Struzhkin, V. V.; Hemley, R. J. Appl. Phys.
2005, 97, 10A922.
[25] Shebanova, O. N.; Lazor, P. J. Solid State Chem. 2003, 174, 424–430.
[26] de Faria, D. L. A.; Silva, S. V.; de Oliveira, M. T. J. Raman Spectrosc.
1997, 28, 873–878.
[27] Shebanova, O. N.; Lazor, P. J. Raman Spectrosc. 2003, 34, 845–852.
[28] Chamritski, I.; Burns, G. J. Phys. Chem. B 2005, 109, 4965–4968.
[29] Chernyshova, I. V.; Hochella, M. F.; Madden, A. S. Phys. Chem. Chem.
Phys. 2007, 9, 1736–1750.
108
[30] Soler, M.; Melo, T.; da Silva, S.; Lima, E.; Pimenta, A.; Garg, V.;
Oliveira, A.; Morais, P. J. Magn. Magn. Mater. 2004, 272–276, 2357–2358.
[31] Qu, Y.; Yang, H.; Yang, N.; Fan, Y.; Zhu, H.; Zuo, G. Mater. Lett. 2006, 60,
3548–3552.
[32] da Silva, S. W.; Melo, T. F. O.; Soler, M.; Lima, E.; da Silva, M. F.;
Morais, P. C. IEEE. T. Magn. 2003, 39, 2645–2647.
[33] Varshney, D.; Yogi, A. Mater. Chem. Phys. 2010, 123, 434–438.
[34] Daou, T. J.; Pourroy, G.; Be´gin-Colin, S.; Grene`che, J. M.; Ulhaq-
Bouillet, C.; Legare´, P.; Bernhardt, P.; Leuvery, C.; Rogez, G. Chem.
Mater. 2006, 18, 4399–4404.
[35] Goya, G. F.; Berquo´, T. S.; Fonseca, F. C.; Morales, M. P. J. Appl. Phys.
2003, 94, 3520–3528.
[36] Lu, A.-H.; Salabas, E. L.; Schu¨th, F. Angew. Chem., Int. Ed. 2007, 46,
1222–1244.
[37] Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. J. Phys. D: Appl.
Phys. 2003, 36, R167–R179.
[38] Pankhurst, Q. A.; Thanh, N. K. T.; Jones, S. K.; Dobson, J. J. Phys. D:
Appl. Phys. 2009, 42, 224001.
[39] Morais, P.; Garg, V.; Oliveira, A.; Silva, L.; Azevedo, R.; Silva, A.; Lima, E.
J. Magn. Magn. Mater. 2001, 225, 37–40.
[40] Maaz, K.; Mumtaz, A.; Hasanain, S.; Ceylan, A. J. Magn. Magn. Mater.
2007, 308, 289–295.
[41] Kim, Y. I.; Kim, D.; Lee, C. S. Physica B 2003, 337, 42–51.
[42] Rajendran, M.; Pullar, R.; Bhattacarya, A.; Das, D.; Chintalapudi, S.; Ma-
jumdar, C. J. Magn. Magn. Mater. 2001, 232, 71–83.
[43] Roy, S.; Ghose, J. J. Appl. Phys. 2000, 87, 6226–6228.
109
[44] Jiang, J. Z.; Goya, G. F.; Rechenberg, H. R. J. Phys.: Condens. Matter
1999, 11, 4063–4078.
[45] Goya, G.; Rechenberg, H. Nanostruct. Mater. 1998, 10, 1001–1011.
[46] Tao, S.; Gao, F.; Liu, X.; Sørensen, O. T. Mater. Sci. Eng. 2000, B77,
172–176.
[47] Despax, C.; Tailhades, P.; Baubet, C.; Villette, C.; Rousset, A. Thin Solid
Films 1997, 293, 22–28.
[48] Thapa, D.; Kulkarni, N.; Mishra, S. N.; Paulose, P. L.; Ayyub, P. J. Phys. D:
Appl. Phys. 2010, 43, 195004.
[49] Deraz, N. M.; Shaban, S. J. Anal. Apply. Pyrolysis 2009, 86, 173–179.
[50] Tang, Z. X.; Sorensen, C. M.; Klabunde, K. J.; Hadjipanayis, G. C. J. Appl.
Phys. 1991, 8, 5279–5281.
[51] Lu, J.; Ma, S.; Sun, J.; Xia, C.; Liu, C.; Wang, Z.; Zhao, X.; Gao, F.;
Gong, Q.; Song, B.; Shuai, X.; Ai, H.; Gu, Z. Biomaterials 2009, 30, 2919–
2928.
[52] Woo, K.; Hong, J.; Choi, S.; Lee, H.-W.; Ahn, J.-P.; Kim, C. S.; Lee, S. W.
Chem. Mater. 2004, 16, 2814–2818.
[53] Lee, J.; Huh, Y.; Jun, Y.; Seo, J.; Jang, J.; Song, H.; Kim, S.; Cho, E.;
Yoon, H.; Suh, J.; Cheon, J. Nat. Med. 2007, 13, 95–99.
[54] Tromsdorf, U. I.; Bigall, N. C.; Kaul, M. G.; Bruns, O. T.; Nikolic, M. S.;
Mollwitz, B.; Sperling, R. A.; Reimer, R.; Hohenberg, H.; Parak, W. J.;
Fo˘rster, S.; Beisiegel, U.; Adam, G.; Weller, H. Nano Lett. 2007, 7, 2422–
2427.
[55] Chen, J. P.; Sorensen, C. M.; Klabunde, K. J.; Hadjipanayis, G. C.; De-
vlin, E.; Kostikas, A. Phys. Rev. B 1996, 54, 9288–9296.
[56] Blake, R. L.; Hessevick, R. E.; Zoltai, T.; Finger, L. W. Am. Mineral. 1966,
51, 123–129.
110
[57] Khollam, Y.; Dhage, S.; Potdar, H.; Deshpande, S.; Bakare, P.; Kulka-
rni, S.; Date, S. Mater. Lett. 2002, 56, 571–577.
[58] Wang, W.-W.; Zhu, Y.-J.; Ruan, M.-L. J. Nanopart. Res. 2007, 9, 419–426.
[59] Hong, R.; Pan, T.; Li, H. J. Magn. Magn. Mater. 2006, 303, 60–68.
[60] Lian, S.; Wang, E.; Kang, Z.; Bai, Y.; Gao, L.; Jiang, M.; Hu, C.; Xu, L.
Solid State Commun. 2004, 129, 485–490.
[61] Cheng, W.; Tang, K.; Qi, Y.; Sheng, J.; Liu, Z. J. Mater. Chem. 2010, 20,
1799–1805.
[62] Liao, X.; Zhu, J.; Zhong, W.; Chen, H.-Y. Mater. Lett. 2001, 50, 341–346.
[63] Corr, S. A.; Gun’ko, Y. K.; Tekoriute, R.; Meledandri, C. J.; Brougham, D. F.
J. Phys. Chem. C 2008, 112, 13324–13327.
[64] Corr, S. A.; Byrne, S. J.; Tekoriute, R.; Meledandri, C. J.; Brougham, D. F.;
Lynch, M.; Kerskens, C.; O’Dwyer, L.; Gun’ko, Y. K. J. Am. Chem. Soc.
2008, 130, 4214–4215.
111
Chapter 4: Polyelectrolyte stabilised magnetic
nanoparticles
4.1 General introduction and objectives
Chapter 3 demonstrated that microwave heating combined with traditional
aqueous co-precipitation methods allows for the fast and easy synthesis of
highly crystalline magnetic nanoparticles. The particles obtained are single
domain and superparamagnetic, making them ideal candidates for further de-
velopment as MRI contrast agents. This chapter aims to prepare a magnetic
nanocomposite using these magnetite cores, stabilised with a hydrophilic coat-
ing in the form of a polyelectrolyte. These polyelectrolytes will be bound to
the nanoparticle surface to bestow water stability on the magnetic cores. A
polyelectrolyte is a charged polymer, where multiple charged groups along the
polymer chain can act as binding sites for surface iron atoms and the resulting
polyelectrolyte-nanoparticle composite is water stable. Such binding is de-
picted in Figure 35.
Figure 35: Schematic of the proposed one pot co-precipitation and stabilisation re-
action of magnetite nanoparticles with poly(sodium-4-styrenesulfonate) (PSSS) and
sodium polyphosphate (SPP) showing multiple possible binding groups to iron oxide
surface.
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The stability could be enhanced by the accompanying electrostatic interac-
tions between the nanoparticle surface and the polyelectrolyte. Other possible
interactions could occur through cross linking of neighbouring polyelectrolyte
strands. The final composite will be a hydrophilic polyelectrolyte platform that
supports multiple magnetite nanoparticles, allowing the normally unstable iron
oxide cores to be dispersed in water. The type of polyelectrolyte employed
could also affect the properties of the final nanocomposites by altering the sur-
face chemistry of the magnetic core.1,2
Two different polyelectrolytes were investigated and the proposed reactions
are shown in Figure 36. Poly(sodium-4-styrene sulfonate) (PSSS) is a neg-
atively charged polyelectrolyte which binds through a sulfonate group to iron
atoms on the magnetite surface. Previous work has demonstrated PSSS as
an effective stabiliser for the preparation of stable iron oxide nanoparticles us-
ing a traditional coprecipitation approach.3,4 To date, microwave approaches
to enhancing the crystallinity and water stability have not been explored. This
is the major aim of the current chapter. Sodium polyphosphate, also a neg-
atively charged polyelectrolyte, was investigated to check the effect, if any, of
the nature of the polyelectrolyte on the resulting particles. This is the first in-
vestigation of the use of this polyelectrolyte for the stabilisation of iron oxide
nanoparticles for biomedical applications.
Figure 36: A schematic illustrating a nanocomposite comprised of iron oxide nanopar-
ticles, with a polyelectrolyte stabiliser (PSSS or SPP). Also included in this scheme
is the proposed incorporation of a fluorescent molecule during the coating process
(Rhodamine B).
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4.2 Characterisation of polyelectrolyte-Fe3O4 nanocompos-
ites
A similar microwave-assisted method to that developed in Chapter 3 has been
employed and is depicted in Figure 36. Here, the polyelectrolyte is added to
the starting iron chloride solution, so that as the particles are precipitated they
are simultaneously stabilised. The precipitated nanoparticles were washed
several times with water and finally with acetone, with the dried powder char-
acterised using XRD, TGA, HRTEM and SQUID measurements. The water
stable washings were retained and characterised using FTIR, DLS, TEM and
AAS. Cytotoxicity and MR efficacy were also investigated.
4.2.1 Structural characterisation
Powder XRD patterns were collected to characterise the iron oxide core and
to calculate the average crystallite size using the Scherrer equation. The pat-
terns for PSSS-Fe3O4 (blue line) and SPP-Fe3O4 (purple line) are shown in
Figure 37, together with unfunctionalised Fe3O4 nanoparticles prepared us-
ing the same method but without the addition of polyelectrolyte (yellow line).
The patterns collected match that of the magnetite standard from the ICSD
database and to previously reported XRD patterns of Fe3O4.5–9 The broad
peaks observed indicate small particles, with crystallite sizes calculated from
the Scherrer equation as 16.1 nm for PSSS-Fe3O4 and 10.9 nm for SPP-Fe3O4
(in comparison to microwave-assisted bare magnetite, with a size of 11.2 nm).
This difference in calculated size indicates the polyelectrolyte stabiliser may
have an effect on the primary particle size.
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Figure 37: XRD patterns for stabilised samples using microwave assisted coprecip-
itation: bare magnetite (orange), PSSS-labelled magnetite (navy) and SSP-labelled
magnetite (purple). For comparison, a standard pattern of magnetite from the ICSD
database (green) is also included.5
4.2.2 Surfactant characterisation
FTIR spectroscopy and TGA were used to confirm the presence of the poly-
electrolyte coating on the nanoparticle surface. Both samples gave an Fe-O
stretch at 533 cm−1 and a smaller O-H broad absorption at 3400 cm−1 due
to water physically adsorbed on the particle surface. In the case of PSSS-
Fe3O4, an Fe-O-S stretch is noted at 669 cm−1 (Figure 38 (a)), which indi-
cates the binding of the charged sulfonate group of PSSS to the magnetite
surface through the surface iron atoms. The sulfonate group also gives S-
O stretches at 830 and 775 cm−1 and R-SO2-OR stretches at 1405, 1160
and 1115 cm−1. The aromatic group of the polyelectrolyte gives a broad C-
C stretch at 1610 cm−1. The C-H bonds in the alkane backbone gives a broad
stretch at 2991 cm−1 which begin to merge with the O-H peaks. All of these
stretches observed here are in good agreement with similar stretches reported
in the literature.3,4,10
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In the case of the SPP-Fe3O4 sample (Figure 38b), an Fe-O-P stretch
is observed at 992 cm−1.11,12 This indicates binding of the polyelectrolyte
through the phosphate groups to surface iron atoms. Asymmetric vibrations
of the phosphate backbone are observed at 869 cm−1 (P-O-P bond) and at
1255 cm−1 (O-P-O bond). Terminal phosphate groups, which are indicative
of free (i.e., unbound to the nanoparticle surface) SPP, are represented by a
stretch at 1085 cm−1. Broadening of the peaks is due to the use of a long chain
polyelectrolyte, as the repeating signals of the bridging phosphate groups inter-
fere with each other, resulting in a broadening effect. Gong et al. undertook an
extensive study into phosphate chains and the effect of binding and pH in ATR-
FTIR measurements.13 They identified that the free P-O signal (1085 cm−1),
shifts to lower wavenumbers when it forms a P-OH group or binds to a metallic
surface. Gosh et al. confirmed that this shifting effect occurs when bound to
iron oxides.14 The shifting of the 1255 cm−1 peak in the SPP-Fe3O4 sample
prepared here to the lower wavelength of 950 cm−1 is indicative of this binding
effect. As the peak is shifted, it begins to overlap with the stretches assigned
to the phosphate backbone (869 cm−1) leading to the formation of the large
peak rather than the series of smaller individual signals, also contributing to
this broadening effect.
TGA was also used to further confirm the presence of the polyelectrolyte
coating on the magnetic cores. Samples were measured in air. Bare mag-
netite presents a single mass loss of 3.4% between 60◦C and 160◦C due to
the removal of solvent molecules (water and acetone) trapped on the iron ox-
ide surface from the washing of the samples (Figure 39, yellow line). The
mass increase between 200-300◦C is due to oxidation of the Fe2+ ions in the
magnetite core from being heated in air. When heated, these groups are ox-
idised into Fe3+ groups, transitioning the core into maghemtite (γ-Fe2O3) and
after prolonged oxidation into hematite (α-Fe2O3). The brick red colour of the
heated sample indicates complete oxidation of Fe2+ to Fe3+ and this transition
is similar to previous reports of TGA measurements by other groups.15,16 They
have observed a mass gain in the TGA measurements due to the oxidation of
Fe2+ groups, and confirmed the transformation of the powder into hematite at
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Figure 38: FTIR spectra of (a) PSSS-Fe3O4 (yellow), bare Fe3O4 (blue) and PSSS
(red). the magnetic nanocomposite stabilised with PSSS (yellow), bare magnetite
(blue) and unbound PSSS (red). (b) FTIR spectra of SPP-Fe3O4 (yellow), bare Fe3O4
(blue) and SPP (red).
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Figure 39: Thermogravimetric analysis for both magnetite (yellow), PSSS stabilised
magnetite (blue) and SPP stabilised magnetite (purple) samples measured in air. The
PSSS and SPP stabilised samples show large mass losses (9.3% and 7.8% respec-
tively), with the heavier PSSS polyelectrolyte showing the greater mass loss. All sam-
ples show a mass increase at 200◦C due to the oxidation of the magnetite cores from
being measured in air.
high temperatures. The stabilised samples have a much greater mass loss due
to removal of the polyelectrolyte. In the case of PSSS-Fe3O4, there is a loss of
9.3% due to removal of the polyelectrolyte stabiliser while for SPP-Fe3O4 this
is lower at 7.8%.
4.2.3 Particle size and crystallinity
Electron microscopy was used to examine the size of the iron oxide nanopar-
ticles and to determine the effects of microwave irradiation and choice of poly-
electrolyte stabiliser on the resulting particle morphology. Primary particle
sizes were measured over 100 particles from TEM images of samples dried
in ambient conditions (see Figures 40 to 42 and Table 10). Aggregation was
observed in all samples dried under ambient conditions. This is due to drying
118
effects from preparing the grids and in the case of polyelectrolyte stabilised
samples the presence of the stabiliser may also cause aggregation.17 The pri-
mary particle sizes for all samples were less than 15 nm, placing them within
the critical size diameter for a single domain iron oxide nanoparticle. The ef-
fect of the polyelectrolyte can be seen in the variation between primary particle
sizes, with the PSSS sample (13.4 nm) being slightly larger than bare mag-
netite (12.1 nm). SPP-Fe3O4 particles are significantly smaller (10.9 nm). The
measured sizes are in good agreement with the Scherrer broadening sizes
calculated from the XRD patterns.
Figure 40: Histograms of the primary particle sizes of PSSS-stabilised magnetite
(blue) and SPP-stabilised magnetite (purple) calculated from TEM images of the parti-
cles dried in ambient conditions (N=100). PSSS-Fe3O4 particles are larger in size but
with a narrower size distribution, whereas SPP-Fe3O4 particles are smaller but larger
in spread.
High resolution electron microscopy images in Figure 41 show that single
crystal magnetite nanoparticles form regardless of the stabiliser used. How-
ever, the stabiliser has a significant effect on the resulting morphology and
crystallinity of the magnetic core. The PSSS stabilised nanocomposites (fig-
ure 41 (a), (c)) appear highly crystalline in nature and are slightly larger than
either the pure Fe3O4 (Chapter 3) or the SPP-Fe3O4 sample. The particle
shape is regular and faceted. The SPP nanocomposites (figure 41 (b), (d))
are much more irregular in shape and less defined. The lattice spacings in
the HRTEM images are characteristic of magnetite crystals and that combined
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with the SAED measurements further confirms the magnetite identity of the
core. The SAED results agrees with previous XRD results and other SAED
magnetite patterns presented in the literature.15,18
Table 10: Particle sizes calculated from TEM images, where N = 100 particles. The
primary particle sizes were calculated from grids dried under ambient conditions. The
assembly widths were also measured from particles dried in the 0.5T external field.
The polyelectrolyte employed significantly affects primary particle size and the forma-
tion of these assemblies.
Stabiliser Particle size S.D. Assembly width S.D.
(nm) (nm) 0.5T field (nm) (nm)
PSSS-Fe3O4 13.4 1.5 61.6 18.2
SPP-Fe3O4 10.9 1.4 477.7 167.5
When exposed to an 0.5 T external magnetic field, the PSSS-Fe3O4
nanocomposites form roughly linear assemblies aligned with the applied field.
SPP-Fe3O4, on the other hand, displays a minimal response (Figures 42 and
43). The PSSS assemblies were a few particles wide but typically over 500
nanometers in length. This behaviour is likely due to the nature of the poly-
electrolytes employed. PSSS is a strong polyelectrolyte that is fully deionised
in the basic solutions that the particles were precipitated in.19–22 When fully
deionised, this has two effects. Firstly, all sulfonate sites are available for bind-
ing. Additionally, the charged sulfonate groups will tend to repel each other
forcing the polyelectrolyte to adopt a linear shape.23,24 When the polyelec-
trolyte is saturated with magnetite nanoparticles, the remaining unbound sul-
fonate groups repel each other promoting the formation of a linear structure.
After washing until neutral, the free sulfonate groups are no longer charged, do
not repel each other and the entire nanocomposite can aggregate when dried
under ambient conditions (Figure 42 b). In the presence of an external mag-
netic field, the nanocomposite can then realign into chains, which may be aided
by cross linking of neighbouring PSSS chains. The linear assembly will have a
much greater surface area than a larger cluster such as SPP-Fe3O4 (Figure 42
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d, e). This is an interesting consideration for MR efficacy, since a higher sur-
face area linear assembly should interact with more of the surrounding protons
thereby enhancing contrast agent effectiveness.
The SPP stabilised sample clustered and agglomerated, with a slight ori-
entation to the external magnetic field instead of forming narrow linear assem-
blies. This is due to SPP being a weak polyelectrolyte and is not completely
disassociated in the basic solution that the particles are precipitated in.21,25,26
This blocks binding sites and reduces the repulsion between monomer groups.
Ultimately this stops the formation of linear assemblies, instead promoting the
formation of loops and curls in the polyelectrolyte which causes clustering and
the formation of a thicker polyelectrolyte layer.21,27–29 Additionally the restricted
binding sites means that less magnetite is bound to each polyelectrolyte chain
making the overall chain less responsive in an external magnetic field.
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Figure 41: High resolution TEM images (images a-d) and SAED images (images e
and f) were taken of both the PSSS (images a, c and e) and SPP (images b, d and f)
stabilised samples. Lattice spacings and SAED measurements confirm the magnetite
core.
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Figure 42: TEM images of (a) bare magnetite nanoparticles, (b) PSSS-Fe3O4 dried
in ambient conditions, (c) PSSS-Fe3O4 dried in an external 0.5 T magnetic field, (d)
SPP-Fe3O4 dried in ambient conditions and (e) SPP-Fe3O4 dried in an external 0.5 T
magnetic field. Clustering observed under ambient conditions for both samples, while
the PSSS sample forms thin linear assemblies in a magnetic field.
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Figure 43: TEM images (a, c) and histograms (b, d) of PSSS-Fe3O4 and SPP-Fe3O4
nanocomposites, respectively, dried in an external magnetic field. The PSSS compos-
ite forms thin linear assemblies, which are several particles wide whereas the SPP
samples formed much larger aggregates normally over 200 nm in size
4.2.4 Suspension behaviour
DLS was used to determine how the composites behave and aggregate in
water suspensions. The addition of the polyelectrolyte coating provides a hy-
drophilic layer for the nanoparticles, allowing dispersion in aqueous suspen-
sion. As the particles are washed to neutral and as pH 7 is approached, they
become more readily dispersed in water. Stability in this case was defined
as a suspension of particles which remained in water without precipitating af-
ter sitting on a 0.5 T magnet overnight. At pH 7, very stable suspensions of
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iron oxide nanoparticles in water were obtained. The suspension behaviour of
each washing was characterised using DLS and the results are presented in
Table 11.
Table 11: DLS measurements of the PSSS-Fe3O4 nanocomposite. Slight differences
can be seen between the polyelectrolyte types, with the SPP based samples having a
larger hydrodynamic radius due to polyelectrolyte folding and looping. Zeta potentials
(Z. Po.) indicate a high water stability
Sample
Dispersion 3 Dispersion 4 Dispersion 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
PSSS-Fe3O4 166 0.248 82.78 0.111 94.7 0.097 -41.5
SPP-Fe3O4 171.5 0.262 137.1 0.204 104.9 0.158 -48.2
As the suspensions approach neutrality, the Z-averages and polydisper-
sity indices (PDIs) decrease and cluster distribution shifts to monomodal (Fig-
ure 44). Clusters with a Z-average of around 100 nm are observed for both
samples at pH 7. Although the Z-averages for both final dispersions are sim-
ilar, there is a large difference in the PDIs, which may be attributed to the
behaviour of the polyelectrolyte. In weak polyelectrolytes, such as SPP, the
presence of loops and folds in the stabiliser results in the formation of a thicker
polyelectrolyte layer.21,27–29 Netz et al. explored the absorption mechanics
of weak polyelectrolytes, detailing how the weak polyelectrolyte chain is more
flexible (due to less repulsion between monomers), and therefore more sus-
ceptible to forming loops and folds in solution.24 Several groups have mea-
sured this thickness increase experimentally using ellipsometery.21,30,31 In all
measurements, it was found that the weak polyelectrolyte forms thicker lay-
ers (with a greater variance in size) than strong polyelectrolytes (which take
a linear conformation due to monomer repulsion and therefore lie flat on the
particle surface). This local clustering of the polyelectrolyte results in a more
polydisperse and slightly larger nanocomposite. Manipulating the formation of
loops and curls is commonly done in the development and tailoring of layer-by-
layer nanocomposites as it allows for the development of pH responsive poly-
electrolyte films.27,30 For most biomedical applications, it is desirable for the
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particles to be 200 nm or less, with the nanocomposites discussed within this
chapter in this size range.32–34 Both samples display enhanced water stability
by staying in suspension for over a month, even in the presence of an external
0.5 T magnetic field. The final PSSS-Fe3O4 suspension was extremely stable
staying in suspension for several months. This enhanced stability compared to
particles prepared without the additional microwave step suggests that these
suspensions show good promise as contrast agents for MR imaging.
Figure 44: Size distribution of PSSS-Fe3O4 and SPP-Fe3O4 in aqueous suspension
measured at pH 7 using DLS. The PSSS stabilised sample showed a smaller size
distribution as the polyelectrolyte will not fold or curl to the same extent as SPP.
The surface charge of the particles was also measured using DLS. This
technique measures the zeta potential of particles in suspension, which is an
indicator of possible agglomeration/clustering. The zeta potential is based on
the surface charge of particles and how water molecules are attracted and
dragged by the particle surface. Zeta potentials below -30 mV or above 30 mV
are considered water stable and will show little agglomeration.35 Bare mag-
netite has a charge (-12.5 mV) and which is reflected by its high instability in
water. When stabilised with polyelectrolytes, the zeta potentials for both com-
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posite types increases to over -40 mV again further supporting the high water
stability.
4.2.5 Magnetic property measurements
The magnetic properties of the nanocomposites were measured using a
SQUID and magnetisation curves recorded at 300 K and 10 K in a magnetic
field of up to 2 x 104 G are shown in Figure 45. From Figure 45, it can be
seen that there is negligible coercivity and remanence noted at 300 K, indica-
tive of superparamagnetic, single-domain iron oxide particles. The magneti-
sation is unsaturated up to 2 T, even at 10 K. Uncoated magnetite prepared
using similar microwave-assisted methods gives a saturation magnetisation of
65.2 emu/g at 300 K, as discussed in Chapter 3.36 While this is lower than the
theoretical value for bulk magnetite of 98 emu/g (most likely due to spin disor-
der on the particle surface), this value is higher than the previously reported
saturation magnetisation values for aqueous routes to iron oxide nanoparticles
(40-50 emu/g).4,37 By employing polyelectrolytes as stabilisers here, it is ob-
served that primary particle sizes and morphologies change and this, in turn,
has a marked effect on the resulting magnetic properties. The SPP-stabilised
particles have a reduced MS value of 49.7 emu/g at 300 K (Figure 45c). The
PSSS-stabilised samples, on the other hand, have an MS value of 71.8 emu/g
at 300 K (Figure 45a). While this value is still lower than that of the theoreti-
cal value for bulk magnetite, this can be explained by a reduction in MS due
to the presence of the nonmagnetic polyelectrolyte stabiliser.18 Interestingly,
the magnetisation value here is significantly higher that MS values previously
obtained from NMRD data for PSSS-stabilised Fe3O4 (30-50 emu/g) prepared
without the additional microwave synthesis step.38
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Figure 45: Magnetic hysteresis loops of PSSS-Fe3O4 at (a) 300 K and (b) 10 K and
SPP-Fe3O4 at (c) 300 K and (d) 10 K.
The saturation magnetisation value is greatly affected by crystallinity of the
sample. A greater saturation magnetisation value means that particles will
generate a stronger magnetic moment when placed in an external magnetic
field. The stronger the moment, the more protons will be affected by the com-
posite. The differences in MS observed here relate to interaction of the poly-
electrolyte with the iron oxide surface, which can either increase or decrease
surface disorder. Disorder in the crystal structure results in a magnetically
”dead” layer which does not contribute to the overall magnetisation. TEM im-
ages of PSSS-Fe3O4 show well-defined particles of high crystallinity, which is
reflected in the higher MS values. Given the MS value for PSSS-Fe3O4 is higher
that bare magnetite, this indicates that the PSSS coating can actually improve
the crystallinity of the magnetite surface. The opposite is true for SPP-Fe3O4,
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where TEM showed the nanoparticles were poorly defined and this is reflected
in the lower MS values. The samples were cooled to 10K and displayed the
expected behaviour, with neither reaching saturation (this is also indicative of
superparamagnetism). Hysteresis loops are observed at lower temperatures,
which indicate residual magnetism. This is expected as at the lower temper-
atures there is not enough thermal energy for the magnetic spins to randomly
align during the measurement, resulting a small degree of residual magnetism.
The PSSS-Fe3O4 sample has a similar MS value to that reported for particles
prepared using high temperature decomposition routes and organic solvents
(80 emu/g).39 The method here has the added advantage over these high tem-
perature route in that the particles can be dispersed in aqueous suspension
without the need for any post processing, vital for use as a contrast agent for
MR imaging. This high magnetisation may influence the MRI properties of the
composite, as the magnetic core can interact more effectively with surrounding
water molecules for greater imaging efficacy.
4.2.6 Determination of iron concentration
Before we can evaluate the MR efficacy of these stable suspensions, the con-
centration of iron in each suspension must be accurately determined. Using
AAS, this can be determined reliably. Iron standards were prepared from a
iron standard (obtained from sigma aldrich) diluted with millipore water to form
7 standards with concentrations of 1, 1.5, 2, 2.5, 5, 7.5 and 10 ppm. Using
the calibration curve, the concentration of iron in stable suspensions of PSSS-
Fe3O4 and SPP-Fe3O4 were calculated. The PSSS sample displayed the best
water stability and the neutral suspension had the highest iron concentration
of 6.09 mg/l in comparison to SPP with 5.09 mg/l.
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Figure 46: The iron content of the PSSS (square) and SPP (diamond) stabilised
nanocomposites plotted with the calibration standards (circle). Iron concentration in-
creased with the washings with the final PSSS sample displaying the highest concen-
tration of 6.09 mg/l
4.3 Biomedical applications
To evaluate any potential cell toxicity and contrast agent efficacy, the neutral
suspensions of PSSS-Fe3O4 and SPP-Fe3O4 were examined. These suspen-
sions were tested in live cells to ensure biocompatibility and with an MRI scan-
ner to determine their ultimate relaxivities.
4.3.1 Live cell testing
The effect of stabiliser on cell toxicity was examined by cell viability studies on
suspensions of the polyelectrolyte-stabilised particles co-incubated at increas-
ing concentrations (0.001 µg to 1000 µg) with a range of cell lines and these
results are depicted in Figure 47. Regardless of the stabiliser employed, all
nanoparticle suspensions tested were found to be non-toxic to three different
mammalian cell lines. This is determined by the fact they did not affect the via-
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bility of UKF-NB-3 neuroblastoma cells, primary human retinal pigment epithe-
lial (RPE) cells, or primary human foreskin fibroblasts (HFF) even in concen-
trations up to 1 mg iron/l. The non-toxicity of these suspensions is promising
for their ultimate biomedical application.
Figure 47: Cytotoxicity profiles of (a) PSSS and (b) SPP stabilised nanocomposites in
UKF-NB-3 neuroblastoma cells, primary human retinal pigment epithelial (RPE) cells
and primary human foreskin fibroblasts (HFF). There was minimal cell death with the
nanocomposites at concentrations of up to 1 mg/L.
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4.3.2 Magnetic resonance imaging testing
Stable neutral suspensions of PSSS-Fe3O4 and SPP-Fe3O4 were tested in a
3 T clinical MRI scanner with increasing Fe concentrations. As the samples
increased in concentration a darkening of the image is observed, indicating
that the composites shorten relaxation times (characteristic of transverse re-
laxation). The PSSS based nanocomposites showed the greatest darkening
effect. The r2 values of the composites were calculated to be 69.2 mM−1 s−1
and 39.9 mM−1 s−1 for the PSSS and SPP sample respectively. This indicates
that the high crystallinity of the PSSS sample resulted in a highly magnetic,
water stable nanocomposite that is reflected in very strong r2 values. Another
factor that further enhances the contrast effect of the PSSS composite is the
formation of a thin linear assembly in magnetic fields (seen in the TEM images,
figure 43). The formation of this linear assembly gives the composite a greater
surface area allowing a larger portion of the water protons to interact with the
magnetite cores. This effect further enhances the r2 values of the composite.
The nanocomposites are in line with commercial MRI contrast agents but the
advantage of this work is that the nanoparticles are prepared and stabilised in
less than an hour in a scalable one pot reaction.40,41
Figure 48: T2-weighted MR images of PSSS stabilised and SPP stabilised magnetite
nanoparticles. As concentration increases a darkening of the image can be observed.
The PSSS-Fe3O4 displayed the best properties with an r2 value of 69.2 mM−1 s−1
whereas the SPP-Fe3O4 composites had an r2 value of 39.9 mM−1 s−1.
The observed r2 values for the SPP-Fe3O4 suspension are lower than for
PSSS-Fe3O4. This can be explained by the ill-defined, poorly crystalline par-
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ticle shape which leads to lower magnetisation values and the formation of
large clustered material. Improved MRI properties from linear assemblies have
been observed previously by the group.3,4 Park et al. also observed this effect
from the linear assemblies of magnetic nanoparticles.42 They prepared dextran
coated iron oxide nanoparticles in the form of a linear assembly (”nanoworms”)
and compared them with unorganised magnetic nanoparticles and commercial
agents. In all cases, the ”nanoworms” proved to have a higher MS and relaxivity
values than the other samples. They also associated this enhanced relaxivity
with the assembly having a greater surface area allowing increased magnetic
interactions with the surrounding water protons. Even with the reduced values,
the SPP nanocomposites can still be used as an MRI contrast agent with a
significant darkening effect seen at low concentrations
4.4 Fluorescent-magnetic nanocomposites
The MRI results demonstrate that the biocompatible PSSS-stabilised
nanocomposites make excellent contrast agents with high r2 values. In or-
der to explore the possibility of engineering a multimodal platform capable of
MR imaging and fluorescent imaging (for cell labelling and tracking), the flu-
orescent dye Rhodamine B was incorporated into the nanocomposite. Fluo-
rescent labelled PSSS-Fe3O4 was prepared by the addition of Rhodamine B
to the PSSS polyelectrolyte solution before particle precipitation, where as-
sociation is driven by the electrostatic interactions between the dye and the
polyelectrolyte. The composite was characterised with FTIR, DLS, UV-Vis and
fluorescence spectroscopy and cellular uptake was observed using confocal
imaging.
4.4.1 FTIR and DLS measurements
FTIR spectroscopy was used to confirm the addition of the Rhodamine B moi-
ety to the nanocomposite (figure 49 (a)). Rhodamine B was added at very
low quantities and gives weak signals which interact with the polyelectrolyte
stretches. The C=C bonds of Rhodamine B give a characteristic broad stretch
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at 1410 cm−1. The C=C Rhodamine B stretches occur in the same region as
the C=C bonds in the polyelectrolyte stabiliser. These signals interact caus-
ing a broadening and intensity increase in the C=C stretch. Persistence of
the stretches associated with PSSS and Fe-O shows that the addition of Rho-
damine B does not have a drastic effect on the existing nanocomposite.
Figure 49: (Left) IR spectra of the magnetite nanoparticles (green) stabilised with
PSSS (blue) and PSSS-Rhodamine B (red). (Right) DLS measurements of PSSS-
stabilised and PSSS-Rhodamine B nanocomposites, in aqueous suspension. The
fluorescent composite has a slightly greater size distribution.
DLS was used to identify any changes in suspension behaviour by the addi-
tion of the fluorescent groups. As the sample is washed, the cluster distribution
becomes monomodal, similar to the non-fluorescent samples (figure 49 (b)).
The addition of Rhodamine B increases the Z-averages and PDI values for all
of the dispersions (Table 12). This increase in cluster size still makes the par-
ticles viable for biomedical applications.32–34 The fluorescent sample displays
extremely high water stability, staying in suspension for over two months. Zeta
potentials for the fluorescent nanocomposite was extremely high (-55.8mV)
again further supporting the high water stability.
UV-Vis spectroscopy was used to study the optical properties of the
nanocomposites and to identify the excitation wavelength of Rhodamine B. Ab-
sorbance peaks for Rhodamine B are hidden due to scattering of light by the
magnetic particles in suspension, with only a slight response seen at 230 nm
(figure 50). A broad bump between 300-450 nm and a small peak at 230 nm is
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expected from the Rhodamine B group (Figure 50).
Table 12: DLS measurements of the PSSS stabilised and PSSS-rhodamine B
nanocomposite dispersions. The Rhodamine B functionalised sample had slightly
larger Z-average and PDI values than traditional PSSS-stabilised samples due to the
increased size from the rhodamine B. Zeta potentials (Z. Po. indicate a high water
stability, despite the composite supporting additional groups.
Sample
Dispersion 3 Dispersion 4 Dispersion 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
PSSS-Fe3O4 166 0.248 82.78 0.111 94.7 0.097 -41.5
RhB-PSSS-Fe3O4 166 0.248 140.8 0.116 148.9 0.142 -55.8
Figure 50: (Left) UV-Vis spectra of Rhodamine B standard (green) and RhB-PSSS-
Magnetite (blue). Scattering of light by the nanoparticles suppresses the Rhodamine
B signal with a sight response at 230 nm. (Right) Emission (navy) and Excitation (light
blue) spectra of PSSS-magnetite functionalised with Rhodamine B. The characteristic
emission and excitation peaks of Rhodamine B confirm the success of the functionali-
sation reaction.
Fluorescence spectroscopy was used to further characterise the nanocom-
posites, with the measurements unaffected by light scattering from the par-
ticles. An excitation and emission spectrum was taken for the final disper-
sion. Characteristic Rhodamine B peaks can be seen in both the excitation
and emission spectra confirming the presence of the fluorescent group in the
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composite. The PSSS-Fe3O4-RhB nanocomposite shows an emission peak at
570 nm and a excitation peak at 540 nm, which agrees with the characteris-
tic peaks of Rhodamine B.43,44 The persistence of fluorescence peaks in the
dispersion after multiple washes indicate that the Rhodamine B molecules are
securely coupled to the nanocomposite.
4.4.2 Confocal imaging
After confirming the fluorescent nature of the nanocomposite, confocal imag-
ing was employed to determine the cellular uptake of the composite and the
materials effectiveness as a fluorescent label. Suspensions of PSSS-Fe3O4
and SPP-Fe3O4 were introduced to cultures of UKF-NB-3 neuroblastoma cells
and multiple images were taken to confirm uptake and labelling.
Figure 51: Confocal imaging of RhB-PSSS-Magnetite nanoparticles. Image (a) is the
fluorescent particles, image (c) is of the cells without the fluorescent imaging while im-
age (b) is an overlay of the fluorescent image with the cells showing the internalisation
of the particles.
Images at a fixed depth show the uptake of the composite by the cells. The
fluorescence emission of the nanocomposite is intense enough to identify and
distinguish the individual cells from each other (Figure 51). Figure 52 confirms
the uptake of the nanocomposite by the cells, showing that the fluorescent
nanocomposite is dispersed throughout the cells at varying depths, rather than
being trapped on the cell surface. These images demonstrate the nanocom-
posites suitability as a fluorescent label, which combined with the earlier MR
images, confirm that the composite can be used as a dual imaging agent.
136
Figure 52: Z-Scan images of the confocal measurements of Rhodamine B functionalised PSSS-Fe3O4 nanoparticles. The depth of the images
increases from left to right. The persistence of the fluorescent groups in the images confirm that the particles were internalised by the cells rather
than trapped on the cell surface.
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4.5 Discussion and conclusions
The method outlined in this chapter successfully demonstrates the use of mi-
crowave irradiation for the synthesis and stabilisation of magnetic nanopar-
ticles. This approach results in a highly crystalline, extremely water stable
and biocompatible iron oxide based nanocomposites. These multifunctional
nanocomposites can be prepared in under an hour, with applications in both
MR and confocal imaging. Two factors are responsible for the efficacy of these
particles, microwave irradiation and the polyelectrolyte stabiliser itself. The
previous chapter already demonstrated the effect of microwave irradiation on
particle crystallinity, and this work explores the link between crystallinity and
polyelectrolyte stabilisation
Previous work by the group and other researchers demonstrated the in situ
stabilisation of iron oxide nanoparticles using the co-precipitation method, not-
ing changes to magnetisation values from stabilisation.4,45–47 HRTEM images
in this chapter show that the stabiliser has a great effect on particle crystallinity.
SQUID measurements then link these changes in crystallinity to magnetisa-
tion values, which is ultimately reflected in the MRI measurements. The two
polyelectrolytes demonstrate how the stabiliser can either enhance (PSSS), or
limit (SPP) particle crystallinity. The literature further confirms this link, with Lin
et al. observing a crystallinity decrease from another polyelectrolyte stabiliser
(PAA). The stabiliser reduced the saturation magnetisation of the particles from
50 emu/g to 35 emu/g. They determined that the polyelectrolyte acted as a
template limiting crystal growth.46 Itoh et al. expands on this through corre-
lating an increase surface anisotropy with the binding of the SPP coating.47
The specific effect of the stabiliser on crystallinity is unique to the material
used though, with examples of organic stabilisers (such as dopamine) improv-
ing crystallinity.48,49 These stabilisers coordinate and repair surface defects,
to increase crystallinity and magnetisation values of the particles. This can
be observed with the PSSS-Fe3O4 sample, which had a higher magnetisation
value than bare magnetite. This highlights the importance of the stabiliser in
the nanoparticle design.
Stabilisers not only positively effect crystallinity, but can also improve par-
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ticle MRI efficacy in other ways. One stabiliser of interest is terephthalic acid,
which has been shown to enhance the iron oxide contrast effect, independent
of particle crystallinity. Maity et al. prepared an terephthalic acid stabilised
iron oxide nanocomposite, and reported one of the highest iron oxide based
MRI relaxivity values in the current literature.50 The prepared particles were
stabilised (in situ) with 2-amino terephthalic acid and terepthalic acid within the
space of 2 hours. The particles had strong magnetisation values (Ms: 73.6
and 74.3 emu g−1 respectively) but the r2 values for the particles are some of
the highest values reported (450.8 and 735.3 mM−1 s−1 respectively). These
high relaxivity values were ultimately reflected in both MRI measurements and
images showing a great contrast effect. They attribute this increase to the
structure of the stabiliser. Terephthalic acid and 2-amino terephthalic acid sta-
bilisers contain pi-conjugation paths that allow spin transfer from electrons in
the magnetic core to the neighbouring water molecules. This allows a greater
distribution of the charge to a larger group of neighbouring protons through
this direct link. This work is interesting, and combining the terepthalic acid sta-
biliser, with microwave irradiation and PSSS might be able to further optimise
MRI relaxivity values.
The other essential element of this synthesis process is microwave irra-
diation. Microwave heating has been shown to further enhance the particle
crystallinity in tandem with the stabiliser (PSSS), or minimise the growth inhi-
bition from less suitable stabiliser materials. Microwave irradiation promotes
crystal growth, resulting in highly crystalline particles similar to solvothermal
methods. This method though allows the particles to be redispersed into water
immediately after precipitation avoiding the need for post processing (common
with high temperature decomposition methods).18,39,51,52 Post processing re-
sults in long multistep methods and the ligand exchange process can further
reduce magnetisation values.53,54 The method outlined here, combines precip-
itation and stabilisation into a single step, with the correct choice of stabiliser
minimising surface defect formation through in situ stabilisation. The method
presented here also enables functionalisation to occur simultaneously with pre-
cipitation and stabilisation. A variety of other approaches can be used to bind
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Rhodamine B to magnetite but this approach offers speed and simplicity. While
microwave irradiation allows stabilisation/functionalisation with little sacrifice to
magnetic properties.
Both polyelectrolytes allow for biocompatible, water stable nanoparticles
which show good promise as MRI contrast agents. The results show that
PSSS is the optimal stabilise though, as the coating further enhances crystal
growth and makes the nanocomposite extremely stable in suspension. These
differences between the samples underlies how essential the polyelectrolyte is
on the composites properties. Not only does the polyelectrolyte bestow water
stability but can also have a significant effect on the particle size, morphology
and magnetic properties. Further work will continue to explore polyelectrolyte
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Chapter 5: Investigating magnetic fluid be-
haviour by varying polyelectrolyte type and
chain length
5.1 General introduction and objectives
Polyelectrolytes can be highly versatile with variations in chain size and
monomer composition allowing for the further enhancement of the nanocom-
posites water stability or the addition of functional groups. As shown in the pre-
vious chapter the iron oxide particle size, morphology and magnetic properties
can change based on the polyelectrolyte bound to the iron oxide surface. The
aim of this chapter is to continue exploring polyelectrolyte materials as potential
iron oxide stabilisers, specifically looking at affect of the polyelectrolyte nature
on the final nanocomposite water stability. The charge and chain length may
have a great affect on the nature of the polyelectrolyte binding to the nanopar-
ticle surface. Changing the length of the polyelectrolyte will alter the number
of binding sites and how many magnetic nanoparticles can be supported by
the polyelectrolyte chain. Varying the charge of the polyelectrolyte chain will
affect how the polyelectrolyte binds to the iron oxide surface. Additionally it
will also alter the nanocomposites surface charge which dictates the water
stability. The effect of charge was seen briefly in chapter 4 when comparing
the fully charged strong polyelectrolyte PSSS against the weak polyelectrolyte
SPP which is only partially charged in solution. This chapter will further explore
the distinction between weak and strong polyelectrolytes, and will also look at
the use of cationic polyelectrolytes.
Two different polyelectrolytes with distinct functional groups will be investi-
gated. The first polyelectrolyte will be poly(acrylic acid) (PAA) which contains
a negatively charged carboxylic acid binding group. PAA is considered to be
a weak polyelectrolyte and is partially ionised in solution.1,2 The deionised
carboxylate groups are available to bind to the iron groups on the particle
surface (figure 53). One advantage of PAA is the possibility of carbodiimide
coupling, which allows the attachment of linkers and functional groups (i.e.
145
chemotherapy agents) to the free carboxylic acid groups, which is key to the de-
velopment of multi-functional nanocomposites.3,4 The second polyelectrolyte
is Poly(diallyldimethylammonium chloride) (pDADMAC) which binds at an al-
ternative site through the polyelectrolyte ammonium groups to the hydroxide
groups on the magnetite surface (figure 53). This is a strong cationic poly-
electrolyte that is fully deionised in solution and will act as a comparison to
the anionic PAA, PSSS and SPP polyelectrolytes explored previously.5,6 Other
groups have used PAA and pDADMAC as iron oxide stabilisers previously but
this work aims to expand on this existing knowledge by using these stabilisers
in a microwave assisted co-precipitation reaction, and to conduct a systematic
study of polyelectrolyte chain length on iron oxide water stability.7–10
Figure 53: Schematic of the one pot co-precipitation and stabilisation reaction of PAA
and pDADMAC on iron oxide nanoparticles. The negatively charged carboxylic acid
group of PAA will bind to the positively charged iron groups on the magnetite surface.
The positively charged ammonium group of pDADMAC will bind to the magnetite sur-
face via the hydroxide groups.
5.2 Characterisation of polyelectrolyte-Fe3O4 nanocompos-
ites
The nanocomposites were prepared in a similar method as discussed in chap-
ter 4. The nanoparticles were stabilised in situ via a single microwave-assisted
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coprecipitation reaction. The reaction conditions were kept at 150◦C, at 100 W
for 20 minutes (plus ramping time). Three different chain lengths were used for
each polyelectrolyte (Table 13). The resulting dried precipitates were charac-
terised with XRD and TGA. The stable and pH neutral dispersions (third to fifth
washings) were analysed with FTIR, TEM and DLS.
Table 13: The sample prepared, and polyelectrolyte chain lengths used to stabilise
iron oxide particles used in this chapter
Sample Name Polyelectrolyte Classification Polyelectrolyte mwt
PAA stabilised nanoparticles
Sample A Very low mwt 1,800
Sample B High mwt 400,000-500,000
Sample C Very High mwt 1,250,000
pDADMAC stabilised nanoparticles
Sample D Low mwt <100,000
Sample E Medium mwt 100,000-200,000
Sample F High mwt 400,000-500,000
5.2.1 Structural characterisation
Powder XRD patterns of the samples identify the iron oxide core and the pri-
mary particle size was calculated using the Scherrer equation. Figure 54
shows the patterns for both the PAA-stabilised samples and pDADMAC-
stabilised samples, along with the unfunctionalised bare Fe3O4 also prepared
by the microwave assisted co-precipitation method (green). The patterns
match the peaks observed for bare magnetite prepared in chapter 3 along with
magnetite standards from the ICSD and reported by other groups.11–15 The
broad peaks indicate that the particles are on the nanoscale with the Scherrer
equation determining the crystallites to be between 9-15 nm for the stabilised
samples (table 14), which is small enough for the particles to be single do-
main.16 There seemed to be little effect of polyelectrolyte length or charge on
the primary particle size, with the particles showing the same size irrespective
of polyelectrolyte coating.
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Figure 54: XRD patterns for bare magnetite (green) and magnetite samples stabilised
with PAA (image (a) Sample A: blue, Sample B: yellow, Sample C: red) and pDADMAC
(image (b) Sample D: blue, Sample E: yellow, Sample F: red). Samples B and E were
characterised under different conditions at the University of Glasgow (more information
can be found in chapter 2). The pattern for all samples are in good agreement to known
magnetite (purple).11
Table 14: Primary particle sizes calculated via Scherrer broadening. Polyelectrolyte
length or charge seems to have little effect on particle size, with all particles small
enough to be single domain.16
Sample Polyelectrolyte mwt Primary particle size (nm)
Magnetite N/A 11.2
PAA stabilised nanoparticles
Sample A 1,800 13.5
Sample B 400,000-500,000 15.2
Sample C 1,250,000 12.9
pDADMAC stabilised nanoparticles
Sample D <100,000 14.1
Sample E 100,000-200,000 9.9
Sample F 400,000-500,000 10.4
148
5.2.2 Surfactant characterisation
FTIR and TGA spectroscopy was used to confirm the polyelectrolyte binding to
the magnetite surface. All samples gave a large Fe-O absorption at 570 cm−1
and a small broad band at around 3400 cm−1 due to water groups physically
adsorbed on the particle surface.17,18
Figure 55: FTIR spectra of magnetic nanocomposites stabilised with PAA (image (a)
Sample A: blue, Sample B: yellow, Sample C: red) and pDADMAC (image (b) Sample
D: blue, Sample E: yellow, Sample F: red) compared to bare magnetite (green). A
series of peaks relating to PAA and pDADMAC indicate successful stabilisation.19–22
For the PAA-Fe3O4 stabilised samples (Figure 55, (a)), the polyelectrolyte
binding is confirmed by the symmetric and asymmetric -COO- vibrations at
1550 and 1390 cm−1. These are ionised carboxylic acid groups, shift from
1600 and 1420 cm−1 respectively when bound to the iron oxide surface indicat-
ing successful stabilisation. Distinction of these peaks is difficult due to back-
ground CO2 but a clear shifting and addition of peaks can be seen when com-
pared to the bare magnetite spectrum (green). Multiple groups have confirmed
this shifting effect and the linking carboxylate peaks at 1550 and 1390 cm−1,
with stabilisation further supported by the formation of water stable suspen-
sions.19–21 Additional unbound C-O stretches occur at 1210 cm−1 causing a
broadening of this peak and the neighbouring carboxylic acid peaks. The C-
C alkane backbone that holds the PAA together gives a signal at 1600 cm−1
which has merged with some of the carboxylic acid peaks. The hydroxide
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group of the carboxylic acid overlaps with the peak for excess water on the
magnetite surface at 3400 cm−1 while weak C-H stretches can be seen at
2921 cm−1 as a slight shoulder. These peaks match with PAA stabilisation
reactions found within the literature, but are absent in the bare magnetite
samples.7,23,24 Little difference can be seen between the polyelectrolyte chain
lengths in the FTIR spectra, with Sample A showing slightly more pronounced
polyelectrolyte peak intensities.
The intensity of the pDADMAC-Fe3O4 signals are weak but there are sev-
eral specific peaks that relate to the polyelectrolyte structure and indicate suc-
cessful binding. The polyelectrolyte coordinates with the magnetic nanoparti-
cle via the interaction of the polyelectrolyte ammonium group with the hydrox-
ide groups on the iron oxide surface. The formation of the linking N-H bond
can be seen with a stretch at 3400 cm−1 and a N-H bend at 2326 cm−1. These
signals are weak and can overlap with hydroxide peaks at 3400 cm−1, but in
samples D and E the N-H bend can clearly be distinguished at 2326 cm−1
when compared to bare magnetite (green). Successful stabilisation can also
be inferred from the formation of a water stable suspension. Stretches from the
anchoring points also support stabilisation with an O-H stretch at 3400 cm−1,
Fe-O stretch at 570 cm−1 and C-N stretch at 1053 cm−1. Work by several other
groups support this binding method by exploring the coordination of other ma-
terials containing amide and ammonium groups with iron oxide surfaces.25,26
There are several other non bonding polyelectrolyte peaks in the spectrum
with the C-C backbone of the structure giving a signal at 1650 cm−1 and C-
H stretches observed at 2941 cm−1. The C-C stretches occur at the same
wavenumber as vibrations from background CO2 (C=O: 1550 cm−1) but the in-
creased intensity supports the presence of polyelectrolyte. The C-H stretches
at 2931 cm−1 have merged with the ammonium peaks at 3400 cm−1 with a
broadening of the peak and the formation of a slight shoulder is observed by
the overlapping signals. The overall peak assignment matches the pDADMAC
magnetite nanoparticles prepared by other groups with the assigned polyelec-
trolyte peaks absent in the bare magnetite spectrum.9 Little difference can be
seen between the polyelectrolyte chain lengths with all samples showing simi-
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lar peaks and intensities.
TGA was also used confirm the polyelectrolyte component in the iron oxide
composites.The stabilised samples show multiple mass losses. The first mass
loss between 60-140◦C is due to solvent molecules (i.e. water, acetone and
ethanol) trapped on the surface of the nanocomposite. The stabilised samples
show a greater mass loss between 200-460◦C from the polyelectrolyte coat-
ing. The temperature range of the mass loss varies depending on the poly-
electrolyte. The PAA samples show losses between 250-460◦C (Figure 56,
(a)) while the pDADMAC coating is lost over a smaller range of 200-350◦C
[(Figure 56, (b)]. The very heavy polyelectrolyte chain for sample C resulted in
a two stage decomposition of the PAA coating over a range of 250-650◦C. The
mass loss profiles are similar to what is found the in the literature for PAA or
pDADMAC stabilised samples further confirming the results.7,23,24,27,28
Figure 56: TGA for magnetite nanoparticles stabilised with PAA (image (a) Sample A:
blue, Sample B: yellow, Sample C: red) and pDADMAC (image (b) Sample D: blue,
Sample E: yellow, Sample F: red). All samples showed a 3 stage mass loss.
The PAA-Fe3O4 samples show a large mass loss of between 6-13% (which
varies based on chain length), with the pDADMAC-Fe3O4 sample showing a
loss of just 2.5% irrespective of chain length (table 15). The difference be-
tween the TGA profiles is primarily due to the mwt of the polyelectrolyte that is
attached but the binding affinity of the polyelectrolyte can also affect the mass
profile. Heavy, long chain polyelectrolytes (sample C) will show the greatest
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mass loss, due to their extreme size and increased mass. For smaller poly-
electrolyte chains, binding affinity also begins to affect the TGA profile. Smaller
chains are less likely to form loops and folds, and cause reduced steric hinder-
ance, allowing for more chains to bind to the iron oxide surface. This results
in the composite supporting more polyelectrolyte mass, despite the lighter in-
dividual polyelectrolyte chains. This is best illustrated in the comparison of
samples A and B. Sample B contains the heavier polyelectrolyte chains, but
has the smallest mass loss in the TGA profile, whereas sample A uses very
small PAA chains, but shows the greater mass loss of the two. This is because
the very small chain length used in sample A, allows for many polyelectrolyte
chains to bind to the composite, compensating for the small individual chain
mass. The advantages of using smaller polyelectrolyte chains can also be
seen in the TEM and DLS results, which are discussed further into the chap-
ter. These effects are harder to distinguish in the pDADMAC TGA profiles as
the mass loss difference between the samples occurs within 1%.
Table 15: Overall Mass losses from the TGA measurements of the stabilised samples.
Sample Polyelectrolyte mwt Mass loss (%)
Magnetite N/A 3.77
PAA stabilised nanoparticles
Sample A 1,800 8.56
Sample B 400,000-500,000 6.02
Sample C 1,250,000 13.15
pDADMAC stabilised nanoparticles
Sample D <100,000 2.60
Sample E 100,000-200,000 2.96
Sample F 400,000-500,000 1.91
5.2.3 Particle size and morphology
Electron microscopy was used to measure the primary particle sizes and mor-
phologies of the iron oxide composites in addition to observing any effects the
varying chain length would have on the composite conformation. Primary par-
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ticle sizes were measured of over 100 nanoparticles, from the TEM images of
the composites dried in ambient conditions (Figures 57 and 58). Clustering
can be observed due to the drying effects from the preparation of the grids.
All samples had a primary particle size under 15 nm (Table 16), making the
crystals small enough to be single domain/superparamagnetic.16,29 The PAA-
Fe3O4 nanoparticles show a slightly greater size variance (Figure 57) than
the pDADMAC-Fe3O4 samples (Figure 58) but neither polyelectrolyte or chain
length has a significant effect on the primary particle size. The measured sizes
are in good agreement with the Scherrer sizes calculated from the XRD pat-
terns. In sample C, unbound material can be seen around the aggregates.
When exposed to an 0.5 T external magnetic field, differences between the
polyelectrolyte types and chain lengths become more apparent. All samples
formed linear assemblies compared to when dried under ambient conditions
as shown in Figures 59 and 60.
Table 16: Particle sizes calculated from TEM images. Assembly widths were mea-
sured from particles dried in an external magnetic field.
Sample mwt Particle size S.D Assembly width S.D
(nm) (nm) (nm) (nm)
PAA stabilised nanoparticles
Sample A 1,800 12.6 3.091 84.1 23.1
Sample B 450,000 13.1 2.626 204.3 62.6
Sample C 1,250,000 14.2 3.518 210.2 64.8
pDADMAC stabilised nanoparticles
Sample D <100,000 14.5 2.769 81.9 28.3
Sample E 100-200,000 13.7 2.529 78.50 30.50
Sample F 400-500,000 13.9 3.447 44.7 13.5
The PAA-Fe3O4 samples showed great variation based on polyelectrolyte
molecular weight as shown in Figure 59. Sample A formed thin linear assem-
blies. As the polyelectrolyte molecular weight (and chain length) increases,
these linear assemblies become thicker and agglomerate with little orientation
to the external field. PAA is considered a weak polyelectrolyte, and forms loops
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and folds in solution due to partial ionisation of the polyelectrolyte.1,2 For sam-
ple A, the composite chain is small enough that the formation of loops and folds
are minimal resulting in thin linear strands as seen in Figure 59 images (a) and
(b). For sample B, the chain is longer and will have more chance to loop and
fold. This leads to a thicker polyelectrolyte strand, with less orientation to the
external magnetic field. This increase in strand thickness can be seen in the
TEM images (images (c) and (d)). Sample C continues to illustrate this point,
with the PAA stabiliser being very long in length, maximising the chance for the
chain to loop and fold. This translates into thick polyelectrolyte strands (image
(f)) with agglomeration between the individual strands (as seen in the TEM im-
ages (image (e)). Lin et al. also stabilised palladium/iron nanoparticles with
a variety of PAA chain lengths (1800-1250,000) confirming the very high mwt
chain aggregating and becoming unusable due to the extreme chain length.19
The pDADMAC-Fe3O4 samples formed very thin linear assemblies (remi-
niscent of the PSSS-Fe3O4 samples in Chapter 4), which aligned in the direc-
tion of the applied magnetic field (Figure 60). This was consistent between
all pDADMAC-Fe3O4 samples with cross linking seen between the strands.
Cross linking between the strands increases as the polyelectrolyte molecular
weight decreases. These assemblies extend to over 1 µm in length. The for-
mation of the linear assemblies is due to several factors, such as the mag-
netite/polyelectrolyte ratio and pDADMAC being a strong polyelectrolyte.5,6
When in solution the pDADMAC chain is fully ionised, with the monomers
repelling each other and exposing all of the binding sites. This stops the
formation of loops and folds while increasing the opportunities for magnetite
nanoparticles to bind to the polyelectrolyte chain. The more magnetite that is
supported, the stronger response the composite has in an external magnetic
field. As was seen with the PSSS results, this linear conformation increases
the composite’s surface area, which may ultimately enhance the MRI efficacy.
This improved MRI behaviour has been previously reported in the literature
and shown in chapter 4.30
The distinction between weak and strong polyelectrolytes can clearly be
seen comparing Samples B and F, as they were stabilised with polyelectrolytes
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of a similar molecular weight. Sample B was bound to a weak polyelectrolyte
(PAA) and forms thick strands due to the loops and folds (as seen in Figure 59
images (c) and (d)). Conversely Sample F is stabilised with a strong polyelec-
trolyte unable to loop and fold, forming much thinner single strands in com-
parison (seen in Figure 60 images (e) and (f)). The thinner assemblies are
more desirable in biomedical applications due to the increased surface area
and smaller size.
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Figure 57: TEM images of PAA-Fe3O4 nanoparticles dried under standard conditions.
Magnetite nanoparticles were stabilised with a variety of PAA chain lengths (Sample
A: (a) and (b), Sample B: (c) and (d), Sample C: (e) and (f)). Little difference between
polyelectrolyte chain lengths can be seen on the particle morphology or sizes.
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Figure 58: TEM images of pDADMAC-Fe3O4 nanoparticles dried under standard con-
ditions. A variety of pDADMAC lengths were used to stabilise the iron oxide cores
(Sample D: (a) and (b), Sample E: (c) and (d), Sample F: (e) and (f)). The pDADMAC
chain length has little effect on the primary particle size.
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Figure 59: TEM measurements of PAA-Fe3O4 nanoparticles forming linear assemblies
when dried in an external magnetic field. Three different PAA chain lengths were used
to stabilise magnetite (Sample A: (a) and (b), Sample B: (c) and (d), Sample C: (e) and
(f)) with significant differences observed between the samples. Strand width increases
with chain length.
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Figure 60: TEM measurements of pDADMAC-Fe3O4 nanoparticles forming linear as-
semblies in an external magnetic field. Different pDADMAC chain lengths were used
(Sample D: (a) and (b), Sample E: (c) and (d), Sample F: (e) and (f)). All samples
formed linear assemblies over 2 µm in length. Interchain clustering can be observed
in the samples, due to the rigid nature of the polyelectrolyte.
5.2.4 Suspension behaviour
DLS was used to determine the effect of chain length on water stability and
composite behaviour. For the majority of samples (excluding sample C) as the
particles were washed to pH neutral, the composite is more readily dispersed
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in water to form a stable suspension. These stable suspensions remained sta-
ble even when suspended over a 0.5 T magnet for 24 hours. As the stabilised
nanocomposites move towards a neutral pH, the Z-averages and polydisper-
sity indices (PDIs) decrease and the cluster distribution becomes mono-modal,
as detailed in Table 17 and Figure 62. The lowest molecular weight samples
for both PAA and pDADMAC samples (Sample A and D) gave the best com-
bination of Z-average, PDI values and smallest range of cluster sizes. For
both stabilisers as the molecular weight increases, the hydrodynamic radius
gets larger and the size distribution also increases, in some cases becoming
multimodal (Figures 61 and 62). This is best illustrated with the PAA-Fe3O4 sta-
bilised composites, with a significant increase in DLS values as the polyelec-
trolyte molecular weight increases. Sample C is so unstable that it is crashing
out of solution during a measurement and cannot be accurately measured. For
most biomedical applications, it is desirable for the particles to be 200 nm or
less, with all of the pDADMAC-Fe3O4 samples and the PAA Sample A prepared
here falling within this size range.31–33
A comparison between samples B and F again highlights the distinction
between weak and strong polyelectrolytes and the importance of charge in
polyelectrolyte stabilisers. Samples B and F are stabilised with different poly-
electrolytes but are of the similar molecular weight allowing for the effect of
charge to be examined. Sample F has the highest DLS of the pDADMAC-
stabilised samples but these values are still significantly less than the PAA
stabilised Sample B. TEM images (Figures 60 (e) and 59 (c)) show that Sam-
ple F forms thin linear assemblies while Sample B aggregates, forming thick
strands due to loops and folds. The formation of the loops and folds also in-
creases the composite size when in solution, resulting in larger DLS values
as shown in Table 17. This is responsible for the higher PDI value for sam-
ple B, with the formation of loops and folds causing variation in the aggregate
sizes. The cationic charge of pDADMAC seems to have little effect on DLS val-
ues and composite behaviour, with the equivalent length anionic PSSS sample
from Chapter 4 showing similar DLS values (Z-average: 94.7 nm, PDI 0.097)
to sample E.
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Figure 61: DLS measurements PAA-stabilised magnetite nanoparticles (Sample A:
blue, Sample B: yellow, Sample C: red). Measurements were taken for the initial
basic washing (washing 3, image (a)) and the pH neutral final washing (washing 5,
image (b)). Z-average and PDI values decreased as the sample approached neutrality.
Sample C values reflect poor water stability.
The differences in Z-averages and PDIs are reflected in water stability, with
the pDADMAC-Fe3O4 samples staying in aqueous suspension for over a month
and sample D lasting over 6 weeks. The PAA-stabilised nanocomposites show
a more varied behaviour, with Sample A being the most stable of all of the
prepared samples staying in solution for over 2 months. As the PAA chain
increased in size, water stability dropped rapidly with sample B being stable
for just under a month and Sample C unable to form a suspension when neu-
tral. As the polyelectrolyte molecular weight increases, the chain length also
presumable increases in size. Therefore, the polyelectrolyte can support more
iron oxide nanoparticles, increasing the composite mass and decreasing water
stability. This effect is most significant with the wide size ranges of the PAA-
Fe3O4 samples, but the lighter pDADMAC-Fe3O4 dispersions also showed a
slight increase in stability.
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Figure 62: DLS measurements of pDADMAC-stabilised magnetite nanoparticles
(Sample D: blue, Sample E: yellow, Sample F: red). Measurements were taken for
the initial basic washing (washing 3, left) and for the pH neutral final washing (washing
5, right). All samples decreased in polydispersity and Z-average as they were washed.
The surface charges of the particles were also investigated and the results
are recorded in Table 17. The extreme DLS properties of Sample C are due to
this sample being unable to form a stable suspension. The pDADMAC-Fe3O4
samples give decreased values when compared to other polyelectrolyte sta-
bilised iron oxides, due to the positive charge of the coating. This is indicative of
the polyelectrolyte coating binding, as the positive polyelectrolyte charge coun-
teracts the overall negative charge of the iron oxide cores. The decrease in
zeta potential is reflected in lower water stability. The decreased values might
also suggest incomplete coverage of the particles. Wotschadlo et al. prepared
iron oxide nanoparticles with pDADMAC stabilised on a carboxymethyldextran
shell.10 They found reduced zeta potentials for the short chain polyelectrolytes
indicating incomplete coverage of the nanoparticle cores. Interestingly, those
decreased values may improve biological properties though, with extreme sur-
face charges presenting problems for biomedical applications. This is because
highly positive coatings can attach non specifically to cells, whereas strongly
negatively charged particles are more likely to be taken up by the liver.34 These
particles can still be considered water stable, lasting over a month in solution
and the effect of decreased surface charge from the coating has been ob-
served previously by other groups.35–38
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Table 17: DLS measurements of the pH neutral nanocomposite washings. As the
samples were washed, the Z-average and PDI values stabilised. Significant differ-
ences can be observed as the chain length increases. The positive charge of the
pDADMAC coating is reflected in decreased zeta potentials (Z. Po.) for samples D-F
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
PAA stabilised nanoparticles
Sample A 64.8 0.176 69.1 0.177 90.74 0.126 -60.0
Sample B 116.3 0.347 405.3 0.986 221.8 0.438 -59.8
Sample C 254.1 0.658 652.4 0.946 1193 1 -63.5
pDADMAC stabilised nanoparticles
Sample D 799.5 0.752 167.7 0.317 116.4 0.228 -24.7
Sample E 1799.6 0.878 103.1 0.194 122.7 0.091 -37.2
Sample F 1554.6 0.866 387.3 0.448 141.4 0.307 -28.5
5.3 Discussion and conclusions
Regulation of polyelectrolyte molecular weight and charge is key to maximis-
ing water stability and controlling composite size. The choice of weak and
strong polyelectrolytes also has a large affect in relation to iron oxide stabil-
isation. These considerations can therefore be vital in optimising iron oxide-
polyelectrolyte nanoparticles as water stable magnetic fluids for MR imaging
or targeted drug delivery. Both polyelectrolytes explored here have previously
been shown to be suitable as stabilisers for iron oxide nanoparticles. However,
up to now, there has been no systematic study of their behaviour as a func-
tion of molecular weight. Lin et al. prepared PAA-Fe3O4 demonstrating the
formation of a water stable suspension with cluster sizes similar to the materi-
als prepared within this chapter, noting a decrease in Ms values from the sta-
biliser.7 Si et al. also observed that the PAA stabiliser can have a size inhibiting
effect which accounts for the reduction in magnetism.24 Unfortunately, it has
not been possible to measure the magnetic properties of each nanocomposite
prepared here due to a SQUID failure. A slight inhibition of magnetisation val-
ues for the PAA-Fe3O4 would be expected, based on the reports by previous
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groups.7,24 Less of a decrease is expected for the pDADMAC-Fe3O4 samples
though, with Yu et al. reporting that the binding of the pDADMAC does not
affect the magnetisation of the particles.39 Despite inhibition from the stabilis-
ers, use of microwave irradiation would ensure that any inhibited crystal growth
and decreases in Ms values would be minimal, as illustrated in Chapter 4. Ad-
ditionally, the formation of linear assemblies when stabilised with pDADMAC
or very low mwt PAA chains will also enhance MRI properties, with the work
by Park et al. identifying that the formation of linear assemblies can increase
Ms values and MRI efficacy.30 Utilising microwave irradiation will ensure a high
crystallinity, which is not lost through the stabilisation of the particles. Both PAA
and pDADMAC stabilisers also have a combined use in layer-by-layer (LBL) re-
actions, where the formation of loops and folds is desirable and can be used
to control layer thickness.40–42
From the results presented here, the most suitable stabiliser for iron oxide
nanoparticles would be either the short chain length PAA (sample A) or pDAD-
MAC (sample D) stabiliser. The short chain length is a must, as this keeps the
composite weight low, ensuring good water stability and the formation of linear
assemblies. Both polyelectrolytes present their own advantages and disadvan-
tages. The formation of linear assemblies with the pDADMAC-Fe3O4 particles
will enhance magnetic properties and the reduced overall surface charge may
facilitate the particles passage through the body.34 However, this is at a cost
to water stability, which is lower than the PAA samples. The water stability of
the PAA-Fe3O4 samples are dependant on molecular weight. Sample A dis-
plays the best water stability of the samples and forms linear assemblies in
solution. The other important consideration of PAA is the functionalisation of
the unbound carboxylic acid groups. Carboxylic acid can undergo carbodi-
imide coupling, which is a versatile functionalisation reaction used in the devel-
opment of multifunctional magnetic nanoparticles.3,4 Support for carbodiimide
coupling allows for the attachment of moieties such as fluorescent tags43,44 or
chemotherapy agents45,46 drastically expanding the potential of the composite.
From the results obtained in Chapters 4 and 5, one potential area of fu-
ture work is utilising multiple polyelectrolytes in the preparation of magnetic
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nanocomposites. The functionalisation options offered by PAA are essential
for the continued development of the nanoparticles. Combining this with the
PSSS stabiliser (from chapter 4) can add excellent water stability and crys-
tallinity for the foundation of this composite. Shortening the length of the PSSS
chain can further increase the nanocomposites water stability. Both materials
have displayed a high affinity for iron oxide cores and incorporating both sta-
bilisers into the composite could take advantage of both these materials. This
may allow for the further development of the composite into a multifunctional
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Chapter 6: Functionalisation of magnetic
nanocomposites
6.1 General introduction
Previous chapters have demonstrated that microwave irradiation combined
with polyelectrolyte stabilisers afford extremely water stable, highly magnetic
nanocomposites, which are effective MRI contrast agents. Also, these can
support a fluorescent molecule through electrostatic interactions. This chapter
will explore the further functionalisation of iron oxide based nanocomposites,
detailing a series of reactions to attach functional groups such as polyelec-
trolytes to maximise water stability, fluorescent molecules for cell imaging and
tracking, and targeting compounds to ensure cell specificity to the core mag-
netic nanoparticles. This is shown for a general case in Figure 63.
Figure 63: Schematic illustrating the covalent functionalisation of magnetite nanopar-
ticles. A multistep method can allow for stabilisation and subsequent functionalisation.
One promising coupling method is covalent attachment using a carbodi-
imide coupling, which promotes the formation of a strong amide bond between
amine and carboxylic acid groups. This provides a stable linker that will hold
the functional group far more securely than electrostatic interactions. A wide
range of biomedical materials contains amine or carboxylic acid groups allow-
ing the carbodiimide approach to be used for many reactions.
One such example is dopamine, which contains amine groups that are ca-
pable of coupling with carboxylic acid based moieties. Dopamine can also be
used as a stabiliser for iron oxide nanoparticles as it is biocompatible and can
bestow water stability.1,2 It can bind to the iron oxide surface via two hydrox-
ide groups, forming a strong bidentate bond which minimises the risk of the
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stabiliser layer desorbing.3,4 The amine groups of dopamine provide sites for
additional functionality as they can easily undergo carbodiimide coupling.5,6 To
further extend the range of materials that can be bound, the dopamine groups
can also be coupled to PAA via carbodiimide coupling. PAA contains carboxylic
acid groups which can both bind to dopamine and provide alternative function-
alisation sites for materials containing amine groups. When conjugated, the
result is a stabiliser material which when bound to the iron oxide, forms a hy-
drophilic surface rich with amine and carboxylic acid coupling sites.
This chapter focuses on a series of functionalisation reactions to dopamine
stabilised magnetic nanoparticles. The individual reactions involve PAA, PSSS,
acridine-9-carboxylic acid (A-9-CA) and folic acid (FA), each of which has been
chosen to add additional functionality to the underlying particles. The bind-
ing of A-9-CA to dopamine stabilised iron oxide nanoparticles has yet to be
done, and will demonstrate that versatility of the coupling method. Additionally,
folic acid will be bound directly to dopamine stabilised nanoparticles, eliminat-
ing the need for linking groups. Finally, a multifunctional platform will be ex-
amined to prepare a highly crystalline, water stable magnetic nanocomposite
supporting both targeting groups (folic acid) and fluorescent moieties (acridine
orange). For all reactions, the iron oxide nanoparticles were first prepared
using the co-precipitation reaction with dopamine (or dopamine based com-
posites) bound during precipitation. Selected reactions were repeated using
microwave-assisted methods to show the applicability of this method to obtain-
ing multifunctional nanocomposites.
6.1.1 The carbodiimide coupling reaction
In carbodiimide coupling, the carboxylic acid group is activated to form a car-
boxylic ester (an O-acylisourea intermediate), which will then react with amine
groups to form the amide bond.7 The excess carbodiimide forms a urea deriva-
tive, but undesirable urea based products can also form in side reactions be-
tween the O-acylisourea intermediate and groups other than the amine linker.
If unreacted with the amine group, the intermediate will hydrolyse, reforming
the carboxylic acid groups and producing a urea byproduct. To assist in the
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activation of carboxylic acid groups, N-hydroxysuccimide (NHS) can be used.
NHS binds to the carboxylic acid groups to form an NHS ester which is more
stable than the O-acylisourea intermediate. This reduces the side product for-
mation and promotes amide bond formation, increasing the reaction efficiency.
NHS has to be used in dry conditions though, as NHS esters can hydrolyse in
water.8–10
The reaction conditions for carbodiimide coupling is dependant on the car-
bodiimide used. Two of the most common carbodiimides are 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDCI) and N,N’-Dicyclohexylcarbodiimide
(DCC). DCC is the most commonly used carbodiimide and is soluble in or-
ganic solvents, making it useful in polymer coupling reactions. However, it is
toxic and requires extensive post processing to remove excess DCC and side
products from the reaction.8,11,12 EDCI is a water soluble alternative that that
can be used for aqueous coupling reactions and as such is more suited to
the development of biological agents.6,7 Additionally EDCI is non toxic, easily
removed by dialysis and can also be used in organic solvents.5,6 Both carbodi-
imides will be explored and compared in this chapter to determine the best
method to functionalise iron oxide nanoparticles.
6.2 Addition of poly(acrylic acid) to dopamine stabilised
iron oxide nanoparticles
The attachment of PAA to dopamine serves a structural purpose rather than
a biological one. Dopamine provides free amine groups for carbodiimide cou-
pling, so the addition of PAA will provide alternative carboxylic acid binding
sites, extending the range of materials that can be bound to the composite via
carbodiimide coupling. The preparation of the magnetite/dopamine/PAA com-
posite was a multistep process. PAA (Mwt 1,800) was bound to free dopamine
first via a carbodiimide coupling reaction. The two EDCI-based carbodiimide
routes explored here are given in Figure 64, an organic approach based on the
work by Na et al., and an aqueous coupling method adapted from the method
presented by Wu et al.5,6 The resulting materials were characterised using
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FTIR, NMR and UV-Vis spectroscopy to identify which approach best suited
iron oxide functionalisation. The organic based reaction formed a vicious dark
brown liquid, whereas the aqueous method formed a white powder.
The dopamine/PAA conjugate was then bound to co-precipitated magnetite
nanoparticles, in a one step stabilisation reaction. This occurs in situ, where
the dopamine/PAA conjugate was bound as the iron oxide particles were pre-
cipitated (similar to other polyelectrolyte stabilisation reactions). A water stable
suspension formed and washings were collected and stored. The material was
characterised with XRD, DLS and FTIR spectroscopy.
Figure 64: Schematic showing preparation and subsequent functionalisation of mag-
netite nanoparticles with dopamine/PAA. The dopamine/PAA composite can be linked
via an EDCI coupling reaction.
6.2.1 Characterisation of the dopamine/PAA conjugate
First, the dopamine/PAA conjugate was characterised, before iron oxide
nanoparticle functionalisation. IR spectroscopy was used to confirm amide
bond formation. Figure 65(a) compares the coupled dopamine/PA0A compos-
ite (organic reaction: orange, aqueous reaction: green) with free dopamine
(black) and free PAA (grey). Amide stretches occur at 1556 cm−1, with a sec-
ond peak associated with the the carbonyl group at 1630 cm−1. Both stretches
are observed for both the organic and aqueous reactions (Figure 65(b)). The
peak positions and assignments are in good agreement with other reports in
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the literature.5,6,13–15 Aromatic stretches for dopamine are seen at 1456 cm−1,
with hydroxide and aromatic C-C stretches of the catechol group resulting in a
broad band above 3380 cm−1.6,16,17 The PAA stabiliser gives carboxylic acid
stretches at 1127 and 1730 cm−1, alkane C-H stretches at 2936 cm−1 and O-H
stretches at 3300 cm−1 which overlap with some dopamine stretches.18 The
water based sample shows more peaks corresponding to the starting materials
(i.e. the carboxylic acid stretch at 1127 cm−1), but dopamine and PAA peaks
can be observed in the organic sample as well.
Figure 65: IR spectra of dopamine/PAA coupling reactions (a), with the expected signal
area for the amide bond expanded (b). The dopamine/PAA conjugate prepared by the
organic carbodiimide reaction is shown in orange, while the dopamine/PAA conjugate
from the aqueous carbodiimide reaction is shown in green. The starting materials are
also shown (dopamine; black, PAA; grey). The two stretches at 1556 and 1630 cm−1
(highlighted in (b)) correspond to the amide bond and the carbonyl group formed dur-
ing the coupling reaction.
The conjugated pi-bonds of dopamine mean UV-vis spectroscopy can be
used to confirm the presence of dopamine in the samples. Both the organic
and aqueous dopamine/PAA composites show an absorbance peak at 280 nm,
seen in Figure 66 and similar to previous reports.6,19 The peak position also
indicates the dopamine component of the sample has not oxidised to quinone,
as this would lead to a shift in peak position to 400 nm.17 Minimising dopamine
oxidation is desirable, as oxidation can reduce dopamine’s affinity for the iron
oxide surface and risk early desorption.20,21
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Figure 66: UV-Vis spectra of the dopamine/PAA composite from the organic (orange)
and aqueous (green) coupling reactions.
NMR spectroscopy was used to further confirm the coupling reaction and
to map the structure of the conjugated components (Figure 67). For pure PAA
(purple spectrum), the peaks between 1 ppm and 2.5 ppm relate to the poly-
electrolyte alkane backbone. The broadening of the peaks is characteristic
of polymers due to the repetition of the signal from the identical monomers.
Dopamine shifts are shown in blue and are observed at higher shifts than
the PAA component. The dopamine alone presents strong alkane signals at
2.7 ppm and 3 ppm as a series of split peaks with the group of signals centred
at 6.7 ppm are characteristic for the catechol aromatic ring.
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Figure 67: NMR data of the dopamine/PAA composite synthesised via organic (or-
ange) and aqueous (green) methods and the starting materials (dopamine; blue, PAA;
purple). Both composites show similarities with the starting materials.
The product from the organic carbodiimide reaction (orange) shows a sig-
nificant difference compared to the free dopamine sample, with an absence of
aromatic peaks at 6.7 ppm which are replaced by two large peaks at 7.7 ppm
and 8.3 ppm. The FTIR and UV-Vis results indicate that the aromatic group
is still present in the structure but the NMR results suggest an incomplete re-
action. These unaccounted peaks could signify an incomplete product or un-
wanted side products from the reaction. These differences indicate that the
organic coupling of dopamine and PAA is unsuitable for further stabilisation
and functionalisation of the iron oxide nanoparticles.
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Figure 68: NMR spectrum of the dopamine/PAA composite prepared via the water-
based EDCI coupling method. Peak assignments based on shifting and splitting have
been calculated with the strongest signals agreeing with the expected structure. Addi-
tional unaccounted peaks are present in the spectra which can be attributed to impu-
rities or residual starting materials.
The NMR spectrum for the dopamine/PAA composite prepared by the aque-
ous method shows peaks for both starting materials, with a slight shifting in
peak position, and an assigned spectrum is given in Figure 68. The only dis-
crepancy is the lack of a signal for the proton of the amide bond. The signal
is expected to have a high chemical shift at 8ppm, as it is attached to a very
electronegative group. The signal could still be present, but as a very weak
broad signal which will be difficult to detect from the background noise. The
FTIR data shows two distinct amide stretches, indicating the presence of the
amide bond, but the NMR data could have further confirmed this. The NMR
data does confirm the structure of the dopamine and PAA components of the
conjugate though. From these results, the aqueous carbodiimide coupling re-
action is the best way to bind PAA to dopamine with both the amide bond and
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individual components confirmed by FTIR and NMR spectroscopy respectively.
The aqueous method is also advantageous as it is more comparable with bi-
ological systems requiring less post processing and can be done in the same
vessel as the co-precipitation reaction. Stabilising iron oxide nanoparticles with
the conjugate, will build upon the work by Wu et al.6 They used the conjugate
in electrostatic layer by layer reactions to form extremely stable PAA/PAH mul-
tilayers. This work will show that the conjugate can also be used directly in the
stabilisation of iron oxide nanoparticles, and will provide multiple different sites
for further carbodiimide coupling
6.2.2 Stabilisation of iron oxide nanoparticles with dopamine/PAA con-
jugate
Using the aqueous carbodiimide coupling method, the dopamine/PAA
conjugate was bound to magnetite nanoparticles in a one pot co-
precipitation/stabilisation reaction shown in Figure 69. Addition of the conju-
gate to the iron chloride solution (a) caused the solution to turn a dark green
(b), which when precipitated with ammonia formed the characteristic jet black
particles (c). The sample was characterised with XRD, FTIR and DLS.
Figure 69: Photos of the co-precipitation/stabilisation reaction of the mag-
netite/dopamine composite. The starting materials form an orange solution (a), which
when exposed to dopamine the solution changes to dark green (b). After addition of
ammonium hydroxide a jet black precipitate forms, characteristic of magnetite (c).
Powder XRD patterns were collected to confirm that the organic conjugate
coating does not effect the phase of the magnetic core of the sample, with
the peak broadening used to calculate the average primary particle size using
the Scherrer equation. The patterns for stabilised PAA-Dopamine-Fe3O4 com-
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posite prepared by coprecipitation (red) are shown in Figure 70. Comparative
patterns for bare Fe3O4 (grey) and dopamine-stabilised Fe3O4 (green) are also
shown. The PAA-Dopamine-Fe3O4 pattern agrees with the previously prepared
magnetite sample (grey) and magnetite standards from the ICSD and previ-
ously reported Fe3O4 patterns.22–25 The broad peaks for the PAA-Dopamine-
Fe3O4 composite suggest small nanoparticles with the Scherrer equation cal-
culating crystallite size as 11.6 nm. These sizes are similar to previously pre-
pared bare Fe3O4 (11.2 nm), with the work by Basti et al. and Kemikli et al.
confirming that the dopamine coating has no oxidising/size inhibiting effect on
the magnetite crystal structure.11,16 The crystallite size is small enough for the
particles to be single domain and therefore superparamagnetic.26,27
Figure 70: XRD patterns of magnetite stabilised dopamine (dark green) and the
dopamine/PAA conjugate (red) prepared by the standard co-precipitation reaction. The
stabilised nanocomposites shows no oxidation and matches bare magnetite prepared
in the same way (grey) and the ICSD crystal pattern (black).22
FTIR spectroscopy was used to further confirm the binding of the organic
conjugate to the iron oxide particles and is shown in Figure 71. The IR
spectrum for PAA-Dopamine-Fe3O4 (red) shows similarities between both bare
magnetite (grey) and the dopamine/PAA conjugate (green). The amide peaks
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at 1549 and 1630 cm−1 still persist when bound to the iron oxide surface. Ad-
ditionally, carboxylic acid and aromatic stretches from the PAA and dopamine
components can be seen at 1731 cm−1 and 1456 cm−1. The Fe-O stretch is
found at 550 cm−1, characteristic for magnetite.28,29 Dopamine binding can be
discerned from the hydroxide peaks above 3000 cm−1 with both C-H and O-H
stretch exclusive to the catechol group of dopamine. Shultz et al. explored
the binding of dopamine to iron oxide surfaces using FTIR spectroscopy, not-
ing that the hydroxide peaks at 3300 cm−1 shift to the higher wave numbers of
3400-3500 cm−1 when bound to the iron oxide surface.30 This can be seen in
Figure 71, with the 3322 cm−1 shoulder broadening and shifting to 3429 cm−1.
Additionally, the formation of a water stable suspension for the standard co-
precipitation of particles and the colour change of the iron chloride starting
solution to green indicated dopamine binding.30 The amide peaks and per-
sistence of PAA peaks after 5 washings also confirms the coupling of PAA to
dopamine.
Figure 71: IR spectra of the dopamine/PAA conjugate (green) and magnetite stabilised
with the conjugate (red). Peaks with A signify aromatic peaks.
The aromatic groups of dopamine cannot be confirmed by UV-Vis spec-
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troscopy, as scattering of light by the magnetic cores suppresses the 280 nm
absorbance peak (figure 72).
The stabilised co-precipitated particles formed a water stable dispersion
which was characterised using DLS to determine the effect of functionalisation
on composite size and water stability. As the suspensions become pH neutral,
the Z-averages and polydispersities decrease and stabilise. Values are given
in Table 18. The addition of the PAA-dopamine conjugate increases the com-
posite cluster distribution when compared to iron oxide nanoparticles stabilised
with either PAA or dopamine alone, shown in Figure 73. Despite the increased
size distribution, the Z-average of the final washing is under 200 nm making
it suitable for biomedical applications.31–33 The particle surface charges were
found to be above -30 mV, indicating high water stability which was confirmed
by the particles staying in solution for over a month.34 These characterisation
results show that the dopamine/PAA conjugate has wide range of stabilisation
applications in addition to forming LBL assemblies. The material can stabilise
and bestow water stability on iron oxide nanoparticles, while presenting a sur-
face rich with amine and carboxylic acid groups for further functionalisation.
Table 18: DLS measurements of magnetite/dopamine/PAA nanocomposite washings.
Strongly negative zeta potentials (Z. Po.) values indicate high water stability for the
final washing
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
Mag/Dop/PAA 61.98 0.262 103.06 0.161 110.7 0.109 -46.3
Mag/Dop 185.03 0.325 155 0.167 163.83 0.090 -50.8
Mag/PAA 64.8 0.176 69.1 0.177 90.74 0.126 -60.0
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Figure 72: UV-Vis spectra of magnetite stabilised with the dopamine/PAA conjugate
(red) along with the unbound dopamine/PAA conjugate (green). Scattering of light by
the magnetic cores suppresses the dopamine absorbance at 280 nm.
Figure 73: Size distribution of the final washing of the nanocomposites stabilised with
either dopamine (olive), PAA (orange) and dopamine/PAA (red) measured using DLS.
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6.3 Addition of acridine-9-carboxylic acid to dopamine-
stabilised iron oxide nanoparticles
The aqueous carbodiimide coupling reaction can be used to graft a wide range
of materials to dopamine, in addition to polyelectrolytes. One such example
is fluorescent groups, which can allow the particles to be used in biomedi-
cal applications such as cell imaging and cell tracking. Acridine-9-carboxylic
acid (A-9-CA) is a highly fluorescent group and was bound to dopamine sta-
bilised nanoparticles instead of PAA. Coupling occurred via the same water
based EDCI carbodiimide coupling reaction but PAA was substituted for A-9-
CA, shown in Figure 74. One difference from the previous reaction was that
A-9-CA was bound to dopamine after it had been used to stabilise magnetite
nanoparticles. Binding after stabilisation minimises the risk of dopamine oxi-
dation before it coordinates with the magnetite surface. Fluorescent dyes have
been bound to iron oxide nanoparticles before but this work is the first re-
ported approach to directly linking A-9-CA to dopamine stabilised magnetite
nanoparticles.35,36 When the dopamine stabiliser was added to the iron chlo-
ride starting solution, a dark green solution formed, which turned jet black on
precipitation with ammonia. The sample forms a water stable suspension af-
ter several washings with the third to fifth washing collected and stored. The
prepared product was characterised with FTIR, DLS, UV-Vis and fluorescence
spectroscopy.
FTIR spectroscopy was used to confirm the binding of A-9-CA to the
dopamine coating via amide bond formation and the stabilisation of magnetite
with dopamine. The two stretches at 1563 and 1650 cm−1 signify the formation
of the amide bond linking the two components.13–15 The A-9-CA component
shows an C-N vibration at 1263 cm−1, with aromatic stretches at 1056 cm−1,
977 cm−1 and 850 cm−1 associated with single and conjugated aromatic rings.
This assignment is in good agreement to previous reports of acridine com-
pounds.37,38 Dopamine components can also be identified, with the C-C aro-
matic stretch identified at 1396 cm−1, and a large broad O-H and C-H stretch
at 3300 cm−1, which indicates dopamine binding to the iron oxide surface. The
Fe-O stretch is seen at 540 cm−1.
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Figure 74: Schematic detailing the preparation of a fluorescent magnetic nanocom-
posites stabilised with both dopamine and acridine-9-carboxylic acid. This is a multi-
step reaction that involves stabilising the magnetite cores with dopamine, before the
attachment of A-9-CA via aqueous EDCI coupling.
Figure 75: FTIR spectra of magnetite cores stabilised with dopamine (olive) and
dopamine/acridine-9-carboxylic acid (violet). A signifies aromatic stretches.
DLS measurements show that the addition of A-9-CA does not drastically
affect the cluster size of the composite (Table 19) and that as the sample
is washed, the z-average and PDI values stabilise. The addition of A-9-CA
does increase the PDI values, indicating an increase in polydispersity. The Z-
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average values for the composites are below 200 nm making them suitable for
biological applications.31–33 The dispersions display excellent water stability,
staying in suspension for over a month. Additionally, the A-9-CA component
has little effect on surface charge, with a zeta potential of -53.2 mV to reflect
this.34
Table 19: DLS measurements of magnetite/dopamine/A-9-CA washings. Negative
zeta potentials (Z. Po.) confirm that water stability is not lost through functionalisation
with acridine groups.
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
Mag/Dop/A-9-CA 173.9 0.443 97.31 0.116 107.4 0.164 -53.2
Mag/Dop 185.03 0.325 155 0.167 163.83 0.090 -50.8
UV-Vis and fluorescence spectroscopy was used to confirm the presence
of the A-9-CA component. UV-Vis measurements show several absorption
peaks for the A-9-CA functionalised composite (Figure 76). The two strongest
peaks are at 250 nm and 350 nm and are characteristic of the pi,pi* transition
of A-9-CA.39,40 The pi,pi* transition is the promotion of electron from the pi
bonding orbital to the pi anti bonding orbital. The transition of the electron
back to the bonding orbital, releases the excited energy through a variety of
different ways including light. This is an allowed transition and is responsible
for the fluorescence of the dye. These peaks agree with the prepared acri-
dine standard and other acridine based fluorescent compounds reported by
other groups.40–42 These peaks are only present for the first two washings of
the composite though, with remaining dispersions showing no peaks. As the
sample is washed, excess A-9-CA is washed out decreasing the samples ab-
sorbance. As more of the composite remains in solution (from washing), the
suspended inorganic cores scatter the UV measurement light, resulting in a
sloping effect. This sloping effect is undesirable as it can hide the fluorescent
signals as seen in dispersions 3-5. The dopamine absorbance at 280 nm also
cannot be seen, either merging with the acridine peaks or hidden by the light
scattering of the particles.
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Figure 76: UV-Vis spectra of the washings of the magnetite/dopamine/A-9-CA
nanocomposite. The absorbances at 250 nm and 350 nm are characteristic of A-9-
CA.39,40 As the sample is washed the 350 nm absorbance decreases due to scattering
of light by the nanoparticles.
Fluorescence spectroscopy was employed to measure the emission and ex-
citation profiles of the magnetite/dopamine/A-9-CA washings (figure 77). The
emission spectra (Figure 77(b)) were obtained by exciting at 350 nm and corre-
sponding excitation spectra were also collected.The A-9-CA-dopamine-Fe3O4
composite show characteristic peaks for acridine groups with an emission peak
at 430 nm and an excitation peak 350 nm.40,43 As the samples are washed, the
fluorescent signal decreases. The initial signal decrease is due to unbound
A-9-CA being washed out of the composite. The final, neutral sample still dis-
plays peaks for A-9-CA indicating the successful coupling to the nanoparticles.
The emission intensity is similar to the Rhodamine-B decorated nanocompos-
ite in chapter 4 which indicates potential in confocal measurements.
This is the first example of acridine-9-carboxylic acid being bound to
dopamine stabilised iron oxide nanoparticles via an aqueous carbodiimide cou-
pling method. The direct attachment of the fluorescent group leads to a quick
and simple coupling reaction that can be done in a single functionalisation
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step. The formation of the amide bond ensures the dye is securely attached
to the composite, as opposed to electrostatic binding. Stabilisation of the iron
oxide particles before functionalisation is also a key element of this synthesis
method. Stabilising in situ allows the magnetic base to be prepared indepen-
dently to the functionalisation reaction. Microwave assisted co-precipitation
methods combined with surface defect coordinating stabilisers (i.e. PSSS or
Dopamine) can be used to ensure the magnetic base is highly crystalline, pre-
cipitated and stable. Once formed further functionalisation can occur with little
effect on the magnetic foundation as it will be interacting with the stabiliser
material not the magnetic base.
Figure 77: (a) Excitation and (b) emission spectra of magnetite/dopamine/A-9-CA
nanocomposites. As the sample is washed, the fluorescence intensities decrease
as more unbound acridine is removed from the washings but the final washings still
show peaks that are characteristic of the acridine group indicating binding.
6.4 Addition of folic acid to dopamine-stabilised iron oxide
nanoparticles
Folic acid is an example of a targeting molecule with a high binding affinity
for folate receptors, which are over-expressed in cancerous cells.8,44 Folic
acid contains multiple carboxylic acid binding sites, suitable for carbodiimide
coupling. DCC has been used here as the coupling agent in organic con-
ditions, due to the solubility of folic acid. A small excess of DCC was used
to ensure that only one of the carboxylic acid sites was activated, and N-
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Hydroxysuccinimide (NHS) was used to activate the acid group.8 Folic acid
contains two carboxylic acid groups (labelled α and γ) with the γ group be-
ing activated by NHS due to the higher reactivity.45,46 The reaction follows
Figure 78 leading to the formation of a folic acid-N-hydroxysuccinimide (FA-
NHS) conjugate. The activation process was based on the work by Chen et
al. who reported the activation of folic acid with NHS for subsequent binding to
an amine-capped silica shell.44 This work was adapted so the activated folic
acid could be stored and bound to dopamine-coated magnetite nanoparticles
instead. The activated folic acid formed an orange powder that was charac-
terised with FTIR, UV-Vis and NMR spectroscopy. This activated folic acid was
then bound to the dopamine-coated magnetite nanoparticles. A colour change
with addition of dopamine to the iron chloride solution was noted and a jet
black precipitate formed upon addition of ammonia. A water stable suspen-
sion formed after repeated washings which was collected and stored. The final
composite was then characterised with FTIR, DLS and UV-Vis spectroscopy.
Figure 78: Schematic detailing the preparation of a magnetite nanoparticles containing
both dopamine and folic acid for stabilisation and targeting purposes.
6.4.1 Characterisation of the activated FA-NHS conjugate
FTIR was used to confirm the activation of folic acid, but due to the complexity
of folic acid, peak assignment can be difficult as below 2000 cm−1 it very diffi-
cult to distinguish individual peaks. Between the 2000 and 4000 cm−1, similari-
ties between the conjugate and starting materials can be observed (Figure 79).
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The FA-NHS conjugate has a large stretch at 3200 cm−1 with a smaller shoul-
der at 2900 cm−1. Folic acid has stretches at 3543, 3412 and 3322 cm−1,
which are assigned to O-H stretches and secondary N-H stretches.47 There is
also a broad peak between 3150-2700 cm−1 for the alkane and alkene groups
of folic acid. NHS has three intense stretches at 3110, 2975 and 2869 cm−1
relating to C-H stretches that make up the structure.48 The FA-NHS conjugate
forms a very large broad band, with individual peaks from both of these com-
ponents seen in this band. The shoulder extending up to 3600 cm−1 and the
small peak at 3245 cm−1 are for the hydroxide and amine groups of folic acid.
Smaller shifted peaks seen at 2938 and 2791 cm−1 relate to C-H stretches.
The shifting effect is indicative of carboxylic acid activation and are in good
agreement with previous reports.49,50
The absorbing aromatic groups of folic acid can be studied using UV-vis
spectroscopy, with a characteristic pi-pi* absorption peak at 280 nm and n-pi*
absorption peak 380 nm (Figure 80). These absorbances are in good agree-
ment with the literature.9,51,52
Figure 79: FTIR spectra of FA-NHS (violet) and the starting materials (Folic acid; grey,
N-Hydroxysuccinimide; black).
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Figure 80: UV-Vis spectra of folic acid-NHS conjugate (violet) and folic acid standard
(grey).
The FA-NHS conjugate and starting materials were also characterised us-
ing NMR spectroscopy and are shown in Figure 81. The alkane structure of
NHS appears as a series of peaks at 2.6 ppm. The folic acid alkane protons
are found at 1.6 ppm (A) and 2.0 ppm (B). The aromatic protons are found at
6.6 ppm (D), 7.4 ppm (E) and 7.8 ppm (F). The amine protons have the high-
est shift at 8.6 ppm (G). Complete peak assignment is not possible, as the
D2O solvent peak hides some of the alkane/amine signals (labelled (S) on the
structure). The assigned peaks in the NMR spectrum agrees with the FTIR
spectrum confirming the activation of FA with NHS. The signal assignments
also agree with literature reports for activated folic acid.53
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Figure 81: NMR spectra of the FA-NHS conjugate in D2O. The conjugate shows peaks
for both the folic acid and NHS components. Unaccounted peaks suggest the pres-
ence of impurities.
6.4.2 Characterisation of the magnetite/dopamine/FA nanocomposite
Figure 82, image (a) compares the FTIR spectra of magnetite nanoparticles
functionalised with dopamine, with those functionalised with both dopamine
and folic acid. Firstly, a close inspection of the response at 1530 cm−1, shows
a slight broadening of the peak for the folic acid functionalised sample. This
broadening is due to amide bond linking the folic acid groups to the compos-
ite, but it is weak due to the low concentration of folic acid used. This peak
is observed in the literature for other folic acid functionalisation reactions and
indicates coupling.10,45,54 The neighbouring peak at 1460 cm−1 increases in in-
tensity when folic acid is bound. This is an aromatic stretch which is increased
by the aromatic groups in folic acid. Additionally two extra peaks formed at
1050 and 1090 cm−1 (image (b)) relate to the folic acid component. These
stretches are characteristic of aliphatic amine which is contained in folic acid.
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A small set of peaks are observed at 2900 cm−1 due to C-H stretches from
folic acid. The weak signals is due to the low concentration of folic acid used
and suggests there are still free binding sites. The persistence of the folic acid
signals after multiple washings indicates the material is securely bound. The
folic acid component could not be further confirmed by UV-Vis spectroscopy
due to scattering of light from the magnetic cores.
Figure 82: (a) FTIR spectra of magnetite nanoparticles functionalised with folic
acid/dopamine conjugate (violet) and dopamine alone (olive). (b) focuses on the 1000-
1140 cm−1 region, where the composite shows N-H peaks found in the unbound folic
acid (grey).
The folic acid bound nanocomposites formed water stable suspensions
which were analysed with DLS. The washed suspensions of the nanocompos-
ite display similar DLS properties to previous dopamine stabilised iron oxide
nanoparticles. As the sample is washed, the DLS values and the size distri-
bution of the washings become more consistent (Table 20) and the samples
stay in suspension for longer. The stabilised composite is slightly larger than
previous samples. This is due to the composite supporting larger folic acid
molecules. However, the low PDI indicate these are monodisperse disper-
sions, which is further supported by the monomodal size distribution of the
sample seen in Figure 83. The final dispersion has a z-average below 200 nm,
making them suitable for biomedical applications.31–33 The sample also has an
high zeta potential (-50.4 mV) indicating good water stability which is reflected
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in the samples staying in suspension for over a month.34
Table 20: DLS measurements of magnetite/dopamine nanoparticles functionalised
with folic acid. High water stability is reflected in strong zeta potentials (Z. Po.)
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
Mag/Dop/FA 84.3 0.294 113.8 0.137 150.3 0.092 -50.4
Mag/Dop 185.03 0.325 155 0.167 163.83 0.090 -50.8
Figure 83: The size distribution of the first and fifth washing of the mag-
netite/dopamine/folic acid composite, measured using dynamic light scattering. The
results show that the size distribution significantly narrows as the particles are washed
reflecting the low PDI values measured for the samples.
The characterisation methods confirm that not only is the folic acid bound to
dopamine stabilised magnetite nanoparticles, but the addition of this group has
little effect on the hydrodynamic properties of the composite. This work is also
a first example of folic acid being directly bound to the magnetite/dopamine
particles. Commonly folic acid is bound to dopamine groups via a organic
linker like PEG or dextran.55,56 The method outlined here shows that folic acid
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can be bound directly with the dopamine group, which quickens and simplifies
the synthesis process. The folic acid component will complement the mag-
netic targeting functionality of the iron oxide base, resulting in a highly selective
composite. Microwave irradiation can then further enhance the iron oxide crys-
tallinity and magnetism, optimising the targeting capabilities of the material.
6.5 Stabilising iron oxide nanoparticles with dopamine and
PSSS
Chapter 4 established PSSS as the best stabiliser for magnetite nanoparti-
cles, resulting in a nanocomposite with excellent DLS values which was water
stable for over 2 months. This chapter demonstrates that dopamine provides
secure anchoring points for carbodiimide coupling. By binding both PSSS and
dopamine onto the iron oxide surface, the excellent water stability of PSSS can
be combined with the functionalisation options provided by dopamine. Unlike
other functionalisation reactions, carbodiimide coupling is not needed for the
attachment of PSSS or dopamine to iron oxide particles, with the stabilisers
bound in a one-pot manner during the precipitation of the nanoparticles. The
dopamine and PSSS stabilisers were added simultaneously to the iron chlo-
ride solution and the schematic is given in Figure 84. The resulting particles
formed water stable suspensions and were characterised with XRD, FTIR and
DLS.
XRD patterns confirm an iron oxide spinel, shown in Figure 85. This pattern
agrees with previously prepared bare magnetite (grey), reports from the litera-
ture and the ICSD.22–25,57 The broad peaks were measured and the average
crystallite size and was calculated to be 13 nm, below the critical diameter for
superparamagnetic behaviour.26,27
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Figure 84: Schematic detailing the one-pot preparation of a magnetite nanoparticles
functionalised with both dopamine and PSSS. The dopamine component will allow for
further functionalisation while the PSSS stabiliser will enhance the composites water
stability.
Figure 85: XRD patterns of magnetite nanoparticles stabilised with dopamine and
PSSS (light blue). The Mag/Dop/PSSS sample was characterised under different con-
ditions at the University of Glasgow (more information can be found in chapter 2).The
stabilised nanocomposites shows no oxidation and matches bare magnetite prepared
in the same way (grey) and the ICSD crystal pattern (black).22
FTIR spectroscopy confirms the presence of both stabilisers and the iron
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oxide core, shown in Figure 86. The Fe-O stretch is seen at 535 cm−1. The
PSSS coating gives S-O stretches at 825 cm−1, 777 cm−1 and R-SO2-OR
stretches at 1119 cm−1 and 1163 cm−1. The alkane backbone of the poly-
electrolyte gives C-H stretches at 1023 and 1001 cm−1 with another stretch at
2942 cm−1 which has merged with the C-H aromatic dopamine peaks. The
PSSS peaks match with previously prepared samples (Chapter 4) and with
work done by previous groups.58–60 Dopamine gives a characteristic broad
band between 2500 and 3500 cm−1, relating to both the hydroxide and aro-
matic groups. A broad C-C aromatic stretch can be seen at 1429 cm−1 for the
aromatic rings of dopamine
Figure 86: FTIR spectrum of magnetite stabilised with dopamine (olive), PSSS (ba-
nana) and PSSS/dopamine simultaneously (blue). A indicates an aromatic stretch.
The composite formed a stable suspension which was investigated using
DLS. As with the previous samples stabilised with PSSS, the Z-average and
DLS values of the composite become more consistent as the sample is washed
(Table 21). Addition of the large polyelectrolyte chain to the composite is re-
flected in the DLS results, with the suspensions showing increased Z-average
values. This polyelectrolyte addition is also reflected in the polydispersity of the
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sample, with a multimodal distribution of sizes seen in figure 87 for even the
final dispersion. The final dispersion has a Z-average below 200 nm though,
making it small enough for biological applications.31–33 The addition of PSSS
does improve water stability, with the particles remaining in suspension for over
6 weeks and this is further confirmed with a zeta potential of -58.1 mV.34
Table 21: DLS measurements of magnetite/dopamine/PSSS composites. Negative
zeta potentials demonstrate the high water stability of the suspensions. High zeta
potentials (Z. Po.) indicate good water stability.
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
Mag/Dop/PSSS 172.5 0.280 186.6 0.190 194.5 0.205 -58.1
Mag/Dop 185.03 0.325 155 0.167 163.83 0.090 -50.8
Mag/PSSS 166 0.248 82.78 0.111 94.7 0.097 -41.5
Figure 87: The size distribution of the third and fifth suspensions of the mag-
netite/dopamine/PSSS nanocomposite. As the sample is washed, little difference can
be seen between the cluster distributions. The stabilisation of the composite with two
organic stabilisers resulted in a multimodal size distribution even after several washes.
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6.6 Developing a multifunctional nanocomposite with fluo-
rescent and targeting capabilities
The final aim of this chapter is to combine several of the stabilisation and
functionalisation reactions to produce a multifunctional nanocomposite. Co-
precipitated magnetite nanoparticles were stabilised with PSSS and dopamine
first to confer water stability and provide anchoring points for further function-
alisation. Theses particles were then functionalised with acridine-9-carboxylic
acid via carbodiimide coupling. Finally, activated folic acid was attached to the
composite via carbodiimide coupling. The resulting composite formed was
stable in water and was characterised using XRD, DLS, FTIR, UV-Vis and
fluorescence spectroscopy. The reaction was then repeated with microwave
irradiation, to ensure this technique can also be used to produce such a mul-
tifunctional platform. The resulting microwave assisted composite formed a
water stable suspension and was characterised with XRD, FTIR , UV-Vis and
fluorescence spectroscopy.
The XRD pattern confirms the iron oxide magnetite spinel for both the co-
precipitated sample and the microwave sample (Figure 88). Scherrer broaden-
ing gives a primary particle size of 10.38 nm for the standard co-precipitation
reaction and 10.22 nm for the microwave sample.
Figure 89 shows the FTIR spectra obtained for the functionalised samples
prepared by the standard co-precipitation method. Amide bond stretches are
seen at 1563 and 1650 cm−1 and Fe-O stretches at 541 cm−1. Between 700
and 1350 cm−1 , stretches for the sulfonate group of the PSSS coating can be
seen as very sharp well defined peaks. With the addition of A-9-CA and FA, the
peaks broaden and shoulders form between the 800-1300 cm−1 region. Not
only do the sulfonate signals (1119 cm−1 and 1163 cm−1) arise in this region
but also responses for the aliphatic amines of FA (1050 and 1090 cm−1) and
the C-N bond and the aromatic rings of acridine orange (1263 cm−1 and 1050-
850 cm−1) as well. Comparing the spectra, shows that addition of FA and
A-9-CA causes multiple peaks in this area to form one single broad band with
several smaller peaks for the individual stretches seen on the band. Previous
FTIR results confirm the individual binding of A-9-CA and FA to iron oxide
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nanoparticles by carbodiimide coupling and this data illustrates that multiple
groups can be attached to the same composite. The persistence of the A-9-
CA and FA peaks after several washing shows that the moieties are securely
bound
Figure 88: XRD patterns of uncoated magnetite nanoparticles (grey) and mag-
netite nanoparticles stabilised with PSSS, dopamine, A-9-CA and folic acid prepared
with (orange) and without (navy) microwave irradiation. The microwave assisted
co-precipitated Mag/PSSS/Dop/A-9-CA/FA sample was characterised under different
conditions at the University of Glasgow (more information can be found in chapter 2).
The patterns match previous reports for magnetite.22
Figure 90 compares the FTIR spectrum of sample prepared by microwave
heating, with the sample prepared by conventional heating methods. The mi-
crowave assisted sample also shows corresponding peaks to the organic com-
ponents, and is in good agreement with the standard co-precipitated sample
(figure 90). The amide peaks are still present along with the sulphonate, aro-
matic amine peaks between 750-1200 cm−1. The only major discrepancy is
the weaker O-H stretch at 3331 cm−1 and the intense two peaks at 2372 and
2332 cm−1 which are N-H and C-N stretches relating to the FA and A-9-CA
groups. These peaks further confirm the functionalisation reaction and demon-
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strate that this approach is applicable with microwave heating.
Figure 89: FTIR spectra (image (a)) of magnetite nanoparticles stabilised with
PSSS/Dopamine (steel), and PSSS/Dopamine/A-9-CA/Folic acid (navy) prepared by
the standard co-precipitation method. Image (b) expands the 700-1350 cm−1 region
when the organic components are most likely to be seen. Broadening of the 1000 and
1500 cm−1 peaks indicates the addition of A-9-CA and folic acid into the sample.
Figure 90: FTIR spectra of magnetite nanoparticles stabilised with PSSS/Dopamine/A-
9-CA/Folic acid via co-precipitation using conventional heating methods (image (a)
blue) or microwave irradiation (Image b, orange). Similarities can be seen between
the samples, with the microwave sample having a weaker O-H stretch, but a very
intense set of peaks at 2372 cm−1 relating to the N-H and C-N groups of A-9-CA and
FA components.
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The DLS measurements shows that even with the composite supporting
additional functional groups there is little effect to the hydrodynamic radius
and polydispersity of the sample. As with previous samples, water stable sus-
pensions formed as the sample was washed and became pH neutral. The
aggregate size and polydispersity decreased significantly as the sample was
washed, as shown in Table 22. The low PDI indicates mono dispersity which is
further confirmed by the size distribution being monomodal in figure 91. The
zeta potential is still above the -30mV threshold indicating water stability, which
is confirmed by the particles staying in suspension for over 6 weeks.34
Figure 91: Size distribution of the first and final (fifth) washing of magnetite nanopar-
ticles functionalised with PSSS, dopamine, acridine-9-carboxylic acid and folic acid in
aqueous solution measured using dynamic light scattering. As with previous samples,
as the material is washed the suspensions become more stable with a monomodal
size distribution for the final fifth washing.
201
Table 22: DLS measurements of magnetite nanoparticles functionalised with PSSS,
dopamine, acridine-9-carboxylic acid and folic acid. The high zeta potentials (Z. Po.)
indicate good water stability despite the addition of multiple functional groups.
Sample
Washing 3 Washing 4 Washing 5
Z. Po.
Z-Average PDI Z-Average PDI Z-Average PDI
(d.nm) (d.nm) (d.nm) (mV)
Mag/.../AO/FA 123.9 0.137 134.5 0.107 129.7 0.112 -50.5
The first two washings for the standard co-precipitated
Magnetite/PSSS/Dopamine/FA/A-9-CA sample show absorption peaks of
280 nm and 350 nm, as seen in Figure 92(a). The absorption at 350 nm is
characteristic for the pi-pi* transition in A-9-CA. The other peak relates to
the folic acid component of the composite with the absorbance at 280 nm
relating to the pi-pi* transition of folic acid. Both signals are lost after the 3rd
washing and a sloping effect can be seen due to the scattering of light by
the nanoparticles. FTIR results suggest that both A-9-CA and FA persist in
the washings even after this scattering effect occurs. Similar results are seen
for the sample prepared using the microwave assisted method as seen in
Figure 92(b).
Figure 92: UV-Vis spectra of magnetite/dopamine/PSSS nanoparticles functionalised
with acridine orange and folic acid prepared by (a) standard co-precipitation methods
and (b) microwave assisted methods.
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Fluorescence spectra collected of the final (fifth) washings of both the stan-
dard and microwave heated samples reveals the presence of A-9-CA and folic
acid in Figure 93. The emission peak is characteristic for A-9-CA at 430 nm,
with the corresponding excitation peak 350 nm. Interestingly there is also a
second excitation peak in the spectrum at 280 nm, indicative of folic acid acid
and confirmed by other literature reports.9,51,52 The fluorescence signals for
both folic acid and acridine-9-carboxylic acid still persist when the reaction
method is combined with microwave irradiation. Additionally strong emission
signals are seen for the samples after several washing indicating their suitabil-
ity for confocal applications.
Figure 93: Emission (navy) and excitation (carrot) spectra of final (final) washing of
magnetite nanoparticles functionalised with PSSS, Dopamine, A-9-CA and folic acid
for the (a) co-precipitated sample (CPT) and (b) the microwave-assisted sample.
The formation of water stable composites indicate successful dopamine
and PSSS binding. The enhanced water stability in comparison to mag-
netite/dopamine samples confirm the attachment of the PSSS stabiliser. The
UV-Vis and fluorescence results confirm that the final nanocomposites contain
A-9-CA and folic acid. The amide bond formation confirms that this is bound
acridine/FA and not free molecules in suspension. The resulting composite
is one of the first examples of acridine-9-carboxylic acid and folic acid being
grafted onto magnetite/dopamine particles through direct carbodiimide cou-
pling. A-9-CA has yet to be bound to magnetite/dopamine nanoparticles and
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folic acid is commonly bound using a linker. Not only does this method show
that both materials can be bound directly to the dopamine surface layer, but it
is quick and facile. This work also shows that the magnetic base can support
multiple groups with little sacrifice to water stability or size.
The microwave results show that the groups are firmly bound to the com-
posite. The result is a unique microwave assisted co-precipitated nanocom-
posite that supports several stabiliser and functional groups such as dopamine,
PSSS, A-9-CA and folic acid. These groups have yet to be seen bound to
nanoparticles prepared using a microwave assisted co-precipitation method
and therefore offer an interesting avenue to further build upon. Microwave heat-
ing complements the functionalisation reactions by enhancing the properties of
the magnetic base. This will improve the composites selectivity (combined with
the folic acid group) and MRI efficacy. This could also enable other biomedical
applications such as magnetic hyperthermia.
6.7 Discussion and Conclusions
This chapter demonstrates a facile and safe approach to preparing a range of
multifunctional magnetic nanocomposites which encompass fluorescent and
targeting moieties. The nanocomposite displays excellent water stability de-
spite supporting additional groups, with the final dispersion showing Z-average,
zeta potentials and PDI values well within the limits for biomedical applica-
tions.31–34 Additionally the use of aqueous carbodiimide reactions and the use
of NHS activation allows functional groups to be bound to the particles quickly
after precipitation with minimal post processing. The flexibility of carbodiimide
coupling provides a route to a highly flexible biomedical platform capable of
supporting a variety of functional groups. Additionally this is the first exam-
ple of acridine-9-carboxylic acid and folic acid being bound to highly crystalline
microwave assisted co-precipitated magnetic nanoparticles.
Functionalisation was achieved by using the dopamine coating as a an-
choring point, but the dopamine coating also offers other advantages in the
stabilisation of iron oxide cores. As discussed earlier, the catechol group
of dopamine binds with under-coordinated surface oxygen sites to form a
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strong bidentate bond.2–4,61 These under-coordinated oxygen sites are sur-
face defects which may reduce the magnetisation of the particles. Therefore,
dopamine binding will affect the surface chemistry and therefore the resulting
magnetisation of the particles. SQUID measurements are required to con-
firm this, but the literature suggests that stabilisation can partially realign mag-
netic spins within the defects and improve the overall particle crystallinity.4,62
Work by other groups supports this theory, observing no change or even an in-
crease in magnetisation values when a dopamine stabiliser is employed.63,64
This is significant because microwave irradiation has already been shown to
significantly improve crystallinity and this coupled with the dopamine stabiliser
could maximise the magnetic potential of the iron oxide cores. PSSS has al-
ready been shown to have a crystallinity enhancing effect in Chapter 4 and
the dopamine coating would not only complement this effect but also provide a
surface for functionalisation.
When compared to nanocomposites prepared by other groups with tar-
geting and luminescent functionalities, several advantages can be seen with
this approach (i.e. quicker reaction times and removing the need for linking
groups). For example Corato et al. bound folic acid and quantum dots to
manganese oxide nanoparticles via a series of carbodiimide coupling reac-
tions using an 2,2’-(ethylenedioxy)bis(ethylamine) linker.65 The nanocompos-
ite was effectively used in confocal microscopy which showed a preferential
uptake of the folic acid stabilised materials but the modification of folic acid
with a linker is a multistep process involving hazardous chemicals and long
reaction times. Zhang et al. prepared iron oxide nanoparticles which bound
folic acid and fluorescein to a aminopropyl-trimethoxysilane linker via an EDCI
coupling reaction which was then attached to the nanocomposite silica surface
via a condensation reaction.54 The particles not only required post process-
ing to coat the nanoparticles with PEG groups making them water stable but
also involved multi-step, time-consuming reactions. The work outlined in this
chapter has demonstrated the stabilisation of magnetic nanoparticles during
co-precipitation and the binding of a functional group to the stabiliser without
the need for a linker. Additionally, the microwave assisted co-precipiatation
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method can also provide water stable suspensions, which retain multifunc-
tional behaviour. Further work is required to confirm the enhanced crystallinity
of these samples.
There are still opportunities to optimise this nanocomposite. For exam-
ple, one interesting avenue is to bind chemotherapy agents (i.e. duoxoru-
bicin, paclitaxel) to the nanocomposite so that they can simultaneously detect
and treat cancerous cells. There have been many examples of carbodiimide
coupling grafting chemotherapy agents to nanoparticles, indicating that the




[1] Amstad, E.; Gillich, T.; Bilecka, I.; Textor, M.; Reimhult, E. Nano Lett. 2009,
9, 4042–4048.
[2] Gu, H.; Yang, Z.; Gao, J.; Chang., C. K.; Xu, B. J. Am. Chem. Soc. 2004,
127, 34–35.
[3] Xu, C.; Xu, K.; Gu, H.; Zheng, R.; Liu, H.; Zhang, X.; Guo, Z.; Xu, B. J.
Am. Chem. Soc. 2004, 126, 9938–9939.
[4] Chen, L. X.; Liu, T.; Thurnauer, M. C.; Csencsits, R.; Rajh, T. J. Am. Chem.
Soc. 2004, 126, 9938–9939.
[5] Na, H. B.; Palui, G.; Rosenberg, J. T.; Ji, X.; Grant, S. C.; Mattoussi, H.
ACS Nano. 2012, 6, 389–399.
[6] Wu, J.; Zhang, L.; Wang, Y.; Long, Y.; Gao, H.; Zhang, X.; Zhao, N.;
Cai, Y.; Xu, J. Langmuir 2011, 27, 13684–13691.
[7] Nakajima, N.; Ikada, Y. Bioconjugate Chem. 1995, 6, 123–130.
[8] Kaaki, K.; Herve´-Aubert, K.; Chipter, M.; Shkilnyy, A.; Souce´, M.;
Benoit, R.; Paillard, A.; Dubois, P.; Saboungi, M.-L.; Chourpa, I. Langmuir
2012, 28, 1496–1505.
[9] Oh, J.-M.; Choi, S.-J.; Lee, G.-E.; Han, S.-H.; Choy, J.-H. Adv. Funct.
Mater. 2009, 19, 1617–1624.
[10] Zhang, J.; Ranan, S.; Srivastava, R.; Misra, R. Acta Biomater. 2008, 4,
40–48.
[11] Kemikli, N.; Kavas, H.; Kazan, S.; Baykal, A.; Ozturk, R. J. Alloy Compd.
2010, 502, 439–444.
[12] Xie, J.; Xu, C.; Kohler, N.; Hou, Y.; Sun, S. Adv. Mater 2007, 19, 3163–
3166.
207
[13] Hua, M.-Y.; Yang, H.-W.; Chuang, C.-K.; Tsai, R.-Y.; Chen, W.-J.;
Chuang, K.-L.; Chang, Y.-H.; Chuang, H.-C.; Pang, S.-T. Biomaterials.
2010, 31, 7355–7363.
[14] Sun, C.; Du, K.; Fang, C.; Bhattarai, N.; Veiseh, O.; Kievit, F.; Stephen, Z.;
Lee, D.; Ellenbogen, R. G.; Ratner, B.; Zhang, M. ACS Nano. 2010, 4,
2402–2410.
[15] Harris, J. J.; DeRose, P. M.; Bruening, M. L. J. Am. Chem. Soc. 1999, 121,
1978–1979.
[16] Basti, H.; Tahar, L. B.; Smiri, L. S.; Herbst, F.; Vaulay, M.-J.; Chau, F.;
Ammar, S.; Benderbous, S. J. Colloid. Interf. Sci. 2010, 341, 248–254.
[17] Shultz, M. D.; Reveles, J. U.; Khanna, S. N.; Carpenter, E. E. J. Am. Chem.
Soc. 2007, 129, 2482–2487.
[18] Lin, C.-L.; Lee, C.-F.; Chiu, W.-Y. J. Colloid. Interf. Sci. 2005, 291, 411–
420.
[19] Xu, C.; Xu, K.; Gu, H.; Zheng, R.; Liu, H.; Zhang, X.; Guo, Z.; Xu, B. J.
Am. Chem. Soc. 2004, 126, 9938–9939.
[20] A´lvarez-Paino, M.; Marcelo, G.; Munn˜oz-Bonilla, A.; Ferna´ndez-
Garcı´a, M. Macromolecules 2013, 46, 2951–2962.
[21] Faure, E.; Falentin-Daudre´, C.; Je´roˆme, C.; Lyskawa, J.; Fournier, D.;
Woisel, P.; Detrembleur, C. Prog. Polym. Sci. 2013, 38, 236–270.
[22] Fleet, M. E. Acta. Cryst. 1981, B37, 917–920.
[23] Mikhaylova, M.; Kim, D. K.; Bobrysheva, N.; Osmolowsky, M.; Se-
menov, V.; Tsakalakos, T.; Muhammed, M. Langmuir 2004, 20, 2472–
2477.
[24] Mahmoudi, M.; Simchi, A.; Milani, A. S.; Stroeve, P. J. Colloid. Interf. Sci.
2009, 336, 510–518.
208
[25] Cheng, F.-Y.; Su, C.-H.; Yang, Y.-S.; Yeh, C.-S.; Tsai, C.-Y.; Wu, C.-L.;
Wu, M.-T.; Shieh, D.-B. Biomaterials 2005, 26, 729–738.
[26] Morais, P.; Garg, V.; Oliveira, A.; Silva, L.; Azevedo, R.; Silva, A.; Lima, E.
J. Magn. Magn. Mater. 2001, 225, 37–40.
[27] Goya, G. F.; Berquo´, T. S.; Fonseca, F. C.; Morales, M. P. J. Appl. Phys.
2003, 94, 3520–3528.
[28] Zaitsev, V. S.; Filimonov, D. S.; Presnyakov, I. A.; Gambino, R. J.; Chu, B.
J. Colloid Inter. Sci. 1999, 212, 49–57.
[29] Hu, L.; Percheron, A.; Chaumont, D.; Brachais, C.-H. J. Sol-Gel. Sci. Tech-
nol. 2011, 60, 198–205.
[30] Shultz, M. D.; Reveles, J. U.; Khanna, S. N.; Carpenter, E. E. J. Am. Chem.
Soc. 2007, 129, 2482–2487.
[31] Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Elst, L. V.;
Muller, R. N. Chem. Rev. 2008, 108, 2064–2110.
[32] Neuberger, T.; Scho¨pf, B.; Hofmann, H.; Hofmann, M.; Rechenberg, B. V.
J Magn. Magn. Mater. 2005, 293, 483–496.
[33] Arruebo, M.; Ferna´ndez-Pacheco, R.; Ibarra, M. R.; Santamarı´a, J. Nan-
oToday 2007, 2, 22–32.
[34] Cunningham, D.; Littleford, R. E.; Smith, W. E.; Lundahl, P. J.; Khan, I.;
McComb, D. W.; Graham, D.; Laforest, N. Faraday Discuss. 2006, 132,
135–145.
[35] Qu, H.; Caruntu, D.; Liu, H.; OConnor, C. J. Langmuir 2011, 27, 2271–
2278.
[36] Das, M.; Mishra, D.; Dhak, P.; Gupta, S.; Maiti, T. K.; Basak, A.; Pra-
manik, P. Small 2009, 5, 2883–2893.
[37] Zimmermann, F.; Hossenfelder, B.; Panitz, J.-C.; Wokaun, A. J. Phys.
Chem. 1994, 98, 12796–12804.
209
[38] Lagutschenkov, A.; Dopfer, O. J. Mol. Spectrosc. 2011, 30, 2843–2848.
[39] Ladner, S. J.; Becker, R. S. J. Phys. Chem.-US 1963, 67, 2481–2486.
[40] Dey, J.; Haynes III, J. L.; Warner, I. M. J. Phys. Chem. A 1997, 101, 2271–
2278.
[41] Hu, F.; Li, Z.; Tu, C.; Gao, M. J. Colloid. Interf. Sci. 2007, 311, 469–474.
[42] White, E. H.; Roswell, D. F.; Dupont, A. C.; Wilson, A. A. J. Am. Chem.
Soc. 1987, 109, 5189–5196.
[43] Yu, Q.; Wei, Z.-Z.; Li, J.-R.; Hu, T.-L. J. Mol. Struct. 2009, 931, 68–75.
[44] Chen, D.; Jiang, M.; Li, N.; Gu, H.; Xu, Q.; Ge, J.; Xia, X.; Lu, J. J. Mater.
Chem. 2010, 20, 6422–6429.
[45] Mohaptra, S.; Mallick, S. K.; Maiti, T. K.; Ghosh, S. K.; Pramanik, P. Nan-
otechnology 2007, 18, 385102.
[46] Zhang, Z.; Lee, S. H.; Feng, S.-S. Biomaterials 2007, 8, 1889–1899.
[47] Dutta, R. K.; Sharma, P. K.; Pandey, A. C. J. Nanopart. Res. 2010, 12,
11211–1219.
[48] Zhang, C.; Luo, N.; Hirt, D. E. Langmuir 2006, 22, 6851–6857.
[49] Chang, Y.; Liu, N.; Chen, L.; Meng, X.; Liu, Y.; Li, Y.; Wang, J. J. Mater.
Chem. 2012, 22, 9594–9601.
[50] Kohler, N.; Fryxell, G. E.; Zhang, M. J. Am. Chem. Soc. 2004, 126, 7206–
7211.
[51] Maeng, J. H.; Lee, D.-H.; Jung, K. H.; Bae, Y.-H.; Park, I.-S.; Jeong, S.;
Jeon, Y.-S.; Shim, C.-K.; Kim, W.; Kim, J.; Lee, J.; Lee, Y.-M.; Kim, J.-H.;
Kim, W.-H.; Hong, S.-S. Biomaterials 2010, 31, 4995–5006.
[52] Wu, H.; Liu, G.; Zhang, S.; Shi, J.; Zhang, L.; Chen, Y.; Chen, F.; Chen, H.
J. Mater. Chem. 2011, 21, 3037–3045.
210
[53] Lu, T.; Sun, J.; Chen, X.; Zhang, P.; Jing, X. Macromol. Biosci. 2009, 9,
1059–1068.
[54] Zhang, Y.; Kohler, N.; Zhang, M. Biomaterials 2002, 23, 1553–1561.
[55] Wang, Z.; Zhu, J.; Chen, Y.; Geng, K.; Qian, N.; Cheng, L.; Lu, Z.; Pan, Y.;
Guo, L.; Li, Y.; Gu, H. RSC Adv. 2014, 4, 7483–7490.
[56] Majd, M. H.; Asgari, D.; Barar, J.; Valizadeh, H.; Kafil, V.; Coukos, G.;
Omidi, Y. J. Drug. Target. 2013, 21, 328–340.
[57] Kim, D. K.; Zhang, Y.; Voit, W.; Rao, K. V.; Muhammed, M. J Magn. Magn.
Mater. 2001, 225, 30–36.
[58] Corr, S. A.; Gun’ko, Y. K.; Tekoriute, R.; Meledandri, C. J.; Brougham, D. F.
J. Phys. Chem. C 2008, 112, 13324–13327.
[59] Isojima, T.; Lattuada, M.; Sande, J. B. V.; Hatton, T. A. ACS Nano 2008,
2, 1799–1806.
[60] Corr, S. A.; Byrne, S. J.; Tekoriute, R.; Meledandri, C. J.; Brougham, D. F.;
Lynch, M.; Kerskens, C.; O’Dwyer, L.; Gun’ko, Y. K. J. Am. Chem. Soc.
2008, 130, 4214–4215.
[61] Fouineau, J.; Brymora, K.; Ourry, L.; Mammeri, F.; Yaacoub, N.; Cal-
vayrac, F.; Ammar-Merah, S.; Greneche, J.-M. J. Phys. Chem. C 2013,
117, 14295–14302.
[62] Yuen, A. K. L.; Hutton, G. A.; Masters, A. F.; Maschmeyer, T. Dalton Trans.
2012, 41, 2545–2559.
[63] Nagesha, D. K.; Plouffe, B. D.; Phan, M.; Lewis, L. H.; Sridhar, S.;
Murthy, S. K. J. Appl. Phys. 2009, 105, 07B317.
[64] Mazur, M.; Barras, A.; Kuncser, V.; Galatanu, A.; Zaitzev, V.; Turche-
niuk, K. V.; Woisel, P.; Lyskawa, J.; Laure, W.; Siriwardena, A.; Boukher-
roub, R.; Szunerits, S. Nanoscale 2013, 5, 2692–2702.
211
[65] Corato, R. D.; Bigall, N. C.; Ragusa, A.; Dorfs, D.; Genovese, A.;
Marotta, R.; Manna, L.; Pellegrino, T. ACS Nano 2011, 5, 1109–1121.
[66] Lee, G. Y.; Qian, W. P.; Wang, L.; Wang, Y. A.; Staley, C. A.; Satpathy, M.;
Nie, S.; Mao, H.; Yang, L. ACS Nano 2013, 26, 2078–2089.
212
Chapter 7: Conclusions and future work
This thesis presents microwave-assisted routes for preparing magnetic
nanoparticles and nanocomposite materials. The methods presented are fast,
efficient and lead to the production of materials with properties suitable for
biomedical applications, including as contrast agents for MR imaging, for cell
imaging use and as drug-delivery agents.
A new microwave-assisted co-precipitation technique has been developed
which affords highly crystalline magnetic nanoparticles and can be applied to
produce a range of ferrite-based nanomaterials. Traditionally, highly crystalline
magnetic nanoparticles may be obtained through high temperature decom-
position reactions. While effective and controllable, these reactions use or-
ganic surfactants and stabilisers during synthesis, which needs to be removed
via post processing ligand exchange reactions before the particles can be re-
dispersed into aqueous solutions. The microwave heating method detailed
here produces particles with Ms values similar to thermal decomposition routes
(65.2 emu/g Vs. 60-85 emu/g, respectively) but with the added advantage of
reduced reaction times and the possibility of the simultaneous stabilisation of
the particles.
Following on from this, a polyelectrolyte surfactant may also be introduced
to the synthesis to enhance water stability, as shown in Chapter 4. An ad-
vantage of this method is that the synthesis takes place in water, without the
need for additional steps to transfer the nanoparticles from organic to aque-
ous solvents. Iron oxide nanoparticles can be stabilised with hydrophilic poly-
electrolytes during the precipitation reaction, eliminating the need for a sep-
arate post processing and stabilisation step. This co-precipitation approach
has quick synthesis times, which when combined with polyelectrolytes and mi-
crowave irradiation allows for the preparation of highly crystalline water stable
nanoparticles in under an hour. Interestingly, the magnetic properties also de-
pend on the nature of the surfactant employed, with the polyelectrolyte, PSSS
displaying high crystallinity and high Ms values, while the phosphate stabiliser,
SPP leads to an irregular nanoparticle shape, which manifests in lower mag-
netisation saturation values. This water stability coupled with the high crys-
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tallinity from microwave heating made the PSSS-Fe3O4 nanocomposite an ex-
cellent candidate as an MR imaging contrast agent, exceeding other commer-
cial iron oxide based agents. Fluorescent groups, such as the organic dye
Rhodamine B, may also be used during synthesis to bind to the polyelectrolyte
via electrostatic interactions, allowing for confocal imaging use.
The increase in crystallinity of the iron oxide nanoparticles through the use
of microwave-assisted synthesis led to the exploration of a range of polyelec-
trolyte stabilisers and chain lengths, as discussed in Chapter 5. Here, it has
been shown that lower molecular weight polyelectrolytes reduce clustering,
maximise water stability and can form linear assemblies in an external mag-
netic field. Stabilising with highly charged polyelectrolytes also leads to the
formation of these linear assemblies. Either cationic or anionic polyelectrolytes
can be used to stabilise iron oxide nanoparticles, with strong cationic polyelec-
trolytes displaying excellent water stability, as shown by DLS measurements.
The formation of linear assemblies may also affect the MR imaging properties,
as the linear assemblies have a greater surface area to interact with neighbour-
ing protons. Linear assemblies have been explored before in the literature1 but
the advantage of using polyelectrolyte chains is that these assemblies extend
to over a micron in length, further increasing the surface area.
Finally, the functionalisation of these iron oxide nanoparticles, in combi-
nation with polyelectrolyte stabilisers, has been explored through a series of
carbodiimide coupling reactions and dopamine-based linkers. The dopamine
anchor strongly coordinates with the iron oxide nanoparticle surface minimis-
ing the risk of early desorption of the attached species. A range of molecules
including PAA, acridine-9-carboxylic acid and folic acid were bound to the
particle surface, which demonstrates the versatility of this approach. Finally,
a single nanocomposite comprised of PSSS-stabilised iron oxide nanoparti-
cles, prepared using a microwave-assisted approach, was functionalised via
a dopamine surface layer with acridine-9-carboxylic acid to promote fluores-
cence, and folic acid to enhance targeting. The final nanocomposite was ex-
tremely water stable and shown by DLS to be small enough for biological ap-
plications. It is reasonable to expect this nanocomposite to show promise as
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a targeting agent as folic acid is found to specifically target cancerous tissues,
while at the same time the MR imaging potential is retained through PSSS
surface coverage. In this way, a multifunctional single platform has been pre-
pared using microwave-assisted synthetic approaches, with potential uses in
MR imaging, confocal microscopy and drug delivery.
The microwave assisted synthetic route shown here is an excellent method
to obtaining highly crystalline ferrite nanoparticles. Further examination of
MFe2O4 (where M = Mn, Co, Zn) could optimise the magnetic properties of the
core nanoparticles and hence the contrast efficacy. For example, manganese
ferrite has been reported to display greater relaxivity values when compared
with standard iron oxide nanoparticles.2,3 The route to these ferrite nanoparti-
cles could also be further explored, for example the development of the one-pot
co-precipitation reaction using urea as a base which was only briefly tested in
Chapter 3. Development of this approach could further reduce reaction times.
Performing the reaction under reflux could avoid the reaction of the iron oxide
seed particles with carbon dioxide that leads to oxidation and the formation of
hematite.4 By modifying the microwave system, the set up could be altered to
allow for reflux during the microwave heating step.
The examination of different stabilisers in combination with microwave as-
sisted synthesis could also provide new nanocomposites with enhanced ther-
anostic properties. For example, recently the highest relaxivity values for iron
oxide nanoparticles has been reported by Maity et al. who have used tereph-
thalic acid to stabilise iron oxides.5 Terephthalic acid stabilisers improve relax-
ivity values by providing pi-conjugation paths to allow spin transfer from elec-
trons in the magnetic core to the surrounding water molecules. The stabiliser
distributes the charge across a larger group of neighbouring water protons
(compared to more traditional stabilisers) increasing the contrast effect. Using
this stabiliser on microwave assisted co-precipitated nanoparticles can further
increase relaxivity values, as microwave heating will improve the magnetism
of the magnetic core, while the stabiliser will better distribute this enhanced
charge.
One area of potential future work is to further functionalise the iron oxide
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nanoparticles with chemotherapy agents via carbodiimide coupling. There are
a number of candidate chemotherapy agents used in the treatment of tumours
that could be explored, including Paclitaxel,6 Vincristine7 and Doxorubicin.8
Another possibility for cancer treatment is the attachment of photosensitive
molecules to the nanoparticle surface for photodynamic therapy. Photody-
namic therapy works by exciting photosensitive groups leading to the formation
of free radicals.9 The free radicals are unstable and destroy nearby cells, which
when dispersed in cancerous cells can be an effective treatment. Unwanted
distribution of the chemotherapy drugs and photosensitive groups in healthy
cells is a concern but the targeting functionality of the nanocomposite would
ensure that only cancerous cells would be attacked.
To conclude, the synthetic methods presented in this thesis detail a highly
flexible route to extremely crystalline iron oxide nanoparticles that display ex-
cellent water stability and are capable of being further functionalised with lu-
minescent and targeting groups. This work highlights the importance of mi-
crowave irradiation and polyelectrolyte stabilisers in the construction of mag-
netic nanocomposites. Use of carbodiimide coupling and dopamine coatings
allows a wide range of materials to be bound to the composite by a strong
amide bond further adding to the potential applications of the nanocompos-
ite. This work not only gives a simple and reliable method for the preparation
of multifunctional nanocomposites for use in biomedical applications, but also
presents an easily modifiable foundation that can be further enhanced for can-
cer diagnosis and treatment.
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